CX 2019: Programme Guide

Vascular & Endovascular

Challenges Update 15–18 APRIL 2019 MONDAY–THURSDAY OLYMPIA GRAND • LONDON • UNITED KINGDOM

Aortic Challenges

Peripheral Arterial Challenges

Venous & Lymphatic Challenges

Acute Stroke Challenges

Vascular Access Challenges

and introducing

Programme

EDUCATION

INNOVATION EVIDENCE

www.cxsymposium.com

Vascular & Endovascular Challenges Update

CX Pick Up Point Delegate bags

Book & Bag Stand

CX Book pick up point Book & Bag Stand

Pavilion Sponsors

CX Programme – Slim Jim Book & Bag Stand

Cook Medical

140

Gore

Endologix

155

Medtronic

450

Getinge

170

Terumo Aortic

240

BD

428

Merit Medical

470

Bentley

419

Philips

444

Boston Scientific

228

RD GLOBAL

238

Cydar Medical

229

Siemens Healthineers

150

JOTEC - CryoLife

440

Straub Medical

418

Lombard Medical

432

Major Sponsors

Exhibitors

250/260

3D Systems Simbionix

315

BTG

212

Abbott Vascular

232

C3 interventional Academy

501

Advanced Oxygen Therapy Inc

138

CACVS / i-MEET /DIVINE ID

118

ALN Implants Chirurgicaux

122

Cardionovum

716

AndraTec

712

CIRSE

644

Aortic Association

710

Clinlogix

736

Avenu Medical

734

Concept Medical

401

BALTON SP. Z.O.O.

304

Corindus

400

BIBA Medtech Insights

110

Edinburgh Surgery Online

135

Biotronik

402

Edizioni Minerva Medica

646

Upper Main Auditorium Accessable via Staircase

CX Poster Gallery

CX Vascular Access Workshop

648

470

450

646

444

644

An Introduction to Vascular Surgery

440

428

533

538

432

438

Entrance to Lower Main

CX Aortic Workshop

523

424

Stairs to Gallery and

Auditorium

Upper Main Auditorium

250

260

240 Catering

Stairs to Gallery and Upper Main Auditorium

155

150

140

238

229

232

170 124 137

Entrance to

138

135 136

132

134

Lower Main Auditorium

10 2019

Ground Floor

131

9

Edwards Lifesciences

137

optimed

404

ESVS

114

Orbus Neich

505

Evarplanning

132

Penumbra

412

EVC

213

Pie Medical Imaging

538

EVF

117

Piur Imaging

215

EVT

119

R&D Surgical

720

F Care Systems

116

Ra Medical Systems

509

Firstkind

131

Regen Medical

124

Fist Assist Devices

718

Scanlan International

211

GE Healthcare

311

Shockwave Medical

424

H&R Healthcare

308

SITE

501

Huntleigh

209

Therenva

533

Intact Vascular

408

Vascular News

110

Laminate Medical

409

Legs Matter

136

Vascular Society and Circulation Foundation 207

Lifetech Scientific

523

LimFlow

714

LINC

648

LSO Medical

220

Medi

217

Micro Medical solutions

738

Mรถlnlycke

134

Nanjing ECO Microwave

208

Venclose

112

Venous News

110

VentureMed

732

Veryan Medical

438

Vivasure Medical

317

Walk Vascular

113

Wisepress Medical Bookshop

725

Ziehm Imaging

223

Stairs to Gallery Suite & Dark Room Learning Centres

Pillar Hall Learning Centre

Gallery Suite Learning Centre

CX Peripheral Workshop

738

Catering

418

Speaker Ready Room

736

Faculty Lounge

Dark Room Learning Centre

Gallery Suite & Dark Room Learning Centres Situated on the Gallery level above the Olympia Room

734

509

505

412

408

401 404

501

732

402

419

409

Faculty Registration

304

308

228

317

315

220

212

Book & Bag

311

Registration

208 725 720

718

223

217

215

211

209

207 122

119 118 117

116

114 113

110 BIBAMedTech Insights

213

716

714

712

710

112

CX Venous City (Workshop & Edited Cases)

London Room Learning Centre

Entrance

400

Plan your Symposium experience with the CX web-app

Browse the programmes Add sessions to your personal agenda Take part in live polling Network with fellow delegates View exhibitors Floorplan News

cx2019app.com

Get involved!

How to get this year’s CX web-app: Log on to our Free WiFi WiFi: CX Symposium Password: CXSymposium2019 You’ll be automatically redirected to cx2019app.com

Simply sign in - no need to download any apps!

Activate your profile now!

Make the most of your time at CX - Visit cx2019app.com to activate your profile

SPONSORED BY EDUCATION

INNOVATION EVIDENCE

Vascular & Endovascular Challenges Update

CX Executive Board Aortic

Dittmar Böckler

Professor of

Stéphan Haulon

Professor of

Vascular Surgery at University of Heidelberg and Head of Department of Vascular Surgery and Endovascular Surgery at University Hospital Heidelberg, Heidelberg, Germany

Vascular Surgery, Université Paris Sud, Hôpital Marie Lannelongue, Le Plessis Robinson, France

Tilo Kölbel

rofessor of Vascular Surgery, University of Hamburg, and Vascular P Surgeon at the University Heart Center Hamburg, Hamburg, Germany

Peripheral Arterial

Andrew Holden

Associate Professor of

Gunnar Tepe

Head of

Thomas Zeller

Professor of

Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand

Diagnostic and Interventional Radiology, RoMed Clinic, Rosenheim, Germany

Angiology at Albert-Ludwigs University of Freiburg and Head of Department of Angiology at Universitäts – Herzzentrum Freiburg, Bad Krozingen, Germany

Venous & Lymphatic

Stephen Black

onsultant Vascular Surgeon at Guy’s and St Thomas’ Hospital, London, C UK and Reader in Venous Surgery at Kings College London

Manj Gohel

onsultant Vascular & Endovascular Surgeon, Addenbrooke’s Hospital, C Cambridge, UK, and Honorary Senior Lecturer, Department of Surgery and Cancer, Imperial College London, London, UK

Acute Stroke

Hugh Markus

rofessor of Stroke Medicine, Honorary Consultant Neurologist, University P of Cambridge, Cambridge, UK

Barbara Rantner

ssociate Professor of Surgery, Medical University Innsbruck, Deputy Director, A Department of Vascular Surgery, University Hospital Innsbruck, Innsbruck, Austria

Vascular Access

Nicholas Inston

Consultant Surgeon and Clinical Lead for Renal Surgery and Transplantation at Queen Elizabeth Hospital Birmingham, Birmingham, UK

Domenico Valenti

Consultant Vascular Surgeon and Honorary Senior Lecturer at King’s College London, London, UK

2019

Vascular Malformations

Krassi Ivancev

Department of Vascular Medicine, University Hospital HamburgEppendorf, Hamburg, Germany; Honorary Professor, Division of Surgery

Fiona Rohlffs

Department of Vascular Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany & Interventional Sciences, Faculty of Medical

Sciences, University College London, London, UK

iWounds

Michael Edmonds

Professor of

Keith Harding

Professor of

Una Adderley

Director, National Wound Care Strategy Programme (NHS England),

Diabetic Foot Medicine and Consultant Diabetologist at King’s College Hospital, London, UK

Wound Healing Research, School of Medicine, Cardiff University, Cardiff, UK

Academic Health Science Network and University of Leeds, Leeds, UK

CX Advisory Board

Frans Moll (Chairman)

Professor of

Vascular Surgery at University Medical Center Utrecht, Utrecht, Netherlands

Peripheral Arterial

Cliff Shearman

Emeritus Professor of Vascular Surgery, University of Southampton and NonExecutive Director, Royal Bournemouth and Christchurch NHS Foundation Trust

Giovanni Torsello

Professor, Chief

of the Department of Vascular Surgery at Franziskus Hospital, MĂźnster, Germany

Trevor Cleveland

Consultant Vascular Radiologist and Honorary Senior Lecturer at Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Robert Hinchliffe

rofessor of Vascular Surgery at University of Bristol and Vascular Surgeon P at North Bristol NHS Trust, Bristol, UK

Aortic

Frank Vermassen

Professor in Vascular and Thoracic Surgery Department of

Vascular

Surgery at Ghent University Hospital, Ghent, Belgium

Janet Powell

Professor of Vascular Biology and Medicine, Imperial College London, London, UK

Eric Verhoeven

hief, University Department of Vascular and Endovascular Surgery, C Paracelsus Medical University, General Hospital Nuremberg, Nuremberg, Germany

Venous & Lymphatic

Alun Davies

rofessor of Vascular Surgery, Head of Section of Vascular Surgery, Imperial P College London and Consultant Surgeon at Imperial College NHS Trust, Charing Cross Hospital and St Mary’s Hospital, London, UK

Gerard O’Sullivan

Consultant Interventional Radiologist, Galway University Hospitals, Galway, Ireland

Claudine Hamel-Desnos

ascular Physician, Hôpital Privé Saint-Martin, Caen, France, and President of V the French Society of Phlebology

Peter Mortimer

rofessor of Dermatological Medicine, Consultant Dermatologist, St George’s, P University of London, London, UK

Acute Stroke

Ross Naylor

Honorary Professor of

Vascular Surgery at University of Leicester and Consultant Vascular Surgeon at Leicester Royal Infirmary, Leicester, UK

Recruitment to Vascular Management

Armando Mansilha

Professor of Angiology and Vascular Surgery, Faculty of

Medicine at the University of Porto, Porto, Portugal, and Secretary General, UEMS Section and Board of Vascular Surgery

Sophie Renton

Consultant Vascular Surgeon at Northwick Park Hospital, Honorary Senior Lecturer for Imperial College London, London, UK, and Honorary Secretary, The Vascular Society for Great Britain and Ireland

CX Abstract Board Meryl Davis (Chair) Colin Bicknell

Paul Moxey

Daryll Baker

Marcus Brooks

Anna Prent

Rachel Bell

Robert Hinchliffe

Celia Riga

10:00-10:30

09:15 09:30 09:45

10:00-10:30

09:15 09:30 09:45

COFFEE BREAK

allenges – p22

edited cases) – p30

– p36

10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15

1

10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15

Medtronic Symposium – p22

Peripheral Proximal Arterial Ischaemia Challenges – p23

RD Global Symposium – p112

Venous & Lymphatic Challenges – p25

Gore Symposium – p30

● CX Aortic Techniques & Technologies (edited cases) – p30 CEC@CX – p31

Rising Stars and

ing Stars and Abstract

1

● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p41 ● CX Acute Stroke Abstract Presentations – p36 ● CX Peripheral Workshop – Day 1 – p34 ● CX Aortic Workshop – Day 1 – p33 ● CX Acute Stroke Selected Posters Presentations – p44

09:15 09:30 09:45

● Peripheral T&T – p58

COFFEE BREAK

●

10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15

Gore Symposium – p52

Abdominal Aortic Challenges – p53

Intact Vascular Symposium – p58

● CX Peripheral Techniques & Technologies (live & edited cases) – p59 ● CX Vascular Access Masterclass – p62 iWounds – p65

Rising Stars and

s and

● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p71 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 2 – p75 ● Venous T&T (edited cases) – ● CX Venous Workshop – Day 1 – p60 Day 1 – p60 ● CX Peripheral Workshop – Day 2 – p68 ● CX Aortic Workshop – Day 2 – p67

●

09:15 09:30 09:45

p87

COFFEE BREAK

10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15

Terumo Aortic Symposium – p84

Thoracic Aortic Challenges – p84

Cook Medical Symposium – p87

Peripheral Arterial Podium 1st Session – p88

C3@CX – p92

● ● ● ● CX Innovation Showcase – p92

ions – p104

● CX Abdominal Aortic Abstract Presentations – p105

Prize Session – p99

European Vascular Surgeons in Training – Prize Session – p99

s and

● CX Peripheral Abstract Presentations – Day 3 – p100 ● Venous T&T (edited cases) – ● CX Venous Workshop – Day 2 – p95 Day 2 – p95 CX iWounds Workshop – Day 2 – p98

● CX Vasc. Access T&T ● CX Vascular Access Workshop – p97 (edited cases) – p97

●

12:30-13:00

13:00-13:30

12:30-13:00 13:00 13:15 13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Acute Stroke Challenges – p16

LUNCH BREAK Philips Symposium – p23

13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Peripheral Proximal Arterial Ischaemia Challenges – p23 Venous & Lymphatic Challenges – p26 ● CX Aortic Techniques & Technologies (edited cases) – p31 ● ● CX Meets Latin America – p32 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p41 ● CX Vascular Access Abstract Presentations – p42

CX Vascular Access Selected Posters Presentations – p45

● CX Venous Selected Posters Presentations – p46

LUNCH BREAK Getinge Symposium – p53

BD Symposium – p63

13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Abdominal Aortic Challenges – p53 ● CX Peripheral Techniques & Technologies (live & edited cases) – p59 ● CX Vascular Access Masterclass – p63 CX Vascular Malformations – p65

● Interactive Cases – p60

● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p71 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 2 – p75 ● CX Venous Workshop – Day 1 – p60

CX iWounds Workshop – p69

● CX Peripheral Arterial Selected Posters – p76

LUNCH BREAK

Medtronic Symposium – p85

13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Thoracic Aortic Challenges – p85 Peripheral Critical Ischaemia Challenges – p88

MDR Symposium – p93

● ● ● ● CX Innovation Showcase – p93 ● CX Abdominal Aortic Abstract Presentations – p105

● CX Peripheral Abstract Presentations – Day 3 – p101 ● CX Venous Workshop – Day 2 – p95 ● Interactive Cases – p95

● CX Aortic Selected Posters Presentations – p107

2019 15:30-16:00 TEA BREAK TEA BREAK Gore Symposium – p24

16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Acute Stroke Challenges – p16

16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Peripheral Proximal Arterial Ischaemia Challenges – p24 Venous & Lymphatic Challenges – p26 ● CX Aortic Techniques & Technologies (edited cases) – p31 ● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 – p38 ● CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p39 ● CX Vascular Access Abstract Presentations – p43

TEA BREAK

16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00

Terumo Aortic Symposium – p54

Abdominal Aortic Challenges – p54

BD Symposium – p59

● CX Peripheral Techniques & Technologies – p59 ● CX Vascular Access Masterclass – p64 CX Vascular Malformations – p66 ● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p72 ● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 – p74

TEA BREAK

16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Thoracic Aortic Challenges – p86 Peripheral Critical Ischaemia Challenges – p89 ● ● ● ● CX Innovation Showcase – p94 ● CX Abdominal Aortic Abstract Presentations – p106

● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2 – p103

Vascular & Endovascular Challenges Update

Faculty Said Abisi, London, UK

Laurence Boon, Brussels, Belgium

Una Adderley, Wakefield, UK

Roshan Bootun, London, UK

Naseer Ahmad, Manchester, UK

Denis Borsuk, Chelyabinsk, Russia

Thomas Albrecht, Berlin, Germany

Dave Bosanquet, Cardiff, UK

Graeme Ambler, Bristol, United Kingdom

Marc Bosiers, Dendermonde, Belgium

Max Amor, Essey-les-Nancy, France

Kursat Bozkurt, Istanbul, Turkey

Konstantin Andreychuk, St Petersburg, Russia Andrew Bradbury, Birmingham, UK Gary Ansel, Columbus, United States

Daniela Branzan, Leipzig, Germany

Michele Antonello, Padua, Italy

Vincenzo Brizzi, Bordeaux, France

Petra Apell, Gothenburg, Sweden

Marianne Brodmann, Graz, Austria

Frank Arko, Charlotte, United States

Jocelyn Brookes, London, UK

John Aruny, New Haven, United States

Ali Baran Budak, Ankara, Turkey

Enrico Ascher, New York, United States

Bao Bui, Sherbrooke, Canada

Mohammed Aslam, London, UK

Nick Burfitt, London, UK

Leanne Atkins, Wakefield, UK

Luke Burke, Eindhoven, The Netherlands

Robert Attaran, Guilford, United States

Mark Burket, Toledo, United States

Martin Austermann, Münster, Germany

Jacques Busquet, Paris St Cloud, France

Domenico Baccellieri, Milan, Italy

Tom Carrell, Barrington, UK

Charles Bailey, San Antonio, United States

Mohamed Cassim, Nawala, Sri Lanka

Daryll Baker, London, UK

Guilherme Centofanti, São Paulo, Brazil

Nilesh Balar, Bronx, United States

Rabih Chaer, Pittsburgh, United States

Tibor Balazs, Bratislava, Slovakia

Yiu Che Chan, Hong Kong

Matteo Barattini, La Spezia, Italy

Sylvain Chastanet, Nice, France

Alex Barnacle, London, UK

Suk Fun (Amanda) Cheng, London, UK

Gareth Bate, Solihull, UK

Mikhail Chernyavskiy, St Petersburg, Russia

Jonathan Beard, Sheffield, UK

Ian Chetter, Hull, UK

Robert Beasley, Miami, United States

Roberto Chiesa, Milan, Italy

Jean-Pierre Becquemin, Champi-

Edward Choke, Singapore

gny-sur-Marne, France

Amine Chouiter, Neuchatel, Switzerland

Rachel Bell, London, UK

Joo-Young Chun, London, UK

Viony Belvroy, Houston, United States

Timothy Clark, Philadelphia, United States

Ruth Benson, Birmingham, UK

Trevor Cleveland, Sheffield, UK

Xavier Berard, Bordeaux, France

Andrew Clifton, London, UK

Luca Bertoglio, Milan, Italy

Rachel Clough, London, UK

Giancarlo Biamino, Mercogliano, Italy

Andreia Coelho, Porto, Portugal

Colin Bicknell, London, UK

Fiona Collins, Eastbourne, UK

Theodosios Bisdas, Athens, Greece

Jason Constantinou, London, UK

Martin Björck, Uppsala, Sweden

Michael Conte, San Francisco, United States

Patrick Bjorkman, Helsinki, Finland

Colette Cook, Wrexham, UK

Stephen Black, London, UK

Raphael Coscas, Boulogne-Billancourt, France

Dittmar Böckler, Heidelberg, Germany

Frank Criado, Baltimore, United States

2019

1

Vascular & Endovascular Challenges Update Csaba Csobay Novák, Budapest, Hungary Martin Czerny, Freiburg, Germany Michael Dake, Tucson, United States Ronald Dalman, Stanford, United States Clement Darling III, Albany, United States Saroj Das, Uxbridge, UK Rajesh Dave, Memphis, United States Alun Davies, London, UK Huw Davies, Birmingham, UK Meryl Davis, London, UK Gianmarco de Donato, Siena, Italy Rick de Graaf, Friedrichshafen, Germany Jean-Paul de Vries, Groningen, Netherlands Colin Deane, London, UK David Deaton, New York, United States Sebastian Debus, Hamburg, Germany Jon Deeks, Birmingham, UK Sapan Desai, Chicago, United States Celine Deslarzes-Dubuis, Stanford, United States

Brahman Dharmarajah, London, UK Lucas Marcelo Dias Freire, Campinas, Brazil Henrik Djerf, Gothenburg, Sweden Konstantinos Donas, Münster, Germany Walter Dorigo, Florence, Italy Steven Dubenec, Sydney, Australia Eric Ducasse, Bordeaux, France Mert Dumantepe, Istanbul, Turkey Sue Duval, Minneapolis, United States Hans-Henning Eckstein, Munich, Germany Michael Edmonds, London, UK Alan Edwards, Ruthin, UK Salma El Batti, Paris, France Ahmed Eleshra, Hamburg, Germany Steve Elias, Englewood, United States Mary Ellis, London, UK William Ennis, Oak Lawn, United States David Epstein, Granada, Spain Ignacio Escotto Sánchez, Mexico City, Mexico

Dominique Fabre, Le Plessis Robinson, France Marten Falkenberg, Gothenburg, Sweden Fabrizio Fanelli, Florence, Italy

2

2019

Jorge Fernández Noya, Santiago de Compostela, Spain

Roberto Ferraresi, Milan, Italy Luis Mariano Ferreira, Buenos Aires, Argentina

Ciro Ferrer, Roma, Italy Mark Field, Warrington, UK Melanie Field, Birmingham, UK Aloke Finn, Gaithersburg, United States Edmund Fitzgerald O'Connor, London, UK Louis Fligelstone, Swansea, UK Alexander Flor, Vienna, Austria Robert Frykberg, Phoenix, United States Gregory Fulton, Wilton, Ireland Luiz Furuya, São Paulo, Brazil Shawn Gage, Raleigh, United States Giambattista Gagliardo, Palermo, Italy Peter Gaines, Sheffield, UK Sidnei Galego, São Paulo, Brazil Raghvinder Gambhir, Chessington, UK Frances Game, Derby, UK Margaret Gardner, Ashtead, UK Mauro Gargiulo, Bologna, Italy Fredrik Gellerstedt, Goteborg, Sweden Patrick Geraghty, St Louis, United States Sergio Gianesini, Ferrara, Italy Athanasios Giannoukas, Larissa, Greece Paul Gibbs, Portsmouth, UK Richard Gibbs, London, UK Kathleen Gibson, Bellevue, United States Leeying Giet, London, UK James Gilbert, Oxford, UK Asimakis Gkremoutis, London, UK Manj Gohel, Cambridge, UK Alejandro Jose Gonzalez Ochoa, St Loius, Mexico

Yann Goueffic, Nantes, France David Gray, Eastbourne, UK Roger Greenhalgh, London, UK Stephen Greenhalgh, London, UK David Greenstein, London, UK Franco Grego, Padua, Italy Aina Greig, London, UK

Vascular & Endovascular Challenges Update Guillaume Guimbretiere, Nantes, France

Gurdeep Jandu, Bolton, UK

Nalaka Gunawansa, Colombo, Sri Lanka

Yee Jia Ng, Singapore

Daqiao Guo, Shanghai, China

Qizhuang Jin, Beijing, China

Wei Guo, Beijing, China

Oscar Johnson, London, UK

Adam Gwozdz, London, UK

Robert Jones, Birmingham, UK

Alison Halliday, Oxford, UK

William Jordan, Atlanta, United States

Claudine Hamel-Desnos, Caen, France

Matthieu Josnin, La Roche-sur-Yon, France

Keith Harding, Cardiff, UK

Jeffrey Jump, Mont-sur-Rolle, Switzerland

David Hargroves, Kent, UK

Michal Juszynski, Warsaw, Poland

Olivier Hartung, Marseille, France

Victor Kalinin, Nyagan, Russia

Stéphan Haulon, Le Plessis Robinson, France Gido Karges, Wangs, Switzerland Paul Hayes, Cambridge, UK

Achilleas Karkamanis, Uppsala, Sweden

Robin Heijmen, Nieuwegein, Netherlands

Narayan Karunanithy, London, UK

Thomas Heller, Rostock, Germany

Nikolaos Karydis, London, UK

Hans Henkes, Stuttgart, Germany

Konstantinos Katsanos, Patras, Greece

Adrien Hertault, Lille, France

Maria Katsarou, Milan, Italy

Jan Heyligers, Tilburg, Netherlands

Barry Katzen, Miami, United States

Phil Hickman, London, UK

Venu Kavarthapu, London, UK

Emily Hillier, London, UK

Narendra Nath Khanna, New Delhi, India

Robert Hinchliffe, Bristol, UK

Aurangzaib Khawaja, Birmingham, UK

Jade Hiramoto, San Francisco, United States

Mahine Kashi-Dakhil, Nanterre, France

Andrew Holden, Auckland, New Zealand

Neil Khilnani, New York, United States

Peter Holt, London, UK

Lois Kim, Cambridge, UK

Nick Hopkins, Buffalo, United States

David Kingsmore, Glasgow, UK

Adam Howard, Lamarsh Bures, UK

Panagiotis Kitrou, Patras, Greece

Dominic Howard, Oxford, UK

Sanne Klaphake, Rotterdam, Netherlands

York Hsiang, Vancouver, Canada

Christoph Knappich, Munich, Germany

Wen Hsien Hsu, Taipei, Taiwan

Tilo Kölbel, Hamburg, Germany

Jeffrey Hull, North Chesterfield, United States

Raghu Kolluri, Columbus, United States

Katie Hurst, Oxford, UK

Ralf Kolvenbach, Düsseldorf, Germany

Pavel Ignatenko, Novosibirsk, Russia

Ahmed Koshty, Siegen, Germany

Osamu Iida, Amagasaki, Japan

Jan Kovac, Leicester, UK

Karl Illig, Tampa, United States

Mario Lachat, Hinteregg, Switzerland

Nicholas Inston, Birmingham, UK

Elena Ladich, Hollywood, United States

Fatih Islamoglu, Bornova, Turkey

Alexander Lamprou, Groningen, Netherlands

Osama Ismail, Sohag, Egypt

Tristan Lane, London, UK

Sriram Iyer, Cresskill, United States

John Lantis, New York, United States

Krassi Ivancev, Hamburg, Germany

Christopher Lattimer, London, UK

Ounali Jaffer, Walton on Thames, UK

Regent Lee, Headington, UK

Usman Jaffer, London, UK

Matt Lemay, Boston, United States

Heinz Jakob, Essen, Germany

Sandro Lepidi, Padua, Italy

Houman Jalaie, Aachen, Germany

Qingle Li, Beijing, China

2019

3

Vascular & Endovascular Challenges Update Michael Lichtenberg, Arnsberg, Germany

Samuel Money, Phoenix, United States

Thomas Liebig, Munich, Germany

Hayley Moore, London, UK

Francesco Liistro, Arezzo, Italy

Randy Moore, Chestermere, Canada

Patrick Lintott, High Wycombe, UK

Robert Morgan, London, UK

Magnus Löndahl, Lund, Sweden

Sean Morris, Missouri City, United States

Lars Lönn, Copenhagen, Denmark

Nick Morrison, Scottsdale, United States

Hassan Lotfy, Alexandria, Egypt

Peter Mortimer, London, UK

Nicolas Louis, Créteil, France

Paul Moxey, London, UK

Ioannis Loukopoulos, London, UK

Alberto Muñoz, Bogotá, Colombia

Xinwu Lu, Shanghai, China

Erin Murphy, Charlotte, United States

Alan Lumsden, Houston, United States

Kieran Murphy, Toronto, Canada

Lindsay Machan, Vancouver, Canada

David Murray, Altrincham, UK

Michel Makaroun, Pittsburgh, United States

Mari Murumets, London, UK

Chris Malaisrie, Chicago, United States

Ahmed Naga, Alexandria, Egypt

Alexandros Mallios, Paris, France

Sriram Narayanan, Singapore

Martin Malina, London, UK

Ross Naylor, Leicester, UK

Misti Malone, Silver Spring, United States

Oskar Nelzen, Linköping, Sweden

Kevin Mani, Uppsala, Sweden

Yii Jia Ng, Singapore

Armando Mansilha, Porto, Portugal

Elias Noory, Bad Krozingen, Germany

Hugh Markus, Cambridge, UK

Isaac Nyamekye, Worcester, UK

John Martin, Annapolis, United States

Gerard O’Sullivan, Galway, Ireland

Kenta Masada, Osaka, Japan

Alfred Obermayer, Vienna, Austria

Tara Mastracci, London, UK

Gustavo Oderich, Rochester, United States

Susan Matthews, Oldham, UK

Thomas O'Donnell, Boston, United States

Francis Matthey, London, UK

Baris Ata Ozdemir, Bristol, UK

Erica Mayer, Boston, United States

Luis Mariano Palena, Abano Terme, Italy

Blandine Maurel, Nantes, France

Gustavo Paludetto Oliveira, Brasília, Brazil

Ian McCafferty, Birmingham, UK

Giuseppe Panuccio, Hamburg, Germany

Charles McCollum, Manchester, UK

Juan Esteban Paolini, Caba, Argentina

Richard McWilliams, Liverpool, UK

Rajiv Parakh, Gurgaon, India

Andrea Melloni, Milan, Italy

Insoo Park, Seoul, South Korea

Erica Menegatti, Ferrara, Italy

Daniel Patel, Daytona Beach, United States

Matthew Metcalfe, Stevenage, UK

Lorenzo Patrone, London, UK

Claude Mialhe, Monaco, Monaco

Chloé Peters, Breda, Netherlands

Jonathan Michaels, Sheffield, UK

Peter Phillips, Didcot, UK

Nicola Milburn, London, UK

Michele Piazza, Padua, Italy

Rene Milleret, Montpellier, France

Olivier Pichot, Grenoble, France

Aleem Mirza, Rochester, United States

Paul Pittaluga, Monaco

Hiren Mistry, London, UK

Mark Portou, London, UK

Bob Mitchell, Irvine, United States

Janet Powell, London, UK

Bijan Modarai, London, UK

Anna Prent, London, UK

Frans Moll, Utrecht, Netherlands

Robert Michal Proczka, Warsaw, Poland

4

2019

Vascular & Endovascular Challenges Update Phillip Puckridge, Marion, Australia

Guerkan Sengoelge, Vienna, Austria

Nadeem Qazi, London, UK

Tomas Serena, Warren, United States

Annette Quinn, London, UK

Carlo Setacci, Siena, Italy

Tarek Radwan, Cairo, Egypt

Nicla Settembre, Nancy, France

Johann Christoph Ragg, Berlin, Germany

Joseph Shalhoub, London, UK

Harishankar Ramachandran Nair,

Cliff Shearman, Southampton, UK

Trivandrum, India

ZhenYu Shi, Shanghai, China

Marta Ramirez Ortega, Madrid, Spain

Cynthia Shortell, Durham, United States

Christos Rammos, Essen, Germany

Daniel Shoukier, Zurich, Switzerland

Hazel Randall, London, UK

Chang Shu, Beijing, China

Barbara Rantner, Innsbruck, Austria

CJJM Sikkink, Bemmel, Netherlands

Hema Rao, London, UK

Henrik Sillesen, Copenhagen, Denmark

Vikram Ravikumar, New York, United States

Mitchell Silver, Columbus, United States

Sudip Ray, London, UK

Chung Sim Lim, London, UK

Álvaro Razuk, São Paulo, Brazil

Tej Singh, Los Altos Hills, United States

Michel Reijnen, Arnhem, Netherlands

Ravinder Singh-Ranger, Swindon, UK

Sophie Renton, London, UK

Aine Smalley, Santa Rosa, United States

Timothy Resch, Malmö, Sweden

Kim Smolderen, Kansas City, United States

Robert Rhee, New York, United States

Ronald Solar, San Diego, United States

Vincent Riambau, Barcelona, Spain

Kate Sommerville, London, UK

Celia Riga, London, UK

Peter Sotonyi, Budapest, Hungary

Steven Rogers, Manchester, UK

Paolo Spada, Milan, Italy

Fiona Rohlffs, Hamburg, Germany

Matjaz Span, Izola, Slovenia

Teresa Rola, London, UK

Konstantinos Spanos, Larissa, Greece

Dmitrii Rosukhovskii, St Petersburg, Russia

Ulrich Speck, Berlin, Germany

Ulrich Rother, Erlangen, Germany

Francesco Squizzato, Padova, Italy

Maria Antonella Ruffino, Turin, Italy

Gerry Stansby, Newcastle-upon-Tyne, UK

Javier Ruiz Aburto, Ponce, United States

Julie Stanton, Eastbourne, UK

Bartosz Rylski, Freiburg, Germany

Konstantinos Stavroulakis, Münster,

Nirvana Sadaghianloo, Nice, France

Germany

Prakash Saha, London, UK

Kate Steiner, Stevenage, UK

Simone Salvati, Milan, Italy

Tobias Steinke, Dusseldorf, Germany

Sandip Sarkar, London, UK

Sofia Stromberg, Gothenborg, Sweden

Dierk Scheinert, Leipzig, Germany

Timothy Sullivan, Minneapolis, United States

Bruno Scheller, Homburg/Saar, Germany

Jakob Susteric, Ljubljana, Slovenia

Marc Schermerhorn, Boston, United States

Attila Szabo, Budapest, Hungary

Andrej Schmidt, Leipzig, Germany

Michael Tal, Tel Aviv, Israel

Thomas Schmitz-Rixen, Frankfurt, Germany

Chas Taylor, Horsham, UK

Peter Schneider, Honolulu, United States

Rex Teeslink, Augusta, United States

Arne Schwindt, Münster, Germany

Gunnar Tepe, Rosenheim, Germany

Eric Secemsky, Boston, United States

Joerg Tessarek, Lingen, Germany

Roshan Rodney Sengodan, Coimbatore,

Bill Tettelbach, Marietta, United States

India

Sarah Thomis, Leuven, Belgium

2019

5

Vascular & Endovascular Challenges Update John Thompson, Exeter, UK

Ido Weinberg, Boston, United States

Matt Thompson, Irvine, United States

Martin Werner, Vienna, Austria

Narayanan Thulasidasan, London, UK

Rodney White, Torrance, United States

Ignace Tielliu, Groningen, Netherlands

Arno Wiersema, Amsterdam, Netherlands

Michael Tones, St Louis, United States

Jason Wilkins, London, UK

Giovanni Torsello, MĂźnster, Germany

Angela Williams, London, UK

Matteo Tozzi, Varese, Italy

Leith Williams, Liverpool, UK

Matthias Trenner, Munich, Germany

Teun Wilmink, Birmingham, UK

Santi Trimarchi, Milan, Italy

Emma Wilton, Oxford, UK

Konstantinos Tsagakis, Essen, Germany

Willem Wisselink, Amsterdam, Netherlands

Pavlos Tsantilas, Munich, Germany

Cees Wittens, Maastricht, Netherlands

Nikolaos Tsilimparis, Munich, Germany

Walter Wohlgemuth, Regensburg, Germany

Karen Tullett, Birmingham, UK

Rochelle Wolfe, Minneapolis, United States

Chris Twine, Cowbridge, UK

Weiwei Wu, Beijing, China

Jean-Francois Uhl, Paris, France

Wayne Yakes, Englewood, United States

Domenico Valenti, London, UK

Dai Yamanouchi, Madison, United States

Sjef van Baal, Almelo, Netherlands

Yaoguo Yang, Beijing, China

Jos van den Berg, Lugano, Switzerland

Halit Yerebakan, Istanbul, Turkey

Joost van Herwaarden, Utrecht, Netherlands

Kak Khee Yeung, Amsterdam, Netherlands

Maarit Venermo, Helsinki, Finland

Derek Young, Dublin, Ireland

Hence Verhagen, Rotterdam, Netherlands

Zhengya Yu, Beijing, China

Eric Verhoeven, Nuremberg, Germany

Jianing Yue, Shanghai, China

Frank Vermassen, Ghent, Belgium

Yoel Zabar, Rehovot, Israel

Fabio Verzini, Turin, Italy

Nicholas Zakikhani, London, UK

Harry Voesten, Drachten, Netherlands

Hany Zayed, London, UK

Robert Vogelzang, Chicago, United States

Thomas Zeller, Bad Krozingen, Germany

Sheng Wang, Beijing, China

Tomasz Zubilewicz, Lublin, Poland

Saima Waseem, Bexleyheath, UK Haimanot Wasse, Chicago, United States

Contents CX Executive Board, CX Advisory Board and CX Abstract Board Faculty Opening times Internet access Programme index Sponsors CME Exhibitors New products at CX 2019 Travel connections and hotels CX timetable Floorplan

6

2019

Cover 1 8 8 9–11 122 123 124 128 130 136 Back cover

Vascular & Endovascular Challenges Update

Welcome to CX 2019!

The Charing Cross International Symposium (CX) continues its three-year cycle of raising vascular and endovascular controversies in order to challenge the available evidence and be able to reach a consensus after discussion with an expert audience. CX 2019 focuses on CHALLENGES. The four-day programme starts on Monday with an afternoon of exploring acute stroke challenges, which will include debates and frequent opportunity for audience participation and discussion. This will be followed by three days of peripheral, aortic, venous, vascular access, vascular malformations and wound care programmes.

A number of “Highlight” sessions have been introduced to the CX 2019 programme. On Tuesday, there is amazing interest in a metaanalysis by Dr Katsanos from Greece suggesting a raised mortality in the follow-up of patients treated with paclitaxel-coated balloons and paclitaxel-eluting stents in the femoropopliteal segment. The FDA and MHRA take this seriously. At CX, “Paclitaxel: The last word” will feature these genuine concerns for patients and the way forward by the entire vascular community in the patient’s interest.

Wednesday will host a special session on the durability of endovascular aortic intervention and will explore the possible impacts of the draft UK NICE guidelines. CX is also proud to support the initiative of the Vascular Society for Great Britain and Ireland to investigate the concern for recruitment into the vascular specialty. On Thursday, in a discussion on the Stroke from Thoracic Endovascular Procedures (STEP) study, investigators will share the latest findings on reducing the risk of stroke following complex thoracic endovascular procedures. This year also boasts a record 26 Podium 1st presentations to highlight new data from late-breaking trials.

This year CX is displaying exciting, innovative features such as live cases with virtual reality. Of the eight live cases scheduled to illustrate data being presented in the programme, four will showcase virtual reality educational aspects – a first for a vascular and endovascular symposium.

Another launch for this year’s CX is the iWounds programme and workshop. This new, interdisciplinary initiative will focus on challenges and innovations in wound care – it will feature three days of activities, with dedicated sessions in the venous and peripheral programmes, the main iWounds programme running across half a day on Wednesday, and the workshop taking place on Wednesday and Thursday.

We hope you have an enjoyable and informative week at CX 2019.

Roger Greenhalgh, on behalf of the CX Executive Board

2019

7

Vascular & Endovascular Challenges Update

Registration desk opening hours Monday 15 April

12.30-18.00

Tuesday 16 April

07.30-18.00

Wednesday 17 April

07.30-18.00

Thursday 18 April

07.30-18.00

Exhibition opening hours Tuesday 16 April

08.00-18.00

Wednesday 17 April

08.00-18.00

Thursday 18 April

08.00-18.00

General session hours – Main Auditorium Monday 15 April

13.00-17.30

Tuesday 16 April

08.00-18.00

Wednesday 17 April

08.00-18.00

Thursday 18 April

07.30-18.00

CX Collection Point Please visit the CX Collection Point to collect the CX Delegate bag and CX Book (for full registrations only). The CX Collection Point is located on stand 202.

Internet access Free WiFi access is available at CX. Access codes are ON YOUR BADGE.

8

2019

Vascular & Endovascular Challenges Update

Monday Plenary Programme Acute Stroke Challenges

16

Tuesday Plenary Programme Peripheral Proximal Arterial Ischaemia Challenges

22

Venous and Lymphatic Challenges

25

CX Additional Events CX Aortic Techniques & Technologies (edited cases)

30

CEC@CX

31

CX Meets Latin America

32

CX Aortic Workshop – Day 1

33

CX Peripheral Workshop – Day 1

34

CX Global Stars and Rising Stars and Abstract sessions CX Acute Stroke Abstract Presentations

36

CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1

37

CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1

39

CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1

40

CX Vascular Access Abstract Presentations

42

CX Acute Stroke Selected Posters Presentations

44

CX Vascular Access Selected Posters Presentations

45

CX Venous Selected Posters Presentations

46

Sponsored Satellite

112

Booth and pavilion activities

112

2019

9

Vascular & Endovascular Challenges Update

Wednesday Plenary Programme Aortic Podium 1st Session

52

Abdominal Aortic Challenges

53

CX Additional Events LINC@CX

58

CX Peripheral Techniques & Technologies (live & edited cases)

58

CX Venous Techniques & Technologies (edited cases) – Day 1

60

CX Venous Workshop – Day 1

60

Vascular Access Masterclass

62

iWounds

64

CX Vascular Malformations

65

CX Aortic Workshop – Day 2

67

CX Peripheral Workshop – Day 2

68

CX iWounds Workshop – Day 1

69

CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2

70

CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1

73

CX Thoracic Aortic Abstract Presentations – Day 2

75

CX Peripheral Arterial Selected Posters Presentations – Day 2

76

An Introduction to Vascular Surgery – Day 1

78

Booth and pavilion activities

10 2019

116

Vascular & Endovascular Challenges Update

Thursday Plenary Programme Thoracic Aortic Challenges

84

Peripheral Critical Ischaemia Challenges

87, 88

Peripheral Arterial Podium 1st Session

88

CX Additional Events CX Innovation Showcase

92

CX Venous Techniques & Technologies (edited cases) – Day 2

95

CX Venous Workshop – Day 2

95

CX Vascular Access Techniques & Technologies (edited cases)

97

CX Vascular Access Workshop

97

CX iWounds Workshop – Day 2

98

European Vascular Surgeons in Training – Prize Session

99

CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Abstract Presentations – Day 3

100

CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2

102

CX Abdominal Aortic Abstract Presentations – Day 2

104

CX Aortic Selected Posters Presentations

107

An Introduction to Vascular Surgery – Day 2

108

Booth and pavilion activities

120

2019

11

Monday 15 April 2019

Monday

Plenary Programme

Vascular & Endovascular Challenges Update Pillar Hall Learning Centre Acute Stroke Challenges

16

Monday 15 April 2019

Monday

Vascular & Endovascular Challenges Update

Monday 15 April 2019 Monday 15 April 2019

ACUTE STROKE CHALLENGES

Pillar Hall Learning Centre Hot carotid challenges

Chairing: Barbara Rantner, Innsbruck, Austria Moderator: Ross Naylor, Leicester, United Kingdom 13:00-13:12

X Debate: It is reasonable to offer urgent carotid endarterectomy C (within the first 48 hours) in patients suffering a minor stroke For the motion: 13:00-13:06 Clement Darling III, Albany, United States Against the motion: 13:06-13:12 Sofia Stromberg, Gothenborg, Sweden

13:12-13:19

Audience participation, discussion and polling

13:19-13:26 ACST-2 lessons to be learnt from the largest trial comparing stenting and surgery Alison Halliday, Oxford, United Kingdom 13:26-13:31

Audience participation and discussion

13:31-13:43

X Debate: The majority of patients with asymptomatic carotid C disease do not benefit from carotid interventions For the motion: 13:31-13:37 Ross Naylor, Leicester, United Kingdom Against the motion: 13:37-13:43 Alun Davies, London, United Kingdom

13:43-13:48

Audience participation, discussion and polling

13:48-13:55 Influence of stenosis severity on risk of stroke distal to asymptomatic carotid stenosis Dominic Howard, Oxford, United Kingdom 13:55-14:00

Audience participation and discussion

14:00-14:07 Local anaesthesia is associated with a lower periprocedural risk in carotid endarterectomy in symptomatic patients – data from ICSS, CREST, EVA3-S, SPACE and GALA (on behalf of the carotid stenosis trialist collaboration) Christoph Knappich, Munchen, Germany 14:07-14:12

Audience participation and discussion

14:12-14:24

X Debate: Carotid revascularisation (surgery or stenting) is safe to C be performed early after stroke thrombolysis For the motion: 14:12-14:18 Maarit Venermo, Helsinki, Finland Against the motion: 14:18-14:24 Alun Davies, London, United Kingdom

14:24-14:29

Audience participation, discussion and polling

14:29-14:41

X Debate: Newer technologies and innovations now make carotid C artery stenting as safe as carotid endarterectomy in the first 14 days after onset of transient ischaemic attack/stroke For the motion: 14:29-14:35 Peter Schneider, Honolulu, United States Against the motion: 14:35-14:41 Ross Naylor, Leicester, United Kingdom

14:41-14:46

Audience participation, discussion and polling

14:46-14:53 A short interval between the neurological index event is a risk factor for carotid artery stenting but not for carotid endarterectomy – data from a national registry on >56,000 symptomatic carotid patients in Germany Pavlos Tsantilas, Munich, Germany 14:53-15:00

Audience participation and discussion

15:00-15:30

TEA

Hot carotid challenges (continued)

Chairing: Barbara Rantner, Innsbruck, Austria Moderator: Ross Naylor, Leicester, United Kingdom

15:30-15:37 Carotid plaque volume as a measure of stroke risk, where next?

Charles McCollum, Manchester, United Kingdom 15:37-15:41

16 2019

Audience participation and discussion

15:41-15:48 Carotid intraplaque haemorrhage and carotid artery risk score are associated with positive microembolic signals on transcranial Doppler monitoring Suk Fun (Amanda) Cheng, London, United Kingdom 15:48-15:52

Audience participation and discussion

cute stroke challenges – Intracranial A thrombectomy

Chairing: Hugh Markus, Cambridge, United Kingdom Moderator: Barbara Rantner, Innsbruck, Austria

15:52-16:03 What thrombectomy trials really tell us and how can the findings be implemented into routine clinical practice?

David Hargroves, Kent, United Kingdom 16:03-16:07

Audience participation and discussion

16:07-16:19

X Debate: Intracranial thrombectomy should be limited to C neurointerventionists For the motion: 16:07-16:13 Andrew Clifton, London, United Kingdom Against the motion: 16:13-16:19 Jan Kovac, United Kingdom

16:19-16:28

Audience participation, discussion and polling

16:28-16:35 The impact of virtual reality on the quality of thrombectomy training

Thomas Liebig, Munich, Germany 16:35-16:39

Audience participation and discussion

16:39-16:46 Arterial transit artefacts on magnetic resonance imaging correlate with presence of recent symptoms and absent collateral pathways in patients with carotid stenosis

Suk Fun (Amanda) Cheng, London, United Kingdom 16:46-16:50 Audience participation and discussion 16:50-16:57 Choices of intracranial thrombectomy stent rival and technique innovation Thomas Liebig, Munich, Germany 16:57-17:01 Audience participation and discussion

Stroke after cardiac surgery

Chairing: Nick Hopkins, Buffalo, United States Moderator: Hugh Markus, Cambridge, United Kingdom 17:01-17:12 Hot topic talk: Stroke after cardiac surgery: More common than appreciated Nick Hopkins, Buffalo, United States 17:12-17:16

Audience participation and discussion

17:16-17:23 Clinical impact of carotid stenosis in patients undergoing transcatheter aortic valve implantation Sandro Lepidi, Padua, Italy 17:23-17:27

Audience participation and discussion

2019

17

Monday 15 April 2019

Vascular & Endovascular Challenges Update

Tuesday 16 April 2019

Tuesday

Plenary Programme & Additional Events

Tuesday Vascular & Endovascular Challenges Update Main Auditorium

Venous and Lymphatic Challenges

25

CX Additional Events CX Aortic Techniques & Technologies (edited cases)

30

CEC@CX 31 CX Meets Latin America

32

CX Aortic Workshop – Day 1

33

CX Peripheral Workshop – Day 1

34

CX Global Stars and Rising Stars and Abstract sessions CX Acute Stroke Abstract Presentations

36

CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 37 CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 39 CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 40 CX Vascular Access Abstract Presentations

42

CX Acute Stroke Selected Posters Presentations 44 CX Vascular Access Selected Posters Presentations 45 CX Venous Selected Posters Presentations

46

Tuesday 16 April 2019

Peripheral Proximal Arterial Ischaemia Challenges 22

Vascular & Endovascular Challenges Update

Tuesday 16 April 2019 PERIPHERAL PROXIMAL ARTERIAL ISCHAEMIA CHALLENGES

Upper Main Auditorium – 08:00-18:00 Peripheral arterial disease issues

Chairing: Cliff Shearman, Southampton, United Kingdom Moderator: Barry Katzen, Miami, United States 08:00-08:08 Treatment of claudication is aimed to increase walking distance, improve quality of life and prevent cardiovascular events by reducing risk factors Sanne Klaphake, Rotterdam, Netherlands

Tuesday 16 April 2019

08:08-08:16 Female gender is a risk factor for poor outcomes after revascularisation for peripheral arterial disease

Ruth Benson, Birmingham, United Kingdom 08:16-08:24

Audience participation and discussion

08:24-08:32 Office-based lower extremity arterial interventions are feasible, safe, cost-effective and patients love it Enrico Ascher, Brooklyn, United States 08:32-08:40 Ambulatory treatment of arterial disease – European perspective

Yann Goueffic, Nantes, France 08:40-08:48

Audience participation, discussion and polling

08:48-08:56 Appropriate follow-up of patients after endovascular procedures

Marianne Brodmann, Graz, Austria 08:56-09:04 Open or endovascular repair for popliteal artery aneurysms – A casecontrol study Martin Björck, Uppsala, Sweden 09:04-09:12

Audience participation and discussion

Imaging

Chairing: Robert Morgan, President CIRSE, London, United Kingdom Moderator: Andrew Holden, Auckland, New Zealand 09:12-09:20 Assessment of the perfusion with indocyanine green fluorescence imaging (ICG-FI) before and after revascularisation tells the success of revascularisation Maarit Venermo, Helsinki, Finland 09:20-09:28 Tips and tricks to optimise CO2 angiography (including work-up with no-contrast MR angiography) Jos van den Berg, Lugano, Switzerland 09:28-09:36 Audience participation and discussion 09:36-09:44 IVUS sizing improves outcomes of DCB therapy in the femoropopliteal segment Phillip Puckridge, Marion, Australia 09:44-09:52 Contrast-enhanced tomographic 3D ultrasound imaging of peripheral arterial disease and potential autologous bypass grafts

Steven Rogers, Manchester, United Kingdom 09:52-10:00

Audience participation, discussion and polling

10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee Symposium: The paclitaxel safety controversy – from patient-level data to big data: What the newest clinical evidence is telling us Chairing: Peter Schneider, Honolulu, United States Moderator: Giovanni Torsello, Münster, Germany

10:03-10:09 Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD? Peter Schneider, Honolulu, United States 10:09-10:15 Two-year outcomes from four pooled multicentre RCTs: Safety after treatment with paclitaxel-coated devices

Thomas Albrecht, Berlin, Germany 10:15-10:21 Big data: What does it tell us about survival following PAD revascularisation using drug technologies?

Eric Secemsky, Boston, United States 10:21-10:28 Audience participation and discussion

22 2019

Vascular & Endovascular Challenges Update

Paclitaxel debate

Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Thomas Zeller, Bad Krozingen, Germany 10:30-10:40

X Debate: DCB alone is enough for the popliteal segment C For the motion: 10:30-10:35 Marc Bosiers, Dendermonde, Belgium Against the motion: 10:35-10:40 Theodosios Bisdas, Athens, Greece

10:40-10:50

Audience participation, discussion and polling

Paclitaxel: The last word

Chairing: Roger Greenhalgh, London, United

Kingdom

Moderators: Andrew Holden, Auckland, New Zealand

Gunnar Tepe, Rosenheim, Germany Thomas Zeller, Bad Krozingen, Germany

Review of the findings of the VIVA Forum

10:50-11:00 Paclitaxel summary of VIVA 11:00-11:10

Gary Ansel, Columbus, United States

Audience participation and discussion

The potential problem

11:10-11:20 My choices of DCB and DES data to combine in meta-analysis and my conclusions Konstantinos Katsanos, Patras, Greece 11:20-11:27 BASIL 3 – withdrawal of paclitaxel use

Jonathan Michaels, Sheffield, United Kingdom 11:27-11:34 SWEDEPAD trials – withdrawal of paclitaxel use

Marten Falkenberg, Gothenburg, Sweden 11:34-11:50

Audience participation, discussion and polling

Scrutiny of paclitaxel and the way forward

11:50-12:00 Statistical review of methodology and legitimacy of results

Sue Duval, Minneapolis, United States 12:00-12:10

Statistical issues

12:10-12:30

Audience participation, discussion and polling

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Jon Deeks, Birmingham, United Kingdom

Lunch Symposium: Optimising DCB results for long-term success Chairing: Michael Lichtenberg, Arnsberg, Germany Moderator: Gary Ansel, Columbus, United States

12:33-12:41 Long-term safety and efficacy of a low-dose DCB

Gary Ansel, Columbus, United States 12:41-12:49 The benefits of IVUS in DCB treatment of the femoropopliteal segment Phillip Puckridge, Marion, Australia 12:49-12:58 The value of effective vessel preparation before DCB use

Theodosios Bisdas, Athens, Greece

Review of paclitaxel usage: The way forward Chairing: Roger Greenhalgh, London, United Kingdom Moderators: Andrew Holden, Auckland, New Zealand Gunnar Tepe, Rosenheim, Germany Thomas Zeller, Bad Krozingen, Germany

13:30-13:38 What the FDA are looking for in data requested

Misti Malone, Silver Spring, United States 13:38-13:46 What MHRA are looking for 13:46-13:56

Hazel Randall, London, United Kingdom

Audience participation, discussion and polling

13:56-14:04 Paclitaxel early advances to limit restenosis

Ulrich Speck, Berlin, Germany 14:04-14:12 Paclitaxel: Why a chemotherapeutic was chosen to prevent restenosis – rationale and early experience

Lindsay Machan, Vancouver, Canada

2019

23

Tuesday 16 April 2019

Vascular & Endovascular Challenges Update 14:12-14:20 Paclitaxel as primary therapy in oncology – benefits, doses, levels compared Erica Mayer, Boston, United States 14:20-14:35

Audience participation, discussion and polling

14:35-14:43 Lessons learned from the experience in the coronary arteries – sirolimus, paclitaxel and everolimus

Bruno Scheller, Homburg/Saar, Germany 14:43-14:51 Potential toxicity of paclitaxel in vascular interventions and pharmacokinetic aspects Aloke Finn, Gaithersburg, United States 14:51-14:59 Paclitaxel effects on the human artery wall and insights from pathology Elena Ladich, Hollywood, FL, United States 14:59-15:30

Audience participation, discussion and polling

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Tea Symposium: Aortoiliac obstructive disease: Endoluminal solutions Tuesday 16 April 2019

Chairing: Michele Antonello, Padua, Italy

15:33-15:39 Complexity of iliac occlusive disease, current treatment algorithm and treatment gaps Michele Antonello, Padua, Italy 15:39-15:45 Challenging bilateral iliac case treated with a new balloonexpandable endoprosthesis Hany Zayed, London, United Kingdom 15:45-15:51 Complex iliac occlusive disease: Treatment with covered stent grafts

Gianmarco de Donato, Siena, Italy 15:51-15:58

Audience participation and discussion

Edited case

Chairing: Michele Antonello, Padua, Italy

16:00-16:30 Edited case: Treating iliac occlusive disease with a covered endoprosthesis Andrew Holden, Auckland, New Zealand

Interventional techniques

Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Robert Hinchliffe, Bristol, United Kingdom 16:30-16:37 Advantages and results of treating SFA-popliteal occlusive lesions with a dual component stent: From the Austrian Registry

Martin Werner, Vienna, Austria 16:37-16:44 How to treat in-stent-restenosis in the femoropopliteal tract – what the literature tells us Marc Bosiers, Dendermonde, Belgium 16:44-16:51 The case for spot stenting – similarities and differences between techniques Thomas Zeller, Bad Krozingen, Germany

Edited case

16:51-17:21 Edited case: Focal dissection repair after femoropopliteal angioplasty Michael Lichtenberg, Arnsberg, Germany 17:21-17:28 Femoropopliteal bypasses with heparin-bonded PTFE are a durable treatment for long SFA-popliteal occlusions: When they are the best treatment and why Walter Dorigo, Florence, Italy 17:28-17:40

Audience participation and discussion

Open bypass

17:40-17:50

X Debate: In the absence of suitable venous graft material C prosthetic bypass is the answer For the motion: 17:40-17:45 Clement Darling III, Albany, United States Against the motion: 17:45-17:50 Andrew Holden, Auckland, New Zealand

17:50-18:00

Audience participation, discussion and polling

24 2019

Vascular & Endovascular Challenges Update

Tuesday 16 April 2019 VENOUS AND LYMPHATIC CHALLENGES

Lower Main Auditorium – 08:00-18:00 Superficial veins

Chairing: Stephen Black, London, United Kingdom Moderator: Raghu Kolluri, Columbus, United States

Truncal vein treatment

08:08-08:16 Foam sclerotherapy can replace phlebectomy for the management of varicosities Claudine Hamel-Desnos, Caen, France 08:16-08:24 The benefit of non-thermal modalities

Steve Elias, Englewood, United States 08:24-08:32 Technique and strategy are as important as modality in the treatment of superficial reflux Manj Gohel, Cambridge, United Kingdom 08:32-08:48

Audience participation and discussion

08:48-08:56 Podium 1st: VeClose Extension Study five-year results

Nick Morrison, Scottsdale, United States 08:56-09:04 Post-procedure care after cyanoacrylate glue closure

Kathleen Gibson, Bellevue, United States 09:04-09:12 The evolution of superficial venous management has moved away from thermal techniques Kursat Bozkurt, Istanbul, Turkey 09:12-09:28

Audience participation, discussion and polling

09:28-09:36 3RF Trial: Randomised trial of three radiofrequency devices for great saphenous vein ablation Isaac Nyamekye, Worcester, United Kingdom 09:36-09:44 Current theories on indications and techniques for perforator ablation Kathleen Gibson, Bellevue, United States 09:44-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

10:00-10:30

Coffee Symposium

Read more on page 112

Advanced venous disease

Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Kathleen Gibson, Bellevue, United States 10:30-10:37 Role of elevated central venous pressures in chronic venous insufficiency Raghu Kolluri, Columbus, United States 10:37-10:44 Chronic venous hypertension: What to do when there is no venous disease to treat Sergio Gianesini, Ferrara, Italy

Lymphoedema

10:44-10:51 Optimal lymphoedema diagnosis and management in 2019

Peter Mortimer, London, United Kingdom 10:51-10:58 A pragmatic approach to the assessment of swollen legs

Sarah Thomis, Leuven, Belgium 10:58-11:12

Audience participation and discussion

Venous ulceration

11:12-11:19 Novel treatments for intractable leg ulcers

Alfred Obermayer, Vienna, Austria 11:19-11:26 How to maximise implementation and impact post-EVRA

Alun Davies, London, United Kingdom 11:26-11:33 Optimal assessment and treatment pathways for recalcitrant leg ulcers Thomas O'Donnell, Boston, United States 11:33-11:40 Novel wound dressings to meet the challenge of recalcitrant venous ulcers Keith Harding, Cardiff, United Kingdom 11:40-11:54

Audience participation, discussion and polling

2019

25

Tuesday 16 April 2019

08:00-08:08 How to choose between endovenous modalities Armando Mansilha, Porto, Portugal

Vascular & Endovascular Challenges Update

Pelvic venous disease

11:54-12:01 How to decide when pelvic venous reflux is clinically relevant and pelvic congestion syndrome Neil Khilnani, New York, United States 12:01-12:15

X Debate: The dangers of stenting for Nutcracker syndrome far C outweigh any benefits For the motion: 12:01-12:08 Gerard O’Sullivan, Galway, Ireland Against the motion: 12:08-12:15 Olivier Hartung, Marseille, France

12:15-12:30

Audience participation, discussion and polling

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOP

Deep venous system

Chairing: Alun Davies, London, United Kingdom Moderator: Rick de Graaf, Friedrichshafen, Germany

Tuesday 16 April 2019

Chronic venous outflow obstruction/ Acute DVT treatment/ Deep venous reflux

13:30-13:38 Optimising pathways for acute DVT treatment

Prakash Saha, London, United Kingdom 13:38-13:54

X Debate: Aggressive thrombus removal for iliofemoral DVT is C overutilised as most patients do not develop significant PTS For the motion: 13:38-13:46 Manj Gohel, Cambridge, United Kingdom Against the motion: 13:46-13:54 Michael Lichtenberg, Arnsberg, Germany

13:54-14:08

Audience participation, discussion and polling

14:08-14:16 Optimal outcomes assessment after acute DVT thrombolysis

Raghu Kolluri, Columbus, United States 14:16-14:26

CAVA trial

Cees Wittens, Maastricht, Netherlands

14:26-14:34 Where next after ATTRACT and CAVA

Mitchell Silver, Columbus, United States 14:34-14:48

Audience participation and discussion

14:48-14:56 Complications and disasters during deep venous stenting procedures Gerard O’Sullivan, Galway, Ireland 14:56-15:04 An update on stent trials and the role of IVUS

Erin Murphy, Charlotte, United States 15:04-15:12 The challenge of inflow – how can we assess it and what to look for

Houman Jalaie, Aachen, Germany 15:12-15:20 What next when stents fail

Stephen Black, London, United Kingdom

15:20-15:30

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOP

Deep venous disease (continued)

Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Stephen Black, London, United Kingdom

16:00-16:07 The challenge of the femoral vein – treating post-thrombotic syndrome with normal iliac outflow Steve Elias, Englewood, United States 16:07-16:14 Latest advances with percutaneous deep venous valves

Steven Dubenec, Sidney, Australia 16:14-16:21 Endovascular rescue strategies for in-stent thrombus lining and occlusion Erin Murphy, Charlotte, United States 16:21-16:35

Audience participation and discussion

16:35-16:42 Meeting the challenges of upper limb venous outflow obstruction

Rick de Graaf, Friedrichshafen, Germany 16:42-16:56

Audience participation and discussion

16:56-17:03 Central vein obstruction – stenting in the SVC and IVC

Narayanan Thulasidasan, London, United Kingdom 17:03-17:10 Strategies and pitfalls for venous stents for the upper limb

Steven Dubenec, Sidney, Australia

26 2019

Vascular & Endovascular Challenges Update

Miscellaneous venous topics

17:10-17:17 Latest advances in managing C1 disease

Paul Pittaluga, Monaco, Monaco 17:17-17:24 New horizons for venous specialists

Sriram Narayanan, Singapore

17:24-17:31 IVUS in venous interventions – reduction in radiation exposure

Narayan Karunanithy, London, United Kingdom 17:31-17:38 Where do we stand with IVC filters in 2019

Richard McWilliams, Liverpool, United Kingdom 17:38-17:45 The current and future role of medical apps in venous care

Oscar Johnson, London, United Kingdom Audience participation and discussion

Tuesday 16 April 2019

17:45-18:00

2019

27

Tuesday 16 April 2019

Tuesday

Additional Events

2019

29

Vascular & Endovascular Challenges Update

CX Aortic Techniques & Technologies (edited cases) l Pillar Hall Learning Centre – 08:00-18:00

B est of Aortic Live and Paris Endovascular Aortic Course

Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Heinz Jakob, Essen, Germany

08:00-08:20 Total endovascular repair in chronic type A aortic dissection

Stéphan Haulon, Le Plessis Robinson, France

Tuesday 16 April 2019

08:20-08:40 Frozen elephant trunk in chronic type A aortic dissection

Konstantinos Tsagakis, Essen, Germany 08:40-09:00 Fenestrated arch repair in chronic type B aortic dissection

Tilo Kölbel, Hamburg, Germany 09:00-09:20 In situ laser fenestration in ruptured aortic arch aneurysm

Dominique Fabre, Le Plessis Robinson, France 09:20-09:40 TEVAR and candy-plug in chronic type B aortic dissection

Fiona Rohlffs, Hamburg, Germany 09:40-10:00 Full transfemoral branched EVAR for thoracoabdominal aortic aneurysms Nikolaos Tsilimparis, Munich, Germany 10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee symposium: Innovative solutions for the treatment of visceral arteries in complex aortic procedures Chairing: Dittmar Böckler, Heidelberg, Germany

10:03-10:13 Best practices of fenestrated cases and the EXPAND registry

Mauro Gargiulo, Bologna, Italy 10:13-10:23 Comparison with existing devices – case presentations and best practices Martin Austermann, Münster, Germany 10:23-10:28

Discussion and conclusion

New device

Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany

10:30-11:00 Edited case: New balloon-expandable endoprosthesis in complex aortic procedures Jorge Fernández Noya, Santiago de Compostela, Spain

Hybrid procedure

Chairing: Michel Makaroun, Pittsburgh, United States Moderator: Tara Mastracci, London, United Kingdom 11:00-11:30 Branched frozen elephant trunk as a platform for second stage TEVAR Mark Field, Warrington, United Kingdom

Type B dissections

11:30-11:50 Endovascular repair of chronic post-dissection thoracoabdominal aortic aneurysms Gustavo Oderich, Rochester, United States 11:50-12:10 Open and endovascular treatment of acute type B dissections

Franco Grego, Padua, Italy

Conversion to open repair

12:10-12:30 Open conversion of endovascular failures

Michel Makaroun, President SVS, Pittsburgh, United States 12:30-13:30

30 2019

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Vascular & Endovascular Challenges Update

TEVAR

Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Barry Katzen, Miami, United States 13:30-14:00 Precise placement and conformability with a thoracic aortic stent graft Dittmar Böckler, President DGG, Heidelberg, Germany

Imaging

14:00-14:30 Artificial intelligence: Deformable anatomy tool for accurate smart overlays Tara Mastracci, London, United Kingdom

Cynthia Shortell, Durham, United States

Thoracoabdominal aneurysms

15:00-15:30 Expedited treatment of TAAAs with proven durability: My experience with an off-the-shelf branched stent graft

Bijan Modarai, London, United Kingdom 15:30-16:00 TEA AND VISIT TO HANDS-ON WORKSHOPS

Juxtarenal aneurysms

Chairing: Timothy Resch, Malmö, Sweden Moderator: Heinz Jakob, Essen, Germany 16:00-16:30 Complex juxtarenal abdominal aortic aneurysm repair with a fenestrated stent graft Michel Reijnen, Arnhem, Netherlands 16:30-16:50 Endovascular repair of complex juxtarenal aortic aneurysm using a combined reverse branched endograft and chimney technique

Wei Guo, Beijing, China 16:50-17:10 Easy open repair instead of complex fenestrations

Dittmar Böckler, President DGG, Heidelberg, Germany

Infection

17:10-17:40 The best open approach for aortic (graft) infection – tips & tricks

Xavier Berard, Bordeaux, France 17:40-18:00 Infections after vascular reconstructions

Konstantin Andreychuk, Saint Petersburg, Russia

CEC@CX London Room Learning Centre – 10:30-12:30 Co-chairs: Wei Guo, Beijing, China Daqiao Guo, China Sheng Wang, Beijing, China Discussants: ZhenYu Shi, Shanghai, China Zhengya Yu, Beijing, China Weiwei Wu, China

CX co-chair: F rans Moll, CX Advisory Board, Utrecht, Netherlands

CX moderator: Tilo Kölbel, Hamburg, Germany CX discussant: Heinz Jakob, Essen, Germany

10:30-10:38 New DCB era for BTK: Six-month results from the China AcoArt Study Wei Guo, Beijing, China 10:38-10:46 Treatment of type II endoleak after endovascular abdominal aortic aneurysm repair Sheng Wang, Beijing, China 10:46-10:54 The endovascular treatment of distal entry of TBAD after proximal TEVAR ZhenYu Shi, Shanghai, China 10:54-11:10

Audience participation and discussion

11:10-11:18 What are the key points for endovascular repair of ruptured abdominal aortic aneurysm?

Yaoguo Yang, Beijing, China

2019

31

Tuesday 16 April 2019

14:30-15:00 Branched repair of type II thoracoabdominal aneurysm with trackable and flexible covered stents Said Abisi, London, United Kingdom

Vascular & Endovascular Challenges Update 11:18-11:26 Endotension following EVAR: Is it real, what causes it and what to do about it?

Jianing Yue, Shanghai, China 11:26-11:34 Modified PAI technique for dialysis access-associated Steal Syndrome Zhengya Yu, Beijing, China 11:34-11:50

Audience participation and discussion

11:50-11:58 In situ laser fenestration of aortic arch stent graft during thoracic endovascular aortic repair of Stanford type A aortic dissection

Xinwu Lu, Shanghai, China 11:58-12:06 Effect evaluation of intravascular thrombolysis for pulmonary embolism with low-dose recombinant tissue plasminogen activator

Weiwei Wu, Beijing, China 12:06-12:14 Management of endoleaks after EVAR for AAA Qingle Li, Beijing, China 12:14-12:30

Audience participation and discussion

Tuesday 16 April 2019

CX Meets Latin America l l London Room Learning Centre – 13:00-15:30 Lunch served in the London Room Learning Centre

Chairing: Luis Mariano Ferreira, Buenos Aires, Argentina Juan Esteban Paolini, President, Argentine College of Cardiovascular Surgery, Caba, Argentina

Moderators: Álvaro Razuk, São Paulo, Brazil Ignacio Escotto Sánchez, Mexico City, Mexico

13:30-13:38 Endovascular treatment of ruptured aortic arch aneurysms

Gustavo Paludetto Oliveira, Brasília, Brazil 13:38-13:42

Audience participation and discussion

13:42-13:50 Updates in how to improve results on outpatient EVAR programme

Álvaro Razuk, São Paulo, Brazil 13:50-13:54

Audience participation and discussion

13:54-14:02 FEVAR due proximal neck dilatation after EVAR

Luis Mariano Ferreira, Buenos Aires, Argentina 14:02-14:06

Audience participation and discussion

14:06-14:14 Endovascular treatment of Lerich Syndrome

Juan Esteban Paolini, President, Argentine College of Cardiovascular Surgery, Caba, Argentina 14:14-14:18

Audience participation and discussion

14:18-14:26 Value of drug-coated balloon in patients with CLI and DM with complex real-world lesions undergoing endovascular interventions in below-the-knee arteries Ignacio Escotto Sánchez, Mexico City, Mexico 14:26-14:30

Audience participation and discussion

14:30-14:38

Short necks – how to do it

14:38-14:42

Audience participation and discussion

Guilherme Centofanti, São Paulo, Brazil

14:42-14:50 Common iliac artery aneurysm: Revascularisation or embolisation

Luiz Furuya, São Paulo, Brazil 14:50-14:54

Audience participation and discussion

14:54-15:02 Why endografting is my first choice to treat popliteal artery aneurysm

Lucas Marcelo Dias Freire, São Paulo, Brazil 15:02-15:06

Audience participation and discussion

15:06-15:14 Strategies on the treatment for complex disease in the femoropopliteal artery Sidnei Galego, São Paulo, Brazil 15:14-15:18

Audience participation and discussion

15:18-15:26 Fenestrated and branched stent-grafting after previous surgery

Luis Mariano Ferreira, Buenos Aires, Argentina 15:26-15:30

32 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update

CX Aortic Workshop – Day 1 l CX Aortic Workshop – 10:00-16:00

Facilitators: A nna Prent, London, United Kingdom Kevin Mani, Uppsala, Sweden

Cydar EV

10:00-10:30 Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

15:30-16:00 Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

12:30-13:30

Complex TAAA

12:30-13:30 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom 15:30-16:00 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom

EVAR ASSIST 2

10:00-10:30 How to simplify fenestrated EVAR procedures using fusion imaging with EVAR ASSIST 2?

Gustavo Oderich, Rochester, United States 15:30-16:00 How to simplify fenestrated EVAR procedures using fusion imaging with EVAR ASSIST 2?

Gustavo Oderich, Rochester, United States

FEVAR

10:00-10:30 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Michel Reijnen, Arnhem, Netherlands 12:30-13:30 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Michel Reijnen, Arnhem, Netherlands

Nick Burfitt, London, United Kingdom 15:30-16:00 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Nick Burfitt, London, United Kingdom

Filler: Aneurysms and AVMs

Murat Katitas, Ankara, Turkey Egemen Okur, Ankara, Turkey

IVUS

10:00-10:30 Technical aspects of IVUS in EVAR and TEVAR procedures

Joerg Tessarek, Lingen, Germany 12:30-13:30 Technical aspects of IVUS in EVAR and TEVAR procedures

Joerg Tessarek, Lingen, Germany 15:30-16:00 Technical aspects of IVUS in EVAR and TEVAR procedures

Joerg Tessarek, Lingen, Germany

PIUR tomographic ultrasound

Vikki Galgerud, Vienna, Austria

2019

33

Tuesday 16 April 2019

he CX Aortic Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the aortic technologies available. During break times there will be supervised learning with key opinion leaders.

Vascular & Endovascular Challenges Update

VesselNavigator image fusion

10:00-10:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands 12:30-13:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Blandine Maurel, Nantes, France 15:30-16:00 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands

Alice Jay, Philips Healthcare, Leusden, Netherlands

Tuesday 16 April 2019

CX Peripheral Workshop – Day 1 l CX Peripheral Workshop – 10:00-16:00 he CX Peripheral Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the peripheral technologies available. During break times there will be supervised learning with key opinion leaders.

Facilitator: F rank Vermassen, Ghent, Belgium

ABPI and early detection of PAD

Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom

Carnelian, Pulsar-18 T3 and Fortress

Georg Bach, Biotronik, Bulach, Switzerland Dabra Excimer Laser Atherectomy Max Amor, Essey-les-Nancy, France

Charles Bailey, San Antonio, United States EndoWars Simulator Challenge SFA

Lynne Teece, Cook Medical, Bournemouth, United Kingdom Indigo System and large volume coils

Miriam Bondrop, Penumbra, Berlin, Germany Jaguar self-expanding nitinol stent

Robert Michal Proczka, Warsaw, Poland Lutonix BTK DCB

Luis Mariano Palena, Abano Terme, Italy

See clearly: The value of peripheral arterial IVUS in decision making

Konstantinos Stavroulakis, Münster, Germany Stealth 360 Peripheral Orbital Atherectomy

Konstantinos Donas, Münster, Germany

Supera and peripheral guidewires

Sanchita Pasi, Abbott Vascular, Diegem, Belgium Tack – how I optimise balloon angioplasty?

Michael Lichtenberg, Arnsberg, Germany Temren atherectomy and Extender drug-coated balloon

Berna Ozata, Ankara, Turkey

Evren Ekingen, Batman, Turkey

The surgical Doppler probe

Jon Evans, Cardiff, United Kingdom

Treat optimally: The use of the Phoenix Atherectomy System

Theodosios Bisdas, Athens, Greece Vessel preparation with JetStream Atherectomy system and Ranger DCB Tibor Balazs, Bratislava, Slovakia

34 2019

Vascular & Endovascular Challenges Update

CX Acute Stroke Abstract Presentations l Dark Room Learning Centre – 08:00-11:30 Acute Stroke Abstract Presentations

Chairing: H ugh Markus, Cambridge, United Kingdom Barbara Rantner, Innsbruck, Austria

08:00-08:05 Preoperative prediction of a vulnerable carotid plaque using the Speculate score in patients submitted for carotid endarterectomy

Daniela Mazzaccaro, San Donato Milanese, Italy 08:05-08:10

Audience participation and discussion

Tuesday 16 April 2019

08:10-08:15 Evaluation of kinetic imaging in carotid and cerebral X-ray angiography Viktor Orias, Budapest, Hungary 08:15-08:20

Audience participation and discussion

08:20-08:25 Carotid plaque volume measured by 3D tomographic ultrasound

Steven Rogers, Manchester, United Kingdom 08:25-08:30

Audience participation and discussion

08:30-08:35 Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing carotid endarterectomy Marjolijn Rots, Utrecht, Netherlands 08:35-08:40

Audience participation and discussion

08:40-08:45 Impact of carotid artery stenosis and carotid endarterectomy on ipsilateral ocular flow density measured by optical coherence tomography angiography Elena Marchiori, Muenster, Germany 08:45-08:50

Audience participation and discussion

08:50-08:55 Ferumoxytol-enhanced magnetic resonance imaging study of patients with symptomatic and asymptomatic carotid artery disease – An exploratory study Umar Sadat, Cambridge, United Kingdom 08:55-09:00

Audience participation and discussion

09:00-09:05 Prevention of neurologic morbidity in carotid surgery

Salvatore Turiano, Nicolosi, Italy 09:05-09:10

Audience participation and discussion

09:10-09:15 Prevention of acute strokes by screening the senior population with a quick carotid scan George Lavenson, Lahaina, United States 09:15-09:20

Audience participation and discussion

09:20-09:25 Guidelines compliance in the use of statins and LDL target in patient in carotid surgery plan Fernando Belcastro, Buenos Aires, Argentina 09:25-09:30

Audience participation and discussion

09:30-09:35 Comparative analysis of carotid artery stenting and carotid endarterectomy in clinical practice

Alexey Khmelnitskiy, San Petersburg, Russia 09:35-09:40

Audience participation and discussion

09:40-09:45 Short non-patch arteriotomy in carotid endarterectomy

Marco Leopardi, L’Aquila, Italy 09:45-09:50

Audience participation and discussion

09:50-09:55 Intermediate results of a prospective randomised study in carotid artery revascularisation: The Acculink stent vs. the mesh covered stent comparative aspect Alexey Khmelnitskiy, San Petersburg, Russia 09:55-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

10:30-10:35 Symptomatic carotid artery stenosis undergoing surgical revascularisation: Improvement in cognitive performance and cerebral haemodynamics Gabriele Pagliariccio, Senigallia (AN), Italy 10:35-10:40

Audience participation and discussion

10:40-10:45 Our experience of surgical treatment at patients with Takayasu disease Viktoriya Tsay, Tashkent, Uzbekistan 10:45-10:50

Audience participation and discussion

10:50-10:55 Incidence and outcomes of cerebral hyperperfusion syndrome after carotid endarterectomy Mary Weisters, Aylesbury, United Kingdom

36 2019

Vascular & Endovascular Challenges Update 10:55-11:00

Audience participation and discussion

11:00-11:05 Patient cooperative general anaesthesia for carotid endarterectomy: A third option Yao Pey Yong, Huddersfield, United Kingdom 11:05-11:10

Audience participation and discussion

11:10-11:15 The clinical relevance of preoperative cerebral small vessel disease for adverse events following carotid endarterectomy

Nathalie Timmerman, Amsterdam, Netherlands 11:15-11:20

Audience participation and discussion

11:20-11:25 Preoperative embolisation of carotid body tumours: Yes or no?

Tiago Soares, Matosinhos, Portugal Audience participation and discussion

CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 l London Room Learning Centre

C X Peripheral Arterial Global Stars and Rising Stars (08:00-10:00) Chairing: P aul Hayes, Cambridge, United Kingdom Robert Hinchliffe, Bristol, United Kingdom

08:00-08:05 The fate of the claudicant; 25 years after Dormandy

Katie Hurst, Oxford, United Kingdom 08:05-08:10

Audience participation and discussion

08:10-08:15 Rotational atherectomy vs. surgical endarterectomy for common femoral artery atherosclerotic disease in high haemorrhagic risk patients: A comparative study Mahine Kashi-Dakhil, Argenteuil, France 08:15-08:20

Audience participation and discussion

08:20-08:25 Podium 1st: FINNPTX final results

Patrick Bjorkman, Helsinki, Finland

08:25-08:30 Audience participation and discussion 08:30-08:35 Zilver PTX drug-eluting stent for treating femoropopliteal lesions: Results from the Zilver PTX China Daqiao Guo, Shanghai, China 08:35-08:40

Audience participation and discussion

08:40-08:45 Patients with infrapopliteal artery lesions treated with a paclitaxel covered balloon in a real-world clinical trial. Twenty four-month results of the BIOLUX P-III all comers registry

Gunnar Tepe, Rosenheim, Germany 08:45-08:50

Audience participation and discussion

08:50-08:55 Real world long-term outcome of patients with femoropopliteal helical interwoven nitinol stents Yiu Che Chan, Hong Kong 08:55-09:00

Audience participation and discussion

09:00-09:05 The variant of improving the long-term results after stenting of the superficial femoral artery: Two-year results of a pilot prospective randomised study Pavel Ignatenko, Novosibirsk, Russia 09:05-09:10

Audience participation and discussion

09:10-09:15 A pilot study to determine vascular functions and patency through interventional atherectomy in peripheral artery disease (safety and efficacy of atherectomy on vascular functions – the SAVIOR trial): Methodology and study design Christos Rammos, Essen, Germany 09:15-09:20

Audience participation and discussion

09:20-09:25 Aspiration thrombectomy for acute limb ischaemia: A single-centre experience Maria Antonella Ruffino, Turin, Italy 09:25-09:30

Audience participation and discussion

2019

37

Tuesday 16 April 2019

11:25-11:30

Vascular & Endovascular Challenges Update 09:30-09:35 Comparison of adjuvant non-drug coated and drug-coated balloon angioplasty populations undergoing peripheral arterial disease interventions involving laser assisted atherectomy

Javier Ruiz Aburto, Ponce, Puerto Rico 09:35-09:40

Audience participation and discussion

09:40-09:45 Challenging baseline lesion characteristics: Subgroup analysis of patients treated in the IMPERIAL randomised trial

Frank Vermassen, Ghent, Belgium 09:45-09:50

Audience participation and discussion

09:50-09:55 Safety and effectiveness of the novel Temren Atherectomy System combined used with Extender drug-eluting balloon in lower extremity arteries Halit Yerebakan, Turkey 09:55-10:00

Tuesday 16 April 2019

Audience participation and discussion

C X Peripheral Arterial Global Stars and Rising Stars (16:00-18:00) Chairing: F rank Vermassen, Ghent, Belgium Enrico Ascher, New York, United States

16:00-16:05 Podium 1st: DRASTICO study two-year results

Francesco Liistro, Arezzo, Italy 16:05-16:10

Audience participation and discussion

16:10-16:15 Podium 1st: Results from the PORTRAIT Claudication Registry

Kim Smolderen, Kansas City, United States 16:15-16:20

Audience participation and discussion

16:20-16:25 Treatment of peripheral arterial disease with endoluminal bypass in long de novo lesions and in-stent restenosis

Athanasios Giannoukas, Larissa, Greece 16:25-16:30

Audience participation and discussion

16:30-16:35 Two-year results of vasculomimetic stents in tortuous, angulated territories, other than the SFA Rajiv Parakh, Gurgaon, India 16:35-16:40

Audience participation and discussion

16:40-16:45 High outward force of self-expanding BMS in the SFA could be a significant risk factor for restenosis at 12 months

Mark Burket, Toledo, United States 16:45-16:50

Audience participation and discussion

16:50-16:55 DCB only vs Bail-out stented outcomes at 24-months, a sub-analysis of BIOLUX P-III global Passeo-18 Lux registry

Marianne Brodmann, Graz, Austria 16:55-17:00

Audience participation and discussion

17:00-17:05 Challenging lesions: Is calcium the Achilles heel of endovascular procedures?

Theodosios Bisdas, MĂźnster, Germany 17:05-17:10

Audience participation and discussion

17:10-17:15 Fusion techniques for treatment of peripheral interventions

Yann Goueffic, Nantes, France 17:15-17:20

Audience participation and discussion

17:20-17:25 DCB in real world complexities: the SAVER registry

Giovanni Torsello, MĂźnster, Germany 17:25-17:30

Audience participation and discussion

17:30-17:35 Endovascular treatment of popliteal aneurysms: Long-term outcomes Ignace Tielliu, Groningen, Netherlands 17:35-17:40

Audience participation and discussion

17:40-17:45 The final results of the hybrid procedure in comparison with the aortofemoral bypass in patients with haemodynamically significant lesions of the iliac arteries and the common femoral artery (type TASC II C, D) Pavel Ignatenko, Novosibirsk, Russia 17:45-17:50

Audience participation and discussion

17:50-17:55 Algorithm for approaching long complex lesions

Jos van den Berg, Lugano, Switzerland 17:55-18:00

38 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update

CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 l

C X Abdominal Aortic Global Stars and Rising Stars Chairing: R onald Dalman, Stanford, United States Samuel Money, Phoenix, United States

16:00-16:05 Magnetic resonance imaging volumetric assessment of small abdominal aortic aneurysm for growth monitoring – implications for power calculation in longitudinal interventional studies

Achilleas Karkamanis, Stockholm, Sweden 16:05-16:10

Audience participation and discussion

16:10-16:15 Next-generation pan-vascular suite: Optimising patient management and outcomes Barry Katzen, Miami, United States 16:15-16:20

Audience participation and discussion

16:20-16:25 Abstract Winner CX 2018 – Integrated physiological and biochemical assessments for the prediction of growth of abdominal aortic aneurysm in humans Regent Lee, Headington, United Kingdom 16:25-16:30

Audience participation and discussion

16:30-16:35 Segmental arterial mediolysis 16:35-16:40

Samuel Money, Phoenix, United States

Audience participation and discussion

16:40-16:45 Episode-based cost reductions in EVAR

Ronald Dalman, Stanford, United States 16:45-16:50

Audience participation and discussion

16:50-16:55 Many EVAR costs are triggered by unnecessary treatment of type II endoleaks: New data indicate that most are benign and do not require intervention Michel Reijnen, Arnhem, Netherlands 16:55-17:00

Audience participation and discussion

17:00-17:05 Early results of a new treatment for large abdominal aortic aneurysms with recurrent endoleaks: Combined endovascular and laparoscopic endoleak repair

Adam Howard, Lamarsh Bures, United Kingdom 17:05-17:10

Audience participation and discussion

17:10-17:15 Mid-term results from the ANCHOR registry: When the use of endoanchors benefits EVAR Colin Bicknell, London, United Kingdom 17:15-17:20

Audience participation and discussion

17:20-17:25 Five-year results from the US IDE trial on the Anaconda stent graft system Randy Moore, Calgary, Canada 17:25-17:30

Audience participation and discussion

17:30-17:35 Emergencies treated with covered stents

Maria Antonella Ruffino, Turin, Italy 17:35-17:40

Audience participation and discussion

17:40-17:45 Post-EVAR graft limb kinking: Aetiology, impact as a cause of limb occlusion and management Andreia Coelho, Porto, Portugal 17:45-17:50

Audience participation and discussion

17:50-17:55 A lifetime efficacy proven by clinical evidence: Twelve years of results of the Excluder endograft Jan Heyligers, Tilburg, Netherlands 17:55-18:00

Audience participation and discussion

18:00-18:05 Clinical study and extended application in complicated AAA with a new IBD Wei Guo, Beijing, China 18:05-18:10

Audience participation and discussion

2019

39

Tuesday 16 April 2019

Gallery Suite Learning Centre – 16:00-18:10

Vascular & Endovascular Challenges Update

CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 l Gallery Suite Learning Centre – 08:00-15:30

Tuesday 16 April 2019

C X Thoracic Aortic Global Stars and Rising Stars Chairing: G ustavo Oderich, Rochester, United States Anna Prent, London, United Kingdom

08:00-08:05 Relative change in temperature and atmospheric pressure are critical mechanistic factors in acute aortic syndrome occurrence in France

Guillaume Guimbretiere, Nantes, France 08:05-08:10

Audience participation and discussion

08:10-08:15 Routine use of cone beam influence on long-term outcomes

Adrien Hertault, Lille, France 08:15-08:20

Audience participation and discussion

08:20-08:25 Cerebroembolic outcomes of right vs. left upper extremity access during fenestrated/branched endovascular aortic repair

Aleem Mirza, United States 08:25-08:30

Audience participation and discussion

08:30-08:35 Physician modified double fenestrated stent grafts for total endovascular aortic arch repair

Baris Ata Ozdemir, Bristol, United Kingdom 08:35-08:40

Audience participation and discussion

08:40-08:45 Endovascular repair of aortic disease from aortic arch to iliac arteries

Konstantinos Spanos, Larissa, Greece 08:45-08:50

Audience participation and discussion

08:50-08:55 Three-years’ follow-up of succesful endovascular interventions in Takayasu arteritis involving aorta and aortic arch vessels

Narendra Nath Khanna, New Delhi, India 08:55-09:00

Audience participation and discussion

09:00-09:05 Subclavian artery plug embolisation (SAPE study): A real experience about endovascular subclavian occlusion prior to thoracic vascular repair Simone Salvati, Monza, Italy 09:05-09:10

Audience participation and discussion

09:10-09:15 Hybrid procedures in aortic arch aneurysm surgery in high risk patients Mikhail Chernyavskiy, St Petersburg, Russia 09:15-09:20

Audience participation and discussion

09:20-09:25 Evaluation of the TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysms

Michael Dake, Stanford, United States 09:25-09:30

Audience participation and discussion

09:30-09:35 Thoraflex Hybrid FDA clinical trial: Early results

Chris Malaisrie, Chicago, United States 09:35-09:40

Audience participation and discussion

09:40-09:45 Interactions between frozen elephant trunk and thoracic endograft

Martin Czerny, Freiburg, Germany 09:45-09:50

Audience participation and discussion

09:50-09:55 Systematic review on current evidence of type Ib endoleak after thoracic endovascular aortic repair Viony Belvroy, Houston, United States 09:55-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

40 2019

Vascular & Endovascular Challenges Update

C X Thoracic Aortic Global Stars and Rising Stars Chairing: B arry Katzen, Miami, United States Martin Malina, London, United Kingdom

10:30-10:35 Outcomes from open surgical repair of Extent IV thoracoabdominal aortic aneurysms: Experience with the use of adjunctive distal perfusion, cerebrospinal drainage, MEP monitoring and Coselli branched grafts Mark Field, Warrington, United Kingdom 10:35-10:40

Audience participation and discussion

10:40-10:45 Selective vs. routine preoperative coronary computerised tomography angiography for patients undergoing thoracoabdominal aortic aneurysm open repair Maria Katsarou, Milan, Italy Audience participation and discussion

10:50-10:55 Short-term outcomes of VBX stent grafts compared to Atrium iCAST stent grafts for fenestrated endovascular repair

Celine Deslarzes-Dubuis, Stanford, United States 10:55-11:00

Audience participation and discussion

11:00-11:05 Outcomes of percutaneous endovascular repair of thoracic and thoraco-abdominal aneurysms with larger introducers and in patients with previous open or percutaneous accesses

Andrea Melloni, Milan, Italy 11:05-11:10

Audience participation and discussion

11:10-11:15 Systematic multistaged endovascular repair of thoracoabdominal aneurysms with fenestrated and branched endografts (STEAR study)

Maria Katsarou, Milan, Italy 11:15-11:20

Audience participation and discussion

11:20-11:25 Totally percutaneous access for thoracic and thoracoabdominal endovascular aortic repair: Upper extremity access

Andrea Melloni, Milan, Italy 11:25-11:30

Audience participation and discussion

11:30-11:35 Aortic aneurysms in Takayasu’s arteritis – outcomes after open surgical treatment Harishankar Ramachandran Nair, Trivandrum, India 11:35-11:40

Audience participation and discussion

11:40-11:45 Endovascular therapy for ischaemic vs. non-ischaemic complicated acute type B aortic dissection Ahmed Eleshra, Hamburg, Germany 11:45-11:50

Audience participation and discussion

11:50-11:55 The use of frozen elephant trunk techniques for acute and chronic type B dissections Celia Riga, London, United Kingdom 11:55-12:00

Audience participation and discussion

12:00-12:05 FEVAR in octogenarians 12:05-12:10

Bijan Modarai, London, United Kingdom

Audience participation and discussion

12:10-12:15 The place of renal revascularisation of late occluded renal artery following complex aortic repair Nikolaos Tsilimparis, Munich, Germany 12:15-12:20

Audience participation and discussion

12:20-12:25 Procedure complexity in fenestrated and branched endovascular

aneurysm repair depends on number of revascularised branches

Kevin Mani, Uppsala, Sweden 12:25-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

C X Thoracic Aortic Global Stars and Rising Stars Chairing: F rank Criado, Baltimore, United States Asimakis Gkremoutis, London, United Kingdom

13:30-13:35 What we have learned from in vitro chimney studies

Kak Khee Yeung, Amsterdam, Netherlands 13:35-13:40

Audience participation and discussion

13:40-13:45 First experience with a noval device with inner branches and funnel like ostium in the treatment of thoracoabdominal and juxrarenal aneurysms as a first step in the development of an “off-the-shelf” stent graft Ahmed Koshty, Siegen, Germany

2019

41

Tuesday 16 April 2019

10:45-10:50

Vascular & Endovascular Challenges Update 13:45-13:50

Audience participation and discussion

13:50-13:55 Experience with covered stents in FEVAR procedures

Daniela Branzan, Leipzig, Germany 13:55-14:00

Audience participation and discussion

14:00-14:05 Global experience with balloon-expandable covered stents as chimney grafts: Insights from the PERICLES registry

Konstantinos Donas, Münster, Germany 14:05-14:10

Audience participation and discussion

14:10-14:15 Results of a novel double layer PTFE graft in the thoracic aorta

Ralf Kolvenbach, Dusseldorf, Germany 14:15-14:20

Audience participation and discussion

14:20-14:25 TEVAR for aortic dissection combined with visceral artery ischaemia

Chang Shu, Beijing, China 14:25-14:30

Tuesday 16 April 2019

Audience participation and discussion

Thoracic Aortic Abstract Presentations

14:30-14:35 Matching analysis between classic and arch first technique in frozen elephant trunk for aortic arch repair Alessandra Fittipaldi, Salerno, Italy 14:35-14:40

Audience participation and discussion

14:40-14:45 Endovascular outcomes of aortic arch disease treated with multiple parallel stents technique Baolei Guo, Shanghai, China 14:45-14:50

Audience participation and discussion

14:50-14:55 Methods and clinical outcomes of in situ fenestration for aortic arch revascularisation during thoracic endovascular aortic repair

Hailei Li, Shenzhen, China 14:55-15:00

Audience participation and discussion

15:00-15:05 Complications of cerebrospinal fluid drainage in TEVAR narrows the therapeutic window Gokay Deniz, Ankara, Turky 15:05-15:10

Audience participation and discussion

15:10-15:15 Mid-term results of TEVAR for thoracic aortic pathologies – a singlecentre experience Carlota Fernandez Prendes, Oviedo, Spain 15:15-15:20

Audience participation and discussion

15:20-15:25 Outcomes after one-stage vs. two-stage open repair of type II thoracoabdominal aortic aneurysms Drosos Kotelis, Aachen, Germany 15:25-15:30

Audience participation and discussion

CX Vascular Access Abstract Presentations Dark Room Learning Centre – 13:30-17:52

Vascular Access Abstract Presentations Chairing: J ames Gilbert, Oxford, United Kingdom Kate Steiner, Stevenage, United Kingdom

13:30-13:35 Long-term patency of arteriovenous fistulas as a vascular access in paediatric age group patients with end-stage renal disease – Egyptian experience Hassan Lotfy, Alexandria, Egypt 13:35-13:38

Audience participation and discussion

13:38-13:43 Systematic review and meta-analysis of randomised-controlled trials comparing drug-coated balloons angioplasty vs. plain balloon angioplasty in arteriovenous fistulae salvage

Fui Jin Chong, Singapore 13:43-13:46

Audience participation and discussion

13:46-13:51 Brachial vein transposition versus arteriovenous grafts – 24 months results Ines Antunes, Porto, 13:51-13:54

42 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update 13:54-13:59 Results of a pivotal trial of vonapanitase to increase fistula use for haemodialysis and secondary patency

Steven Burke, Sudbury, United States 13:59-14:02

Audience participation and discussion

14:02-14:07 Our experience of primary patency of PTFE patch closure at the venous anastomotic site for arteriovenous graft thrombosis

Chandrashekar AR, Bangalore, India 14:07-14:10

Audience participation and discussion

14:10-14:15 Use undersized stent grafts to treat haemodialysis access-related severe central venous occlusive disease: Midterm results

Chien Hwa Chang, New Taipei City, Taiwan 14:15-14:18

Audience participation and discussion

14:18-14:23 Over 80s renal failure patients – radiocephalic vs. brachiocephalic outcomes Nuno Coelho, Vila Nova de Gaia, Portugal Audience participation and discussion

14:26-14:31 The need for an early fistuloplasty as a poor prognostic factor for vascular access patency Mohamed Elzawahry, London, United Kingdom 14:31-14:34

Audience participation and discussion

14:34-14:39 “Low-flow“ vascular access grafts 14:39-14:42

Marco Franchin, Varese, Italy

Audience participation and discussion

14:42-14:47 The Surfacer system – a single-centre prospective observational study in central venous occlusion to demonstrate safety and efficacy

Tobias Steinke, Dusseldorf, Germany 14:47-14:50

Audience participation and discussion

14:50-14:55 Long-term outcomes of a new technique of brachiobasilic elevation fistula for haemodialysis Manel Gharbi, Besancon, France 14:55-14:58

Audience participation and discussion

14:58-15:03 Significant reduction of radiation exposure using wrist access with the second generation 4F endoAVF catheter system to create endovascular AV fistulae Tobias Steinke, Dusseldorf, Germany 15:03-15:06

Audience participation and discussion

15:06-15:11 Can we define adequate surveillance timing for arteriovenous grafts?

Andrej Isaak, Basel, Switzerland 15:11-15:14

Audience participation and discussion

15:14-15:19 Longivety and outcomes of central double lumen permanent catheters for haemodialysis Mohamed Ismail, Cairo, Egypt 15:19-15:22

Audience participation and discussion

15:22-15:27 Stent grafting as first intervention for venous stenosis improves outcomes in incident arteriovenous grafts

Andrej Isaak, Basel, Switzerland 15:27-15:30

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS ON WORKSHOPS

Vascular Access Abstract Presentations Chairing: H iren Mistry, London, United Kingdom Paul Gibbs, Portsmouth, United Kingdom

16:00-16:05 Risk of iodinated contrast use in predialysis patients undergoing percutaneous endovascular arteriovenous fistula formation: A singlecentre experience Aurangzaib Khawaja, Birmingham, United Kingdom 16:05-16:08

Audience participation and discussion

16:08-16:13 Artificial intelligence and functional maturation of radiocephalic arteriovenous fistula Ali Kordzadeh, Broomfield, United Kingdom 16:13-16:16

Audience participation and discussion

16:16-16:21 A study of upper extremity AV grafts and single-stage basilic vein transposition: A single-centre analysis from South India

Luv Luthra, Bangalore, India 16:21-16:24

Audience participation and discussion

16:24-16:29 A new technique to repair high-flow arteriovenous fistula using a novel external support device Vladimir Matoussevitch, Cologne, Germany 16:29-16:32

Audience participation and discussion

2019

43

Tuesday 16 April 2019

14:23-14:26

Vascular & Endovascular Challenges Update 16:32-16:37 Distal revascularisation and interval ligation for the treatment of dialysis access steal syndrome: A systematic review

Ali Kordzadeh, Broomfield, United Kingdom 16:37-16:40

Audience participation and discussion

16:40-16:45 Transradial approach for arteriovenous fistula salvage: An Indian perspective Pranay Pawar, Chennai, India 16:45-16:48

Audience participation and discussion

16:48-16:53 Revision using distal inflow for the treatment of dialysis access steal syndrome: A systematic review Ali Kordzadeh, Broomfield, United Kingdom 16:53-16:56

Audience participation and discussion

16:56-17:01 Paediatric haemodialysis in the UK – time for national guidance?

Muhammad Khurram, London, United Kingdom 17:01-17:04

Audience participation and discussion

17:04-17:09 VITAE Registry: Vascular access Indigo CATD thromboaspiration registry Marco Tadiello, Castronno, Italy

Tuesday 16 April 2019

17:09-17:12

Audience participation and discussion

17:12-17:17 Arteriovenous fistula surveillance using 3D tomographic ultrasound

Steven Rogers, Manchester, United Kingdom 17:17-17:20

Audience participation and discussion

17:20-17:25 Ultrasound assessment of arteriovenous access stenosis in native arteriovenous fistulae and correlation with histology analysis

Kate Steiner, Stevenage, United Kingdom 17:25-17:28

Audience participation and discussion

17:28-17:33 The impact of type of anastomosis of AVF in ESRD on the rate of maturation: A randomised controlled trial

Mohammed Elkassaby, Galway, Ireland 17:33-17:36

Audience participation and discussion

17:36-17:41 Interim results of a randomised controlled trial comparing the incidence of steal syndrome in two types of antecubital fossa arteriovenous fistulae Aaron Goh, London, United Kingdom 17:41-17:44

Audience participation and discussion

17:44-17:49 Haemodialysis access induced distal ischaemia; effectiveness of different types of revisional surgeries

Hesham Aly Mohamed Sharaf Eldin, Mansoura, Egypt 17:49-17:52

Audience participation and discussion

CX Acute Stroke Selected Posters Presentations l Poster Gallery – 12:00-12:30

Acute Stroke Poster Presentations

Chairing: Daryll Baker, London, United Kingdom Moderators: Dominic Howard, Oxford, United Kingdom Nick Hopkins, Buffalo, United States

12:00-12:03 Two strategies in patients with severe bilateral carotid stenosis in cardiac surgery plan Fernando Belcastro, Buenos Aires, Argentina 12:03-12:05

Audience participation and discussion

12:05-12:08 Endovascular treatment of rare supra-aortic steal syndrome

Nelson Camacho, Lisbon, Portugal 12:08-12:10

Audience participation and discussion

12:10-12:13 Evaluation of [18F]NaF uptake in symptomatic and asymptomatic carotid plaques and assessment of predictive vulnerable plaque patterns Marta Mari, Padua, Italy 12:13-12:15

44 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update 12:15-12:18 External to internal carotid transposition to treat a symptomatic internal carotid aneurysm: An open surgical challenge on the endovascular era Nelson Camacho, Lisbon, Portugal 12:18-12:20

Audience participation and discussion

12:20-12:23 A case series about the changed antiplatelet protocol for carotid endarterectomy in a teaching hospital: More patients with complications?

Martijn Marsman, Tilburg, Netherlands 12:23-12:25

Audience participation and discussion

12:25-12:28 Utility of ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma – feasibility and temporal dependance study Ammara Usman, Cambridge, United Kingdom Audience participation and discussion

Tuesday 16 April 2019

12:28-12:30

CX Vascular Access Selected Posters Presentations Poster Gallery – 12:30-13:00

Vascular Access Poster Presentations

Chairing: James Gilbert, Oxford, United Kingdom Moderator: Robert Jones, Birmingham, United Kingdom

12:30-12:33 Use of incisional negative pressure wound therapy in preventing brachial-basilic arteriovenous fistula infection

Muthaiah Arunaachalam, Singapore 12:33-12:35

Audience participation and discussion

12:35-12:38 Paclitaxel-coated balloon vs. plain angioplasty balloon for dysfunctional dialysis access: A prospective double-blinded randomised controlled trial – six-month result shows promising outcome in DCB group Skyi Yin Chun Pang, Hong Kong 12:38-12:40

Audience participation and discussion

12:40-12:43 A prospective randomised study comparing the use of an uncoated balloon for primary balloon angioplasty vs. hydrostatic dilatation to prepare the cephalic vein prior to creation of radiocephalic arteriovenous for dialysis Mohamed Rizk, Cairo, Egypt 12:43-12:45

Audience participation and discussion

12:45-12:48 Covered stent grafts are an important endovascular option for haemodialysis patients Tobias Steinke, Dusseldorf, Germany 12:48-12:50

Audience participation and discussion

12:50-12:53 Five years’ follow-up to of endovascular management of arteriovenous fistula complications

Nelson Encarnacion Santana, Mexico City, Mexico 12:53-12:55 Audience participation and discussion 12:55-12:58 Arterial percutaneous angioplasty in haemodialysis access-induced distal ischaemia Ines Antunes, Porto, Portugal 12:58-13:00

Audience participation and discussion

2019

45

Vascular & Endovascular Challenges Update

CX Venous Selected Posters Presentations l Poster Gallery – 13:00-13:30

Venous Poster Presentations

Chairing: Alun Davies, London, United Kingdom Moderators: Chung Sim Lim, London, United Kingdom Mitchell Silver, Columbus, United States

Tuesday 16 April 2019

13:00-13:03 Adrenal vein sampling for primary aldosteronism: Long-term experience from a national referral centre

Anita Dobrovolec, Velenje, Slovenia 13:03-13:05

Audience participation and discussion

13:05-13:08 Concomitant sclerotherapy during endovenous laser ablation

Chia-Ying Lin, Taichung, Taiwan 13:08-13:10

Audience participation and discussion

13:10-13:13 Radiofrequency ablation of isolated calf perforator reflux; a simple and highly effective treatment for resistant venous ulcers

Nalaka Gunawansa, Colombo, Sri Lanka 13:13-13:15

Audience participation and discussion

13:15-13:18 Aspirin is more effective than LMWH in prevention of rethrombosis in pregnancy Mosaad Soliman, Mansoura, Egypt 13:18-13:20

Audience participation and discussion

13:20-13:23 Residual reflux despite technical successful treatment of great saphenous vein incompetence using plethysmography and Duplex ultrasound: One-year data Oskar Nelzen, LinkĂśping, Sweden 13:23-13:25

Audience participation and discussion

13:25-13:28 New approach for hemorrhoidal disease by intravascular ultrasound and iliac venous system stenting Juan Guilleuma, Madrid, Spain 13:28-13:30

46 2019

Audience participation and discussion

Wednesday 17 April 2019

Wednesday

Plenary Programme & Additional Events

Wednesday Vascular & Endovascular Challenges Update Main Auditorium Aortic Podium 1st Session

52

Abdominal Aortic Challenges

53

CX Additional Events

CX Peripheral Techniques & Technologies (live & edited cases)

58

CX Venous Techniques & Technologies (edited cases) – Day 1

60

CX Venous Workshop – Day 1

60

Vascular Access Masterclass

62

iWounds 64 CX Vascular Malformations

65

CX Aortic Workshop – Day 2

67

CX Peripheral Workshop – Day 2

68

CX iWounds Workshop – Day 1

69

CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 70 CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1

73

CX Thoracic Aortic Abstract Presentations – Day 2

75

CX Peripheral Arterial Selected Posters Presentations – Day 2

76

An Introduction to Vascular Surgery – Day 1

78

Wednesday 17 April 2019

LINC@CX 58

Vascular & Endovascular Challenges Update

Wednesday 17 April 2019 AORTIC PODIUM 1ST SESSION

Upper Main Auditorium – 08:00-10:00

Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany Moderator: Michel Makaroun, President SVS, Pittsburgh, United States

Abdominal Aortic

08:00-08:07 Podium 1st: ACT-guided heparinisation during non-cardiac arterial interventions: First results of the ACTION trial

Arno Wiersema, Amsterdam, Netherlands 08:07-08:14 Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR

Marc Schermerhorn, Boston, United States 08:14-08:21 Podium 1st: Exercise for abdominal aortic aneurysm patients: Early results from the AAA Get Fit Trial

Charles McCollum, Manchester, United Kingdom Audience participation and discussion

08:21-08:31

08:31-08:38 Podium 1st: Early results and implication of internal iliac preservation on quality of life Fabio Verzini, Turin, Italy 08:38-08:45 Podium 1st: EVAR plus endoanchors in the treatment of short proximal necks is a viable option: Two-year clinical results

Frank Arko, Charlotte, United States Audience participation, discussion and polling

08:45-08:55

08:55-09:02 Podium 1st: FRONTIER IV data with a large bore closure device

Daniela Branzan, Leipzig, Germany

Wednesday 17 April 2019

09:02-09:09 Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy

Bijan Modarai, London, United Kingdom 09:09-09:16 Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE

Hence Verhagen, Rotterdam, Netherlands Audience participation, discussion and polling

09:16-09:26

Thoracic Aortic

Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Frank Vermassen, Ghent, Belgium 09:26-09:33 Podium 1st: Thirty-day clinical results of global cohort with new thoracic aortic endograft Fabio Verzini, Turin, Italy 09:33-09:40 Podium 1st: Use of inner branches in complex aneurysms – early results of the Iberian Study

Jorge Fernández Noya, Santiago de Compostela, Spain 09:40-09:47 Podium 1st: T-branch registry: Results of an off-the-shelf endograft for thoracoabdominal aneurysms

Martin Austermann, Münster, Germany 09:47-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee Symposium: Expanding aortic treatment indications

Chairing: Robert Rhee, New York, United States

10:03-10:09 The importance of precise placement, optimal seal and conformability in treating challenging thoracic aortic cases

Dittmar Böckler, President DGG, Heidelberg, Germany 10:09-10:15 An innovative solution to expand on-label aortic treatment

Salma El Batti, Paris, France 10:15-10:21 A treatment algorithm for EVAR: Anatomical considerations, disease state and proper device selection Michel Reijnen, Arnhem, Netherlands 10:21-10:28

52 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update

ABDOMINAL AORTIC CHALLENGES

Upper Main Auditorium – 10:30-18:00

Edited case

Chairing: Robert Rhee, New York, United States

10:30-11:00 Edited case: Expanding EVAR indications with a next-generation AAA endograft conforming to 90-degree neck angulations and seal in short 10mm necks Jorge Fernández Noya, Santiago de Compostela, Spain

D urability of endovascular aneurysm repair and the NICE guidelines

11:00-12:30 Chairing: Roger Greenhalgh, London, United

Kingdom

Moderators: Tilo Kölbel, Hamburg, Germany Maarit Venermo, Helsinki, Finland

Live case with virtual reality from Paris

Low-profile abdominal aortic stent graft (30min)

Stéphan Haulon, Le Plessis Robinson, France

NICE aortic guidelines – the latest (5min)

Andrew Bradbury, Birmingham, United Kingdom

EVAR – a standard of care (5min)

Tara Mastracci, London, United Kingdom

Sac reduction as primary indicator of success after EVAR (5min)

Vincent Riambau, Barcelona, Spain

Audience participation, discussion and polling (10min)

Estimation of Long-Term Aortic Risk (LEAR) Model to improve EVAR surveillance (5min) Peter Holt, London, United Kingdom

EVAR durability and endoleaks in 2019 the US perspective (5min)

Ronald Dalman, Vice-President SVS, Stanford, United States

Indications for reinterventions after EVAR (5min)

Lars Lönn, Copenhagen, Denmark

Audience participation, discussion and polling (10min)

Optimising surveillance and reintervention strategy following elective EVAR Fiona Rohlffs, Hamburg, Germany (4min)

Maarit Venermo, Helsinki, Finland (4min)

Lois Kim, Cambridge, United Kingdom (10min)

David Epstein, Granada, Spain (5min)

Roger Greenhalgh, London, United Kingdom (1min)

Audience participation, discussion and polling (10min)

12:20-12:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Lunch symposium: Over 15 years of experience with a reliable, proven, trusted balloon-expandable covered stent Chairing: Jean-Paul de Vries, Groningen, Netherlands

12:30-12:40 Reliable performance and proven long-term results of a balloonexpandable covered stent Eric Verhoeven, Nuremberg, Germany 12:40-12:50 How does the leading balloon-expandable covered stent make a difference?

Tilo Kölbel, Hamburg, Germany 12:50-13:00

Audience participation and discussion

2019

53

Wednesday 17 April 2019

NICE AAA draft guidelines: a viewpoint from Wales (5min)

Louis Fligelstone, Swansea, United Kingdom

Vascular & Endovascular Challenges Update

G lobal recruitment into the Vascular Specialty This session is in support of the Vascular Society for Great Britain and Ireland’s efforts to tackle the slow recruitment into the Vascular Specialty.

Chairing: Trevor Cleveland, President BSIR, Sheffield, United Kingdom Moderator: Ronald Dalman, Vice-President SVS, Stanford, United States 13:30-13:35 The sooner the better – How can medical students be attracted to (vascular) surgery Hans-Henning Eckstein, Munich, Germany 13:35-13:40 Recruitment into the venous specialty in Wales

Louis Fligelstone, Swansea, United Kingdom 13:40-13:45

Audience participation and discussion

13:45-13:50 The European perspective

Henrik Sillesen, President ESVS, Copenhagen, Denmark 13:50-13:55 The US perspective Michel Makaroun, President SVS, Pittsburgh, United States 13:55-14:00

Audience participation and discussion

14:00-14:05 The Latin American perspective

Alberto Muñoz, President WFVS, Bogotá, Colombia 14:05-14:10 The EBVS perspective

Armando Mansilha, President EBVS, Porto, Portugal

14:10-14:15 The UK perspective

Sophie Renton, Secretary General VSGBI, London, United Kingdom 14:15-14:20

Audience participation, discussion and polling

Volume and outcomes

Chairing: Janet Powell, London, United Kingdom Moderator: Eric Verhoeven, Nuremberg, Germany

Wednesday 17 April 2019

14:20-14:27 Impact of the patient risk on the volume-outcome effect for AAA surgery Matthias Trenner, Munich, Germany 14:27-14:34 Volume outcome in AAA repair

Marc Schermerhorn, Boston, United States 14:34-14:41 Systematic review of volume-outcome relationship in open and endo AAA repair Dittmar Böckler, President DGG, Heidelberg, Germany 14:41-14:48 Regionalisation of ruptured abdominal aortic aneurysm is safe and cost-effective Clement Darling III, Albany, United States 14:48-15:00

Audience participation, discussion and polling

Challenging aortic issues

Chairing: Frans Moll, CX Advisory Board, Utrecht, Netherlands Moderator: Ronald Dalman, Vice-President SVS, Stanford, United States 15:00-15:07 Innovation in 3D navigation using light instead of fluoroscopy: First-in-human trial and case review

Joost van Herwaarden, Utrecht, Netherlands 15:07-15:14 Risk prediction model of in-hospital mortality following elective abdominal aortic aneurysm repair

Thomas Schmitz-Rixen, Immediate Past President DGG, Frankfurt, Germany 15:14-15:21 Late secondary rupture after EVAR: 10 years' experience

Vincenzo Brizzi, Bordeaux, France 15:21-15:30

Audience participation, discussion and polling

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Tea symposium: From infrarenal AAA to complex TAAA repair: Endovascular outcomes and future hybrid innovations Chairing: David Murray, Altrincham, United Kingdom

15:32-15:40 Early results from a registry of endovascular repair of abdominal aortic aneurysm David Murray, Altrincham, United Kingdom 15:40-15:48 Fenestrated endovascular treatment of juxtarenal and suprarenal aortic aneurysms Randy Moore, Chestermere, Canada 15:48-15:56 Future innovations to address complex TAAA repair

Sebastian Debus, Hamburg, Germany

54 2019

Vascular & Endovascular Challenges Update

Challenging aortic issues (continued)

Chairing: Tara Mastracci, London, United Kingdom Moderator: Tilo Kölbel, Hamburg, Germany 16:00-16:10

X Debate: Hostile necks should be treated with standard EVAR C devices For the motion: 16:05-16:10 Hence Verhagen, President Elect Dutch Vascular Society, Rotterdam, Netherlands Against the motion: 16:05-16:10 Giovanni Torsello, Münster, Germany

16:10-16:15 Audience participation, discussion and polling 16:15-16:22 On-label treatment of short and angulated necks with a new conformable EVAR device Robert Rhee, New York, United States 16:22-16:29 Gender disparities in the outcome of aortic repair

Janet Powell, London, United Kingdom 16:29-16:36 Impact of female gender in the outcomes of severe aortoiliac obstructive disease Michele Antonello, Padua, Italy 16:36-16:43 Patients with familial abdominal aortic aneurysm have more complications and a higher 30-day mortality after EVAR

Hence Verhagen, Rotterdam, Netherlands

16:50-17:05

Audience participation and discussion

17:05-17:15

X Debate: The vast majority of failed EVARs can be treated C endovascularly For the motion: 17:05-17:10 Jean-Pierre Becquemin, Champigny-sur-Marne, France Against the motion: 17:10-17:15 Michel Makaroun, Pittsburgh, United States

17:15-17:20

Audience participation, discussion and polling

17:20-17:27 Embolisation of renal artery aneurysms

Joo-Young Chun, London, United Kingdom 17:27-17:34 Management of visceral artery aneurysms

Lindsay Machan, Vancouver, Canada 17:34-17:41 Sac embolisation during EVAR – results from a prospective randomised study Dominique Fabre, Le Plessis Robinson, France 17:41-17:48 Endoleak diagnosis and clinical outcomes of embolisation with a liquid embolic agent Frank Arko, Charlotte, United States 17:48-18:00

Audience participation and discussion

2019

55

Wednesday 17 April 2019

16:43-16:50 The changing face of aortic disease – the implications of an ageing population Dominic Howard, Oxford, United Kingdom

Vascular & Endovascular Challenges Update

Monday 15 April 2019

Tuesday 16 April 2019

Wednesday 17 April 2019

Thursday 18 April 2019

56 2019

Wednesday 17 April 2019

Wednesday

Additional Events

2019

57

Vascular & Endovascular Challenges Update

LINC@CX l Lower Main Auditorium – 08:00-09:30

P ioneering techniques for BTK revascularisation in CLI

Moderator: Giancarlo Biamino, Mercogliano, Italy Moderator: Dierk Scheinert, Leipzig, Germany Panel: Andrej Schmidt, Leipzig, Germany Panel: Marianne Brodmann, Graz, Austria Panel: Daniela Branzan, Leipzig, Germany Panel: Luis Mariano Palena, Abano Terme, Italy 08:00-08:10 Percutaneous deep venous arterialisation for end-stage CLI – current experience Daniela Branzan, Leipzig, Germany 08:10-08:25 Edited case: Percutaneous deep venous arterialisation

Andrej Schmidt, Leipzig, Germany 08:25-08:35 Latest experience with a minimal metal solution technology for focal sealing of dissections Marianne Brodmann, Graz, Austria 08:35-08:45 Local drug delivery: Early results with sirolimus in BTK arteries

Dierk Scheinert, Leipzig, Germany 08:45-09:00 Edited case: Local delivery of xylocaine for local anaesthesia during treatment of highly calcified arteries Andrej Schmidt, Leipzig, Germany 09:00-09:10 Real-world experience with the Lutonix DCB in BTK arteries

Luis Mariano Palena, Abano Terme, Italy 09:10-09:25 Edited case: BTK recanalisation with DCB treatment and focal scaffolds Andrej Schmidt, Leipzig, Germany

Wednesday 17 April 2019

09:25-09:30

Discussion

CX Peripheral Techniques & Technologies (live & edited cases) l Lower Main Auditorium – 09:30-17:30

Peripheral live and edited cases

Chairing: Barry Katzen, Miami, United States Moderator: Gunnar Tepe, Rosenheim, Germany

09:30-10:00 Live case from Bad Krozingen: The rationale for using a swirling flow stent in combination with DCB Thomas Zeller, Bad Krozingen, Germany 10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee Symposium: The rationale and evidence for focal dissection repair Chairing: Marianne Brodmann, Graz, Austria

10:03-10:10 A minimal metal solution for dissection repair

David Deaton, New York, United States 10:10-10:17 TOBA II trial one-year results

Marianne Brodmann, Graz, Austria

10:17-10:24 Optimised treatment strategies for post-PTA dissection

Andrew Holden, Auckland, New Zealand 10:24-10:28

58 2019

Discussion

Vascular & Endovascular Challenges Update

Peripheral live and edited cases (continued)

Chairing: Barry Katzen, Miami, United States Moderator: Gunnar Tepe, Rosenheim, Germany

10:30-11:00 Edited case: Excimer laser atherectomy in retrograde, no stump SFA case Max Amor, Essey-les-Nancy, France 11:00-11:30 Edited case: IN.PACT drug-coated balloon in AV access

Andrew Holden, Auckland, New Zealand 11:30-12:00 From simple to complex with an interwoven nitinol stent

Lorenzo Patrone, London, United Kingdom 12:00-12:30 Edited case: Challenging diabetic foot management with DCB

Luis Mariano Palena, Abano Terme, Italy 12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Peripheral live and edited cases (continued)

Chairing: Samuel Money, Phoenix, United States Moderator: Gunnar Tepe, Rosenheim, Germany

13:30-14:00 Live case with virtual reality from Bad Krozingen: Directional atherectomy plus drug-coated balloon in the common femoral artery Thomas Zeller, Bad Krozingen, Germany 14:00-14:30 Edited case: Using percutaneous deep vein arterialisation to treat end-stage critical limb ischaemia Andrew Holden, Auckland, New Zealand 14:30-15:00 Live case from Bad Krozingen: Orbital atherectomy in below-theknee lesions Thomas Zeller, Bad Krozingen, Germany

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Tea symposium: Data update on a safe and efficient DCB in lower limb

15:33-15:40 Long-term safety data: Deep analysis of the LEVANT 2 studies, analysis of Lutonix Global Registry, IDE AV and IDE BTK

Marianne Brodmann, Graz, Austria 15:40-15:47 Comparing SFA CTO to non-CTO subjects from the Levant 2, Levant 2 Continued Access, Global Registry and Long Lesion studies

Patrick Geraghty, St Louis, United States 15:47-15:54 Comparison of overall LTX BTK IDE six-month outcomes to Global Registry Marianne Brodmann, Graz, Austria 15:54-15:58

Audience participation and discussion

Peripheral live and edited cases (continued)

Chairing: Enrico Ascher, Brooklyn, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 16:00-16:30

ive case with virtual reality from Münster: New L balloon-expandable endoprosthesis in iliac lesions

Arne Schwindt, Münster, Germany

16:30-17:00

ive case from Bad Krozingen: Below-the-knee intervention with a L pedal access device Thomas Zeller, Bad Krozingen, Germany

17:00-17:30 How to manage repeating TLR

Luis Mariano Palena, Abano Terme, Italy

2019

59

Wednesday 17 April 2019

15:00-15:30 Edited case: Crossing occlusions for endovascular treatments remains a challenge – intraluminal approach

Trevor Cleveland, President BSIR, Sheffield, United Kingdom

Vascular & Endovascular Challenges Update

CX Venous Techniques & Technologies (edited cases) – Day 1 l Venous City – 09:30-10:30 and 13:00-13:30

CX Venous edited cases – Morning

Chairing: Stephen Black, London, United Kingdom Moderator: Steve Elias, Englewood, United States 09:30-09:50 Customised superficial therapy in advanced venous disease and ulceration Manj Gohel, Cambridge, United Kingdom 09:50-10:10 VenaSeal procedure

Kathleen Gibson, Bellevue, United States

10:10-10:30 Ultrasound valve diagnostics

Johann Christoph Ragg, Berlin, Germany

CX Venous edited cases – Afternoon

13:00-13:30 Interactive case vignettes

Manj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom

Wednesday 17 April 2019

CX Venous Workshop – Day 1 l Venous City – 09:30-15:30

Practical hands-on skills

Facilitators: T ristan Lane, London, United Kingdom Hayley Moore, London, United Kingdom

Cannulation

Roshan Bootun, London, United Kingdom

Device positioning

Tumescent anaesthesia

Gregory Fulton, Wilton, Ireland Saroj Das, Uxbridge, United Kingdom Joseph Shalhoub, London, United Kingdom Matthew Metcalfe, Stevenage, United Kingdom

D iagnostic venous ultrasound

Diagnostic venous ultrasound

Mary Ellis, London, United Kingdom Hema Rao, London, United Kingdom

PIUR tomographic ultrasound

Gurdeep Jandu, Bolton, United Kingdom

Thermal ablation techniques

Endothermal treatment (laser and RF) of very large veins

Denis Borsuk, Chelyabinsk, Russia

Dmitrii Rosukhovskii, St Petersburg, Russia ClosureFast EVRF

Steam ablation

Thermal station

Ravinder Singh-Ranger, Swindon, United Kingdom Attila Szabo, Budapest, Hungary Rudi Devers, Antwerp, Belgium Huw Davies, Birmingham, United Kingdom Rene Milleret, Montpellier, France Egemen Okur, Ankara, Turkey

Microwave therapeutic system for varicose vein

Brian Day, Nanjing, China Hands-on with the new SnakeBack technology

Philippe Rochon, Loos, France

60 2019

Vascular & Endovascular Challenges Update

Non-thermal ablation techniques

Flebogrif method for saphenous reflux

Marek Ilzecki, Lublin, Poland Tomasz Zubilewicz, Lublin, Poland

VariClose adhesive

Kursat Bozkurt, Istanbul, Turkey

ClariVein mechanochemical ablation

Leith Williams, Liverpool, United Kingdom VenaSeal closure device

Kathleen Gibson, Bellevue, United States

VenaBLOCK/VeinOFF/ICT

Talha Kocer, RD Global, Ankara, Turkey

Tributary treatment

Foam phlebectomy

Rochelle Wolfe, Minneapolis, United States

Aesthetic phlebology

Hand vein treatment options

Alexander Flor, Vienna, Austria

Surgical treatment of reticular veins

Sylvain Chastanet, Nice, France

Sclerotherapy

Foam sclerotherapy for tributaries

Isaac Nyamekye, Worcester, United Kingdom Foam sclerotherapy for truncal reflux

Gareth Bate, Solihull, United Kingdom

Plethysmography

Air plethysmography

Christopher Lattimer, London, United Kingdom Teresa Rola, London, United Kingdom

Strain gauge plethysmography

Oskar Nelzen, Linkรถping, Sweden

Lymphoedema

Surgical procedures for lymphoedema

Harry Voesten, Drachten, Netherlands

Aina Greig, London, United Kingdom

Alexander Lamprou, Groningen, Netherlands Graded hydrotherapy for lymphoedema

Compression techniques

Novel compression device

Erica Menegatti, Ferrara, Italy

Johann Christoph Ragg, Berlin, Germany

Compression bandaging techniques

Angela Williams, London, United Kingdom

Additional stations

Treatment of perforator veins

Steve Elias, Englewood, United States

Venous embryology and anatomy and virtual reality teaching

Jean-Francois Uhl, Paris, France Cynoacrylate glue to treat erectile dysfunction

Sriram Narayanan, Singapore Choosing between endovenous modalities

Armando Mansilha, Porto, Portugal AVM treatment strategy Hydroptherapy for leg oedema Assessment of swollen legs

Walter Wohlgemuth, Regensburg, Germany Sergio Gianesini, Ferrara, Italy Sarah Thomis, Leuven, Belgium

Decision making for pelvic vein disease

Neil Khilnani, New York, United States

PPG for dynamic assessment of venous function

Mohammed Aslam, London, United Kingdom

Saphenous sparing treatment

Sergio Gianesini, Ferrara, Italy

2019

61

Wednesday 17 April 2019

Sclerotherapy for reticular veins and telangiectasia

Margaret Gardner, Ashtead, United Kingdom

Claudine Hamel-Desnos, Caen, France

Matthieu Josnin, La Roche-sur-Yon, France

Vascular & Endovascular Challenges Update

CX Vascular Access Masterclass Pillar Hall Learning Centre – 08:00-17:55

Maintaining and optimising dialysis access Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

Introduction: Defining the problem

08:00-08:08 Why vascular access fails

Nicholas Inston, Birmingham, United Kingdom

08:08-08:16 Central venous catheters – are they bad or are they badly managed?

Haimanot Wasse, President of ASDIN, Chicago, United States

Preventing failure

08:16-08:24 The use of AVGs instead of CVCs helps to reduce infection rates in patients needing haemodialysis

Ioannis Loukopoulos, London, United Kingdom 08:24-08:32 Graft failure: How much is cannulation to blame?

Shawn Gage, Raleigh, United States 08:32-08:37

Audience participation and discussion

Stenosis 08:37-08:45

Are all stenoses the same?

Kate Steiner, Stevenage, United Kingdom

08:45-08:53 Preventing stenosis – the RADAR technique

Nirvana Sadaghianloo, Nice, France

Wednesday 17 April 2019

08:53-09:01 Preventing stenosis – pharmacological

Paul Gibbs, Portsmouth, United Kingdom 09:01-09:09 Preventing stenosis – mechanical

Nikolaos Karydis, London, United Kingdom 09:09-09:17 Can we prevent stenosis with AVGs?

David Kingsmore, Glasgow, United Kingdom 09:17-09:25 Drug-coated balloons in preventing restenosis in vascular access – the Lutonix AV Global Registry Panagiotis Kitrou, Patras, Greece

AVF stenosis: Case-based presentations Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

09:25-09:33

Surgical

Karl Illig, Tampa, United States

09:33-09:41 How to investigate and when to treat

Haimanot Wasse, President of ASDIN, Chicago, United States 09:41-09:49

Endovascular

09:49-09:57

USS-guided angioplasty

09:57-10:03

Audience participation and discussion

10:03-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Robert Jones, Birmingham, United Kingdom Olivier Pichot, Grenoble, France

Can we prevent thrombosis?

Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

10:30-10:38

Role of surveillance

10:38-10:44

Audience participation and discussion

Colin Deane, London, United Kingdom

T reating thrombosis in VA: Case-based presentations

10:44-10:52

Surgery

Teun Wilmink, Birmingham, United Kingdom

10:52-11:00

Interventional radiology

Robert Jones, Birmingham, United Kingdom

11:00-11:08

When to treat, when to give up

11:08-11:14

Audience participation and discussion

62 2019

Jason Wilkins, London, United Kingdom

Vascular & Endovascular Challenges Update

Treating vascular thoracic outlet stenosis

11:14-11:22

Surgical approaches

11:22-11:30

Radiological

11:30-11:36

Audience participation and discussion

Karl Illig, Tampa, United States

Jeffrey Hull, North Chesterfield, United States

Central stenosis

11:36-11:44 Classifying central venous stenosis: When to treat? How to treat?

John Aruny, New Haven, United States 11:44-11:50

Audience participation and discussion

Central occlusion

11:50-11:58

Recanalisation – inside/out

James Gilbert, Oxford, United Kingdom

11:58-12:06

Recanalisation – outside/in

Timothy Clark, Philadelphia, United States

12:06-12:21 The access algorithm: Can we define an algorithmic approach to vascular access preservation and maintenance?

Nicholas Inston, Birmingham, United Kingdom

Domenico Valenti, London, United Kingdom 12:21-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Lunch Symposium: New technologies and multi-disciplinary approach: How I treat failing access in my ESRD patients Chairing: Haimanot Wasse, President of ASDIN, Chicago, United States

Using WavelinQ for fistula creation

12:41-12:49

Patient with a stenosed fistula

12:49-12:57

Patient with a stenosed central vein

Ounali Jaffer, London, United Kingdom

Panagiotis Kitrou, Patras, Greece Tobias Steinke, Dusseldorf, Germany

I nnovations in vascular access: Technologies, techniques, and trial updates Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

Pre-access optimisation

13:30-13:38 Fist Assist: Coming to Europe for fistula vein enlargement

Tej Singh, Los Altos Hills, United States 13:38-13:46 Choosing the right vessel prep device to optimise long-term results for dialysis access patients Matteo Tozzi, Varese, Italy 13:46-13:54 Reducing pain for dialysis access patients: How to improve comfort by using a new balloon technology

Narayan Karunanithy, London, United Kingdom 13:54-14:09

Wednesday 17 April 2019

12:33-12:41

Audience participation and discussion

Pharmacology

14:09-14:17 Vonapanitase PATENCY-2 trial results in radiocephalic fistulae

Paul Gibbs, Portsmouth, United Kingdom 14:17-14:25 AV fistula outcomes following intra-operative pharmacologic intervention using a perivascularly delivered sirolimus formulation

Sriram Iyer, Cresskill, United States 14:25-14:37

Audience participation and discussion

Drug-coated balloons (trial updates)

14:37-14:41 Latest update on the Lutonix AV Global Registry & IDE Trial

Panagiotis Kitrou, Patras, Greece 14:41-14:49 A study of haemodialysis arteriovenous fistulae stenosis treated with Aperto Qizhuang Jin, Beijing, China 14:49-14:57 IN.PACT AV: Baseline data from the full cohort

Andrew Holden, Auckland, New Zealand

14:57-15:17 DCBs: Is the data on PVD applicable to vascular access?

Moderator: Nicholas Inston, Birmingham, United Kingdom Panel: P anagiotis Kitrou, Patras, Greece Andrew Holden, Auckland, New Zealand Robert Jones, Birmingham, United Kingdom Kate Steiner, Stevenage, United Kingdom 15:17-15:30

Audience participation and discussion

2019

63

Vascular & Endovascular Challenges Update 15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

AV fistulae

Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

16:00-16:08 Vascular access – using patient reporting to guide decision making

Melanie Field, Birmingham, United Kingdom 16:08-16:16 AV fistulae – VasQ device 16:16-16:28

Nikolaos Karydis, London, United Kingdom

Audience participation and discussion

Grafts and stent grafts

16:28-16:36 Avoiding central venous catheters: How early cannulation grafts decrease complications and improve patient care

Sapan Desai, Arlington Heights, United States 16:36-16:44 Thrombotic failures: Making the case for use of stent grafts to treat AV access circuits John Aruny, New Haven, United States 16:44-16:52 Viabahn stent for haemodialysis shunt: Efficacy, long segment recanalisation and prognostic factors for reintervention

Matteo Barattini, La Spezia, Italy 16:52-17:00 Results of stent graft placement to treat cephalic arch stenosis in hemodialysis patients with dysfunctional brachiocephalic arteriovenous fistulae Robert Jones, Birmingham, United Kingdom

Wednesday 17 April 2019

17:00-17:12

Audience participation and discussion

17:12-17:32

X Debate: Interventional nephrology improves dialysis patient C outcomes For the motion: 17:12-17:22 Haimanot Wasse, Chicago, United States Against the motion: 17:22-17:32 Paul Gibbs, Portsmouth, United Kingdom

17:32-17:42

Audience participation, discussion and polling

17:42-17:50

Summary and close of day 1

London Room Learning Centre – 08:00-12:30 In collaboration with the American College of Wound Healing and Tissue Repair

Wound care challenges

Chairing: Una Adderley, England, United Kingdom Moderator: Michael Edmonds, London, United Kingdom 08:00-08:10 The problem of underperforming ankle-brachial index measurements

Matjaz Span, Izola, Slovenia 08:10-08:20 Advances in diagnostic biomarkers and imaging for chronic wounds

Tomas Serena, President of AAWC, Warren, United States 08:20-08:30 Surgical wound healing by secondary intention management pathway – from assessment to treatment

Ian Chetter, Hull, United Kingdom 08:30-08:35

Audience participation and discussion

08:35-08:45 Designing services to optimise wound care: One-stop assessment clinics Naseer Ahmad, Manchester, United Kingdom 08:45-08:55 Imaging and adjudication of lower extremity wounds in arterial and venous clinical trials Raghu Kolluri, Columbus, United States 08:55-09:00

Audience participation and discussion

09:00-09:10 The importance of collaborative work between disciplines in wound care Keith Harding, Cardiff, United Kingdom

64 2019

Vascular & Endovascular Challenges Update 09:10-09:20 How to measure success in wound healing patients

Dave Bosanquet, Cardiff, United Kingdom 09:20-09:30 Setting up research studies with wound patients

Robert Hinchliffe, Bristol, United Kingdom 09:30-09:35

Audience participation and discussion

09:35-09:45 The role of podiatrists in wound healing

TBA

09:45-09:55 The approach to the ischaemic limb

Susan Matthews, Oldham, United Kingdom 09:55-10:00

Audience participation and discussion

10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Innovations in wound care

Chairing: Robert Hinchliffe, Bristol, United Kingdom Moderator: Keith Harding, Cardiff, United Kingdom 10:30-10:38

Optical detection of bacteria: Results from a multicentre clinical trial Tomas Serena, President of AAWC, Warren, United States

10:38-10:46 Wound outcomes, artificial intelligence and predictive analytics, necessary or nice to have William Ennis, Oak Lawn, United States 10:46-10:54

LeucoPatch Study

Magnus Löndahl, Lund, Sweden

10:54-11:02 MMP inhibitor dressing — Explorer study

Michael Edmonds, London, United Kingdom 11:02-11:09

Audience participation and discussion

11:09-11:17 Nitric oxide release dressing

Michael Edmonds, London, United Kingdom

11:17-11:25 Multicentre clinical study of healing of diabetic foot ulcers using EpiFix Bill Tettelbach, Marietta, United States 11:25-11:45 Edited case: Epifix – a credible option for hard to heal venous ulcers

Leanne Atkins, Wakefield, United Kingdom Audience participation and discussion

11:53-12:01 Therapeutic approaches for leg ulcers in patients with sickle cell disease John Lantis, New York, United States 12:01-12:09

Natrox Study

Paul Hayes, Cambridge, United Kingdom

12:09-12:17

TWO2 Study

Robert Frykberg, Phoenix, United States

12:17-12:25 Plastic surgery – alternatives to skin grafts

Edmund Fitzgerald O’Conner, London, United Kingdom 12:25-12:30

Audience participation and discussion

CX Vascular Malformations London Room Learning Centre – 13:30-18:00

Introduction

Speaker: Fiona Rohlffs, Hamburg, Germany

Basic background

Chairing: Fiona Rohlffs, Hamburg, Germany Moderator: Ian McCafferty, Birmingham, United Kingdom 13:32-13:40 ISSVA classification and what recent genetics can teach us in the management of VMs Laurence Boon, Brussels, Belgium 13:40-13:48 The need for a classification system in the treatment of high-flow VMs Fiona Rohlffs, Hamburg, Germany 13:48-13:56 Finding a useful classification for the treatment of low-flow VMs

Jocelyn Brookes, London, United Kingdom 13:56-14:00

Audience participation and discussion

Low-flow malformations

Chairing: Walter Wohlgemuth, Regensburg, Germany Moderator: Wayne Yakes, Englewood, United States 14:00-14:08 Management of low-flow VMs – technique and materials

Walter Wohlgemuth, Regensburg, Germany

2019

65

Wednesday 17 April 2019

11:45-11:53

Vascular & Endovascular Challenges Update 14:08-14:16 Results and long follow-up of treatment of low-flow VMs

Ian McCafferty, Birmingham, United Kingdom 14:16-14:24 Intraosseous vascular malformations

Fiona Rohlffs, Hamburg, Germany

14:24-14:32 Egyptian experience with capillary venous malformations

Tarek Radwan, Cairo, Egypt 14:32-14:40 Managing dangerous communications in low flow malformations – how to avoid disasters!

Robert Vogelzang, Chicago, United States 14:40-14:48 Extreme and complex venous lymphatic low-flow VM – results

Wayne Yakes, Englewood, United States 14:48-14:56 Patient radiation exposure from embolo-sclerotherapy of vascular malformations Leeying Giet, London, United Kingdom

Debate

Chairing: Fiona Rohlffs, Hamburg, Germany Moderator: Laurence Boon, Brussels, Belgium 14:56-15:16

ow do we define “cure” in low-flow VMs? Can we actually “cure H them” – Yes/No? Yes: Wayne Yakes, Englewood, United States No: Ian McCafferty, Birmingham, United Kingdom Yes: Robert Vogelzang, Chicago, United States No: Walter Wohlgemuth, Regensburg, Germany

15:16-15:24 Rebuttal

Wayne Yakes, Englewood, United States Ian McCafferty, Birmingham, United Kingdom Robert Vogelzang, Chicago, United States Walter Wohlgemuth, Regensburg, Germany

15:24-15:30

Conclusion and vote

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Wednesday 17 April 2019

High-flow malformations

Chairing: Robert Vogelzang, Chicago, United States Moderator: Wayne Yakes, Englewood, United States 16:00-16:08 Failure to control symptomatic AVMs using polymerising agents, salvaged by alcohol embolotherapy

Robert Vogelzang, Chicago, United States 16:08-16:16 Outcomes and follow-up of treatment of AVMs

Robert Vogelzang, Chicago, United States 16:16-16:24 Management of extreme AVMs

Wayne Yakes, Englewood, United States

Imaging

16:24-16:32 Imaging: pre- and post-treatment of VMs

Alex Barnacle, London, United Kingdom

The complimentary role of surgery in VMs

Chairing: Robert Vogelzang, Chicago, United States Moderator: Wayne Yakes, Englewood, United States

16:32-16:40 Deciding whether surgery and rapamycine are friends or enemies

Laurence Boon, Brussels, Belgium 16:40-16:48 Surgical management of arteriovenous malformation

Laurence Boon, Brussels, Belgium

Case presentations: Help, I am stuck!!

Panel: All speakers 16:48-17:48 Optimisation of methods of diagnostics and treatment of arteriovenous forms of congenital vascular malformations of extremities

Summary and closing remarks

17:48-18:00

66 2019

Speaker: Wayne Yakes, Englewood, United States

Vascular & Endovascular Challenges Update

CX Aortic Workshop – Day 2 l CX Aortic Workshop – 10:00-16:00 he CX Aortic Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the aortic technologies available. During break times there will be supervised learning with key opinion leaders.

Facilitators: A nna Prent, London, United Kingdom Kevin Mani, Uppsala, Sweden Mari Murumets, London, United Kingdom

Complex TAAA, BEVAR/FEVAR

10:00-10:30 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom 12:30-13:30 Introduction into complex BEVAR/FEVAR cases

CJJM Sikkink, Bemmel, Netherlands

Cydar EV

10:00-10:30 Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

12:30-13:30 Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

15:30-16:00 Fusion imaging simplified

Tom Carrell, Barrington, United Kingdom

Filler: Aneurysms and AVMs

Murat Katitas, Ankara, Turkey Egemen Okur, Ankara, Turkey

IVUS

10:00-10:30 Technical aspects of IVUS in EVAR and TEVAR procedures

Fabrizio Fanelli, Florence, Italy 12:30-13:30 Technical aspects of IVUS in EVAR and TEVAR procedures

Fabrizio Fanelli, Florence, Italy 15:30-16:00 Technical aspects of IVUS in EVAR and TEVAR procedures

Fabrizio Fanelli, Florence, Italy

TEVAR

10:00-10:30 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy 12:30-13:30 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy 15:30-16:00 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy

VesselNavigator Image Fusion

10:00-10:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands 12:30-13:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Blandine Maurel, Nantes, France 15:30-16:00 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands

2019

67

Wednesday 17 April 2019

15:30-16:00 Introduction into complex BEVAR/FEVAR cases

CJJM Sikkink, Bemmel, Netherlands

Vascular & Endovascular Challenges Update

CX Peripheral Workshop – Day 2 l CX Peripheral Workshop – 10:00-16:00 he CX Peripheral Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the peripheral technologies available. During break times there will be supervised learning with key opinion leaders.

Facilitator: F rank Vermassen, Ghent, Belgium ABPI and early detection of PAD

Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom

Carnelian, Pulsar-18 T3 and Fortress

Georg Bach, Biotronik, Bulach, Switzerland Dabra Excimer Laser Atherectomy Max Amor, Essey-les-Nancy, France

Charles Bailey, San Antonio, United States EndoWars Simulator Challenge BTK

Lynne Teece, Cook Medical, Bournemouth, United Kingdom Indigo System and large volume coils

Miriam Bondrop, Penumbra, Berlin, Germany Jaguar self-expanding nitinol stent

Robert Michal Proczka, Warsaw, Poland Lutonix BTK DCB

Luis Mariano Palena, Abano Terme, Italy

Wednesday 17 April 2019

See clearly: The value of peripheral arterial IVUS in decision making

Konstantinos Stavroulakis, Münster, Germany Stealth 360 Peripheral Orbital Atherectomy

Konstantinos Donas, Münster, Germany

Supera and peripheral guidewires

Sanchita Pasi, Abbott Vascular, Diegem, Belgium Tack – how I optimise balloon angioplasty?

Michael Lichtenberg, Arnsberg, Germany Temren atherectomy and Extender drug-coated balloon

Berna Ozata, Ankara, Turkey

Evren Ekingen, Batman, Turkey

The surgical Doppler probe

Jon Evans, Cardiff, United Kingdom

Treat optimally: The use of the Phoenix Atherectomy System

Theodosios Bisdas, Athens, Greece

How to simplify peripheral CTO recanalisation using fusion imaging with Vessel ASSIST

Nicolas Louis, Créteil, France (10:00-10:30 and 15:30-16:00) Vessel preparation with JetStream Atherectomy system and Ranger DCB Tibor Balazs, Bratislava, Slovakia

68 2019

Vascular & Endovascular Challenges Update

X C Day 1

Workshop –

CX iWound Workshop – 13:30-15:30

Facilitators: W illiam Ennis, Oak Lawn, United States Keith Harding, Cardiff, United Kingdom John Lantis, New York, United States Thomas O’Donnell, Boston, United States

Complex lower limb compression

Curettage wound debridement

Julie Stanton, United Kingdom David Gray, United Kingdom

Automatic ankle-brachial index system

Anita Roberts, Cardiff, United Kingdom Debridement and compression solutions

Epifix/ReGen

Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom

Bill Tettelbach, Marietta, United States Leanne Atkins, United Kingdom

Optical detection of bacteria

3C Patch autologous therapy

Oxygen therapy

Tomas Serena, Warren, United States Magnus Löndahl, Lund, Sweden Robert Frykberg, Phoenix, United States

Diabetic foot and infra-red tomography

Susan Matthews, Oldham, United Kingdom

Michael Edmonds, London, United Kingdom Geko for leg ulcers

Mölnlycke Granulox

Dawn Smiles, Leeds, United Kingdom Andrew Costello, Milton Keynes, United Kingdom

Footwear technology for diabetic foot ulcer patients

Sjef van Baal, Almelo, Netherlands

2019

69

Wednesday 17 April 2019

Vascular & Endovascular Challenges Update

CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 l Gallery Suite Learning Centre – 08:00-17:30

C X Peripheral Arterial Global Stars and Rising Stars Chairing: G ary Ansel, Columbus, United States Jonathan Beard, Sheffield, United Kingdom

08:00-08:05 Medicolegal issues including issues of content

Jonathan Beard, Sheffield, United Kingdom 08:05-08:10

Audience participation and discussion

08:10-08:15 High platelet reactivity and low platelet response to aspirin in patients with peripheral artery disease treated with percutaneous transluminal angioplasty of the arteries of lower limbs

Michal Juszynski, Warsaw, Poland 08:15-08:20

Audience participation and discussion

Wednesday 17 April 2019

08:20-08:25 Antiplatelet therapy in peripheral arterial disease: Umbrella review, meta-analysis and rationale for randomised trial after endovascular intervention Chris Twine, Bristol, United Kingdom 08:25-08:30

Audience participation and discussion

08:30-08:35 Indocyanine green fluorescence imaging in predicting wound healing after limb revascularisation

Nicla Settembre, Vandoeuvre Les Nancy, France 08:35-08:40

Audience participation and discussion

08:40-08:45 Open repair vs. endovascular treatment of complex aortoiliac lesions in low-risk patients Francesco Squizzato, Castelfranco V (TV), Italy 08:45-08:50

Audience participation and discussion

08:50-08:55 Treatment of iliac occlusive disease with new balloon-expandable endoprosthesis Ahmed Koshty, Siegen, Germany 08:55-09:00

Audience participation and discussion

09:00-09:05 Advances in treatment for aortoiliac occlusive disease

Frank Arko, Charlotte, United States 09:05-09:10

Audience participation and discussion

09:10-09:15 IN.PACT SFA Japan: Three-year clinical outcomes

Osamu Iida, Amagasaki, Japan 09:15-09:20

Audience participation and discussion

09:20-09:25 How do drug-coated balloons perform over the long term? An analysis of drug-coated balloon clinical outcomes 3–5 years postprocedure Giovanni Torsello, Münster, Germany 09:25-09:30

Audience participation and discussion

09:30-09:35 Do IDE study results mirror the results we see in our real-world patients? Insights from the three-year IN.PACT global study outcomes Gary Ansel, Columbus, United States 09:35-09:40

Audience participation and discussion

09:40-09:45 The SUPER B randomised controlled trial shows Viabahn endografts perform as well as open surgical femoropopliteal bypass grafts for two years Michel Reijnen, Arnhem, Netherlands 09:45-09:50

Audience participation and discussion

09:50-09:55 Heparin-bonded covered stents vs. bare metal stents for complex femoropopliteal artery lesions Csaba Csobay Novák, Budapest, Hungary 09:55-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

70 2019

Vascular & Endovascular Challenges Update

C X Peripheral Arterial Global Stars and Rising Stars Chairing: C liff Shearman, Southamptom, United Kingdom Asimakis Gkremoutis, London, United Kingdom

10:30-10:35 Comparative study of clinical outcomes of post-intervention good vs. poor pedal runoff in successful infrapopliteal angioplasty

Roshan Rodney Sengodan, Coimbatore, India 10:35-10:40

Audience participation and discussion

10:40-10:45 Changes and significance of T helper 9 T lymphocytes and interleukin-9 expression in patients with atherosclerotic chronic lower limb ischaemia Hassan Lotfy, Alexandria, Egypt 10:45-10:50

Audience participation and discussion

10:50-10:55 Risk of major amputation following revascularisation for intermittent claudication – a population-based study

Henrik Djerf, Gothenburg, Sweden 10:55-11:00

Audience participation and discussion

11:00-11:05 Tibial occlusive arterial disease in patients with chronic kidney disease; saving the limb and the kidney

Nalaka Gunawansa, Colombo, Sri Lanka 11:05-11:10

Audience participation and discussion

11:10-11:15 Autologous platelet-rich plasma in diabetic foot ulcers, new preparation technique Osama Ismail, Sohag, Egypt 11:15-11:20

Audience participation and discussion

11:20-11:25 Cost-effectiveness of the treatments for critical limb ischaemia in the elderly population Chloé Peters, Breda, Netherlands Audience participation and discussion

11:30-11:35 International consensus document on the treatment of chronic, nonhealing wounds Leanne Atkins, Wakefield, United Kingdom 11:35-11:40

Audience participation and discussion

11:40-11:45 Simultaneous and staged reconstruction on brachiocephalic arteries

Victor Kalinin, Nyagan, Russia 11:45-11:50

Audience participation and discussion

11:50-11:55 Impact of calcification modelling and planning circles with fusion imaging for the chronical total occlusion of iliac and femoropopliteal arteries Nicolas Louis, Créteil cx, France 11:55-12:00

Audience participation and discussion

12:00-12:05 Digital variance angiography as a risk reduction measure in peripheral endovascular interventions Peter Sotonyi, Budapest, Hungary 12:05-12:10

Audience participation and discussion

12:10-12:15 A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord allograft for the treatment of diabetic foot ulcers Bill Tettelbach, Marietta, United States 12:15-12:20

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Peripheral Arterial Abstract Presentations Chairing: T BA

13:30-13:35 The role of female gender on outcomes after stenting for aortoiliac arterial obstructive disease Francesco Squizzato, Castelfranco V. (TV), Italy 13:35-13:40

Audience participation and discussion

13:40-13:45 Biomechanical properties of subclavian and iliac arteries and implications for endovascular implant design

Tina Cohnert, Graz, Austria 13:45-13:50

Audience participation and discussion

13:50-13:55 Atherectomy for peripheral arterial disease

Bethany Wardle, Bristol, United Kingdom 13:55-14:00

Audience participation and discussion

14:00-14:05 Patient injuries in treatment of peripheral arterial disease in Finland: Review of national patient insurance charts

Minna Laukkavirta, Piikkio, Finland 14:05-14:10

Audience participation and discussion

2019

71

Wednesday 17 April 2019

11:25-11:30

Vascular & Endovascular Challenges Update 14:10-14:15 Distal embolisation at the below the knee and common femoral artery. Endovascular management Claudia Martinez, Dublin, Ireland 14:15-14:20

Audience participation and discussion

14:20-14:25 Blunt brachial artery injury in pediatric patients

Ahmed Naga, Alexandria, Egypt 14:25-14:30

Audience participation and discussion

14:30-14:35 Implementation of a multidisciplinary team approach in lower extremity amputation prevention programme for diabetic foot ulcers referral from primary healthcare to a tertiary centre vascular surgery clinic: Initial experience in an Asian population

Irene Ng, Singapore 14:35-14:40

Audience participation and discussion

14:40-14:45 Peripheral endovascular training in live animals: Appropriate hands on training in UK Shadeh Parsapour, London, United Kingdom 14:45-14:50

Audience participation and discussion

14:50-14:55 In-stent restenosis: Can vessel preparation improve procedural outcomes?

John Pigott, Toledo, United States 14:55-15:00

Audience participation and discussion

15:00-15:05 Safety and feasibility of vascular surgical procedures in nonagenarians in the era of increasing life expectancy and advanced ageing Zachary Chadwick, Staten Island, United States 15:05-15:10

Audience participation and discussion

15:10-15:15 Novel use of infrared thermal imaging to monitor graft patency of infrainguinal bypass in the immediate postoperative period and assess the angiosome concept

Julien Al Shakarchi, Halesowen, United Kingdom 15:15-15:20

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Wednesday 17 April 2019

Peripheral Arterial Abstract Presentations Chairing: P aul Moxey, London, United Kingdom Meryl Davis, London, United Kingdom

16:00-16:05 Safety and efficacy of covered endovascular reconstruction of the aortic bifurcation technique for complex aortoiliac occlusive disease: A single-centre experience Maria Antonella Ruffino, Turin, Italy 16:05-16:10

Audience participation and discussion

16:10-16:15 Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): Results from a multicentre randomised-controlled feasibility trial Graeme Ambler, United Kingdom 16:15-16:20

Audience participation and discussion

16:20-16:25 New scoring method to assess lesions involving the common femoral artery: Its relation to the stage of ischaemia and revascularisation method Alexey Baryshnikov, Chelyabinsk, Russia 16:25-16:30

Audience participation and discussion

16:30-16:35 Predictive failure’s results in the spectral analysis during the surveillance of infrainguinal revascularisation through vascular ultrasound Ricardo Bernardo da Silva, Londrina, Brazil 16:35-16:40

Audience participation and discussion

16:40-16:45 First-in-human results from a novel device providing real time, quantitative feedback on tissue perfusion during peripheral intervention Paul Hayes, Cambridge, United Kingdom 16:45-16:50

Audience participation and discussion

16:50-16:55 Distal hybrids for long chronic total occlusion of superficial femoral artery with severely compromised runoff

Pavel Kuryanov, Saint Petersburg, Russian Federation 16:55-17:00

Audience participation and discussion

17:00-17:05 Single-centre experience of subintimal recanalisation of femoropopliteal TASC II C-D disease using primary stenting with mimetic stents Ornella Pancheri, Livonia, Italy 17:05-17:10

72 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update 17:10-17:15 Chronic total occlusion of popliteal artery with vs. without distal landing zone: Comparison of PVI outcome

Pavel Kuryanov, Saint Petersburg, Russian Federation 17:15-17:20

Audience participation and discussion

17:20-17:25 Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenosis Marianne Brodmann, Graz, Austria 17:25-17:30

Audience participation and discussion

CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 l Dark Room Learning Centre

C X Venous Global Stars and Rising Stars (08:00-09:30) Chairing: A lun Davies, London, United Kingdom Johann Christoph Ragg, Berlin, Germany

08:05-08:10

Audience participation and discussion

08:10-08:15 Mid-term clinical outcome of minimally invasive vein restoring treatment method for chronic venous insufficiency

Serdar Gunaydin, Ankara, Turkey 08:15-08:20

Audience participation and discussion

08:20-08:25 Kissing stents for bilateral iliac venous outflow obstruction

Wen Hsien Hsu, Taipei, Taiwan 08:25-08:30

Audience participation and discussion

08:30-08:35 Obturator hook sign as a marker of chronic iliofemoral venous outflow obstruction in computed tomography venography: Multicentric evaluation of incidence and clinical significance

Andreia Coelho, Porto, Portugal 08:35-08:40

Audience participation and discussion

08:40-08:45 Acute improvement in haemodynamic parameters in patients treated with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension Ido Weinberg, Boston, United States 08:45-08:50

Audience participation and discussion

08:50-08:55 Early results of mechanochemical ablation, ClariVein, under automatic injection technique using a syringe pump

Insoo Park, Seoul, South Korea 08:55-09:00

Audience participation and discussion

09:00-09:05 Podium 1st: UK Celect Platinum data

Richard McWilliams, Liverpool, United Kingdom 09:05-09:10

Audience participation and discussion

09:10-09:15 Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting Robert Attaran, Guilford, United States 09:15-09:20

Audience participation and discussion

09:20-09:25 The use of cyanoacrylate in geriatric patients

Kathleen Gibson, Bellevue, United States 09:25-09:30

Audience participation and discussion

2019

73

Wednesday 17 April 2019

08:00-08:05 Viscous biomatrix sclerofoam for large recurrent varices

Johann Christoph Ragg, Berlin, Germany

Vascular & Endovascular Challenges Update

C X Venous Global Stars and Rising Stars (16:00-16:10) Chairing: M anj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom

16:00-16:05 Patient radiation exposure in endovascular unilateral iliofemoral stenting for chronic central venous outflow obstruction

Saima Waseem, Bexleyheath, United Kingdom 16:05-16:10

Audience participation and discussion

C X Venous Abstract Presentations (16:10-18:10)

16:10-16:15 Neuroinflamation and venous lesion of the neck veins in patients with Ménière’s disease Aldo Bruno, Benevento, Italy 16:15-16:20

Audience participation and discussion

16:20-16:25 Single-centre experience with open and endovascular treatment of the Nutcracker syndrome Alessandro Grandi, Milan, Italy 16:25-16:30

Audience participation and discussion

16:30-16:35 Age-adjusted D-dimer cut-off level and idiopathic distal deep vein thrombosis in outpatients Xavier Jimenez-Guiu, Barcelona, Spain 16:35-16:40

Audience participation and discussion

16:40-16:45 Early results of a randomised clinical trial of mechanochemical ablation vs. cyanoacrylate adhesive for the treatment of varicose veins Amjad Belramman, London, United Kingdom 16:45-16:50

Audience participation and discussion

16:50-16:55 Randomised controlled trial of compression following endothermal ablation (COMETA trial) Roshan Bootun, London, United Kingdom 16:55-17:00

Audience participation and discussion

Wednesday 17 April 2019

17:00-17:05 Long-term vein diameter reduction by perivenous hyaluronan instead of tumescence for endovenous procedures

Johann Christoph Ragg, Berlin, Germany 17:05-17:10

Audience participation and discussion

17:10-17:15 Endovascular management of arteriovenous malformation: Tips and tricks Hesham Aly Mohamed Sharaf Eldin, Mansoura, Egypt 17:15-17:20

Audience participation and discussion

17:20-17:25 Six stages of acquired vein valve insufficiency

Johann Christoph Ragg, Berlin, Germany 17:25-17:30

Audience participation and discussion

17:30-17:35 Ascending venogram in patients with active ulcer to predict wound healing: A single centre experience Vimalin Samuel, Vellore, India 17:35-17:40

Audience participation and discussion

17:40-17:45 Mid-term improvement of persistent headaches in patients with multiple sclerosis undergoing balloon venoplasty of internal jugular veins Pierfrancesco Veroux, Catania, Italy 17:45-17:50

Audience participation and discussion

17:50-17:55 Treating veins with EVRF monopolar radiofrequency – six years’ follow-up results and modified pullback Attila Szabo, Budapest, Hungary 17:55-18:00

Audience participation and discussion

18:00-18:05 Endovascular management of iliac vein compression syndrome: A prospective case series of 61 patients Ahmed Allam, Benha, Egypt 18:05-18:10

74 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update

CX Thoracic Aortic Abstract Presentations – Day 2 l Dark Room Learning Centre – 10:30-15:10

Thoracic Aortic Abstract Presentations Chairing: P aul Moxey, London, United Kingdom Emma Wilton, Beaconsfield, United Kingdom

10:30-10:35 The impact of bird-beak configuration after TEVAR on postoperative outcomes: A systematic review and meta-analysis

Benedetta Spampinato, Milan, Italy 10:35-10:40

Audience participation and discussion

10:40-10:45 Management of patients with intramural haematoma or penetrating aortic ulcer of the thoracic aorta Salvatore Turiano, Nicolosi, Italy 10:45-10:50

Audience participation and discussion

10:50-10:55 The rationale of endovascular aortic graft repair for penetrating atherosclerotic ulcer of abdominal aorta Mingli Li, Taichung, Taiwan 10:55-11:00

Audience participation and discussion

11:00-11:05 Experimental evaluation of endovascular fenestration scissors in an ovine model of aortic dissection Iannis Ben Abdallah, Paris, France 11:05-11:10

Audience participation and discussion

11:15-11:20

Audience participation and discussion

11:20-11:25 A single-centre review of aortic remodelling in patients with type B aortic dissection in an Asian population Jun Han Tang, Singapore 11:25-11:30

Audience participation and discussion

11:30-11:35 Extend petticoat strategy in difussed (DeBakey III) aortic dissection type B. New strategy to stop aneurysmatic degeneration

Piotr Gutowski, Bezrzecze, Poland 11:35-11:40

Audience participation and discussion

11:40-11:45 Influence of TEVAR on blood pressure in type B aortic dissection patients with refractory and non-refractory arterial hypertension

Marco Virgilio Usai, Muenster, Germany 11:45-11:50

Audience participation and discussion

11:50-11:55 Aortic dilatation following type B aortic dissection: A single-centre retrospective study Kitty Hiu Fung Wong, Bristol, United Kingdom 11:55-12:00

Audience participation and discussion

12:00-12:05 Feasibility and early results of a new-generation Candy Plug II for endovascular false lumen occlusion with TEVAR in chronic aortic dissection Ahmed Eleshra, Hamburg, Germany 12:05-12:10

Audience participation and discussion

12:10-12:15 Intentional targeted false lumen occlusion after aortic dissection

Konstantinos Spanos, Larissa, Greece 12:15-12:20

Audience participation and discussion

12:20-12:25 Renal stent complications following standard fenestrated endovascular aneurysm repair Kenneth Tran, California, United States 12:25-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Thoracic Aortic Abstract Presentations Chairing: R achel Bell, London, United Kingdom Jason Constantinou, London, United Kingdom

13:30-13:35 Relevance of SLPI as biomarker of acute kidney injury after open and endovascular complex aortic surgery

Alexander Gombert, Aachen, Germany 13:35-13:40

Audience participation and discussion

2019

75

Wednesday 17 April 2019

11:10-11:15 Risk factors for distal stent graft-induced new entry in type B aortic dissections: A systematic review and meta-analysis

Reuban D'Cruz, Singapore

Vascular & Endovascular Challenges Update 13:40-13:45 Endovascular repair of juxtarenal and thoracoabdominal aortic aneurysms with fenestrated/branched endografts after previous aortic repair Maciej Juszczak, Birmingham, United Kingdom 13:45-13:50

Audience participation and discussion

13:50-13:55 Modular branched stent grafts for redo and urgent interventions to treat pararenal and thoracoabdominal aortic aneurysm

Reinhard Kopp, Zurich, Switzerland 13:55-14:00

Audience participation and discussion

14:00-14:05 Percutaneous F/BEVAR in patients with post-dissection thoracoabdominal aortic aneurysm: Midterm results of a prospective observational study Jost Philipp Schaefer, Kiel, Germany 14:05-14:10

Audience participation and discussion

14:10-14:15 A single-centre experience using automated intracranial pressurecontrolled cerebrospinal fluid external drainage

Maria Pilar Lamarca Mendoza, Toledo, Spain 14:15-14:20

Audience participation and discussion

14:20-14:25 Evolution of graft design, proximal sealing zone and outcomes in early vs. late experience with fenestrated and branched stent grafts

Pablo Marques de Marino, Nuremberg, Germany 14:25-14:30

Audience participation and discussion

14:30-14:35 Percutaneous F/BEVAR in patients with thoracoabdominal aortic aneurysm: Midterm results Jost Philipp Schaefer, Kiel, Germany 14:35-14:40

Audience participation and discussion

14:40-14:45 Kidney autotransplant for treatment of complex aneurysms of the renal artery Marco Franchin, Varese, Italy 14:45-14:50

Audience participation and discussion

Wednesday 17 April 2019

14:50-14:55 Impact of aortic stent graft oversizing on outcomes of the chimney endovascular technique based on a new analysis of the PERICLES registry Marco Virgilio Usai, Muenster, Germany 14:55-15:00

Audience participation and discussion

15:00-15:05 The impact of suprarenal aortic diameters on outcomes following endovascular aneurysm repair Arunesh Majumder, Dunedin, New Zealand 15:05-15:10

Audience participation and discussion

CX Peripheral Arterial Selected Posters Presentations l Poster Gallery – 12:30-13:30

Peripheral Poster Presentations

Chairing: Meryl Davis, London, United Kingdom Moderator: TBA

12:30-12:33 Catheter-directed thrombolysis with alteplase in treatment of acute arterial occlusion: Challenging cases

Gulen Sezer Erkul, Kutahya, Turkey 12:33-12:35

Audience participation and discussion

12:35-12:38 Role of catheter-directed thrombolysis in patients with acute on chronic limb ischaemia due to Buerger's disease with no distal reformation Sridhar Murugesan, Chennai, India 12:38-12:40

Audience participation and discussion

12:40-12:43 Drug coated balloons in BTK disease – an Indian perspective

Nadumaskeri Subraya Rahul, Bengaluru, India

76 2019

Vascular & Endovascular Challenges Update 12:43-12:45

Audience participation and discussion

12:45-12:48 Low velocity rotational artherectomy with variable tip radius for chronic total occlusions: Preliminary results of a CE-mark trial

Joerg Tessarek, Lingen, Germany 12:48-12:50

Audience participation and discussion

12:50-12:53 Tibiopedal retrograde access for treatment of critical limb ischaemia – experience at a vascular centre in Mexico City

Fausto Julian Virgen Barron, Mexico City, Mexico 12:53-12:55

Audience participation and discussion

12:55-12:58 The level of the qualitative and the quantitative malnutrition in patients suffering from the critical limb ischaemia

Anna Danowsa, Warszawa, Poland 12:58-13:00

Audience participation and discussion

13:00-13:03 Infection risk in vascular surgery; a wound based classification

Thomas Joseph, Preston, United Kingdom 13:03-13:05

Audience participation and discussion

13:05-13:08 Experience of hybrid revascularisations over a period of two years at the Centre for Cardiovascular Surgery in Vienna, Austria

Karin Elisabeth Schimdt, Vienna, Austria 13:08-13:10

Audience participation and discussion

13:10-13:13 Endovascular patient with renal insufficiency – techniques that need minimum volume of iodine contrast

Piotr Myrcha, Warsaw, Poland 13:13-13:15

Audience participation and discussion

13:15-13:18 Portable infrared thermography: A useful tool in the management of diabetic feet?

Colette Cook, Wrexham, United Kingdom Audience participation and discussion

13:20-13:23 Modified surgical approach to treat thoracic outlet compression syndrome: The venetian blind technique

Ali Navi, London, United Kingdom 13:23-13:25

Audience participation and discussion

13:25-13:28 Pediatric vascular trauma experience: 10-year review

Ronza Salem, Jerusalem, Israel 13:28-13:30

Audience participation and discussion

2019

77

Wednesday 17 April 2019

13:18-13:20

Vascular & Endovascular Challenges Update

An Introduction to Vascular Surgery An Introduction to Vascular Surgery, Exhibition Hall – 09:00-15:30 The Vascular Society of Great Britain & Ireland, Rouleaux Club and CX Symposium are running An Introduction to Vascular Surgery for medical students, foundation doctors and core surgical trainees considering a career in Vascular Surgery.

Chairing: Sophie Renton, Secretary General VSGBI, London, United Kingdom

09:00-09:30

Registration

09:30-10:15

elcome and introduction to the Course W What is Vascular Surgery?

A career in Vascular Surgery – a junior’s perspective

10:15-12:15 Groups A and B: Hands-on training in vascular anastomosis Groups C and D: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops

Wednesday 17 April 2019

12:15-13:00

LUNCH

13:00-13:30

ow to prepare your portfolio H How to apply for training in Vascular Surgery Why choose Vascular Surgery?

13:30-15:30

roups C and D: Hands-on training in vascular anastomosis G Groups A and B: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops

15.30

Feedback and close

78 2019

Plenary Programme & Additional Events

Thursday 18 April 2019

Thursday

Thursday Vascular & Endovascular Challenges Update Main Auditorium Thoracic Aortic Challenges

84

Peripheral Arterial Podium 1st

88

Peripheral Critical Ischaemia Challenges

87, 88

CX Additional Events CX Innovation Showcase

92

CX Venous Techniques & Technologies (edited cases) – Day 2

95

CX Venous Workshop – Day 2

95

CX Vascular Access Workshop

97

CX iWounds Workshop – Day 2

98

European Vascular Surgeons in Training – Prize Session

99

CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Abstract Presentations – Day 3

100

CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2

102

CX Abdominal Aortic Abstract Presentations – Day 2

104

CX Aortic Selected Posters Presentations

107

An Introduction to Vascular Surgery – Day 2

108

Thursday 18 April 2019

CX Vascular Access Techniques & Technologies (edited cases) 97

Vascular & Endovascular Challenges Update

Thursday 18 April 2019 THORACIC AORTIC CHALLENGES

Upper Main Auditorium – 08:00-18:00 S troke from Thoracic Endovascular Procedures

Chairing: Roger Greenhalgh, London, United Kingdom Moderator: Stéphan Haulon, Le Plessis Robinson, France Moderator: Tilo Kölbel, Hamburg, Germany Speaker: Fiona Rohlffs, Hamburg, Germany Moderator: Hugh Markus, Cambridge, United Kingdom Moderator: Heinz Jakob, Essen, Germany

Live case with virtual reality from Hamburg

New low-profile thoracic aortic stent graft (30min)

Giuseppe Panuccio, Tilo Kölbel's group, Hamburg, Germany

STEP Study Phase 2: DW MRI – a standard of care (7min)

Fiona Rohlffs, Hamburg, Germany

STEP 2 Hamburg experience (7min) Tilo Kölbel, Hamburg, Germany

Discussant: Hugh Markus, Cambridge, United Kingdom

STEP 2 Paris experience (7min)

Stéphan Haulon, Le Plessis Robinson, France

Discussant: Hugh Markus, Cambridge, United Kingdom

Arch branch repair using single, double or triple branched devices (7min)

Gustavo Oderich, Rochester, United States

Discussant: Hugh Markus, Cambridge, United Kingdom Audience participation, discussion and polling (11min)

The value of TCD during thoracic endovascular procedures involving the ascending aorta and aortic arch (7min)

Alan Lumsden, Houston, United States

New updates on ascending aortic endografts (7min)

Rodney White, Torrance, United States Discussant: Hugh Markus, Cambridge, United Kingdom

Audience participation and discussion (7min)

Prospective MRI findings of cerebral infarction after TEVAR for aortic arch pathologies (7min) Kenta Masada, Osaka, Japan

Stroke prevention in thoracic endografting (7min)

Richard Gibbs, London, United Kingdom

Incidence and prediction of neurological complications after TEVAR: Global Registry data (7min) Michele Piazza, Padua, Italy

Thursday 18 April 2019

Audience participation and discussion (7min)

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee Symposium: A roundtable on global trends and outcomes in aortic arch repair Chairing: Robin Heijmen, Nieuwegein, Netherlands

10:03-10:12 Italian and Dutch national registry results with double-branch devices for aortic arch disease Ciro Ferrer, Rome, Italy 10:12-10:21 Complex arch repair: When and why to treat with hybrid or endovascular Robin Heijmen, Nieuwegein, Netherlands 10:21-10:30 The right ratio of open to endovascular repair of complex arch aneurysms and type A aortic dissections

Joost van Herwaarden, Utrecht, Netherlands

Live case from Bad Krozingen

Chairing: Robin Heijmen, Nieuwegein, Netherlands

10:30-11:00 Live case: Distal TEVAR extension after total aortic arch replacement in a complex anatomy Martin Czerny, Bad Krozingen, Germany

Bartosz Rylski, Bad Krozingen, Germany

84 2019

Vascular & Endovascular Challenges Update

Chosen access for aortic reconstruction

Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Michel Makaroun, President SVS, Pittsburgh, United States 11:00-11:07 Transfemoral access in complex aortic repair

Stéphan Haulon, Le Plessis Robinson, France 11:07-11:14 Comparison of fascial closure technique to cut-down in TEVAR

Nikolaos Tsilimparis, Munich, Germany 11:14-11:21 Percutaneous subclavian access 11:21-11:30

Luca Bertoglio, Milan, Italy

Audience participation, discussion and polling

Thoracoabdominal aortic aneurysms

11:30-11:37 Innovative modalities for organ protection during thoracoabdominal aortic aneurysm open repair Roberto Chiesa, Milan, Italy 11:37-11:44 Anatomical suitability and challenges with an off-the-shelf branched endoprosthesis – analysis of CT scans of 500 patients

Luca Bertoglio, Milan, Italy 11:44-11:51 Clinical outcomes with a balloon-expandable covered stent in BEVAR cases – multicentre experience Eric Verhoeven, Nuremberg, Germany 11:51-12:00

Audience participation and discussion

Radiation

Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany Moderator: Andrew Holden, Auckland, New Zealand 12:00-12:07

Radiation dose to the eye

Lindsay Machan, Vancouver, Canada

12:07-12:14 IVUS in aortic repair to reduce radiation and contrast use

Joerg Tessarek, Lingen, Germany 12:14-12:21 Occupational radiation exposure and risk of cancer

Bijan Modarai, London, United Kingdom 12:21-12:30

Audience participation, discussion and polling

12:30-13:30 LUNCH AND VISIT TO HANDS-ON WORKSHOP

Lunch Symposium: The freedom to do more with a new conformable and low-profile thoracic endograft

Chairing: Colin Bicknell, London, United Kingdom Moderator: Dittmar Böckler, President DGG, Heidelberg, Germany

12:33-12:40 Key findings and insights from the global clinical trial with new stent graft Fabio Verzini, Turin, Italy 12:40-12:47 How to expand patient applicability with a new-generation thoracic endograft Paul Hayes, Cambridge, United Kingdom

12:54-12:57

Audience participation and discussion

Descending aorta

Chairing: Michel Makaroun, President SVS, Pittsburg, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 13:30-13:35 Results of IFU versus non-IFU TEVAR procedures

Dittmar Böckler, President DGG, Heidelberg, Germany 13:35-13:40 TEVAR outcome in real-life practice

Kevin Mani, Uppsala, Sweden

13:40-13:45 New TEVAR delivery system allows staged, predictable endograft deployment and in situ angulation control, while avoiding windsocking and bird-beaking Giovanni Torsello, Münster, Germany 13:45-13:50 Five-year experience with a low-profile thoracic endograft

Eric Verhoeven, Nuremberg, Germany 13:50-14:00

Audience participation, discussion and polling

Dissections

Chairing: Gustavo Oderich, Rochester, United States Moderator: Martin Malina, London, United Kingdom 14:00-14:07 Outcomes of branched arch repair for post type A dissections

Tilo Kölbel, Hamburg, Germany

2019

85

Thursday 18 April 2019

12:47-12:54 Case example of the clinical value of this new thoracic endograft

Frank Arko, Charlotte, United States

Vascular & Endovascular Challenges Update 14:07-14:14 Management and results of acute dissection with arch tear

Santi Trimarchi, San Donato Milanese, Italy 14:14-14:21 Limited and extended repair for acute type A dissection

Heinz Jakob, Essen, Germany 14:21-14:30

Audience participation and discussion

14:30-14:37 TEVAR plus bare metal stent vs. TEVAR alone

Stéphan Haulon, Le Plessis Robinson, France 14:37-14:44 Evidence for and risks of endovascular treatment of asymptomatic acute type B aortic dissection Rachel Clough, London, United Kingdom 14:44-14:51 Changing paradigms for treating acute type B aortic dissection

William Jordan, Atlanta, United States 14:51-15:00

Audience participation and discussion

15:00-15:07 Evidence and compliance for best medical therapy for chronic type B aortic dissection Colin Bicknell, London, United Kingdom 15:07-15:14 Decision-making process and influencing factors for the treatment of uncomplicated type B aortic dissections

Dittmar Böckler, President DGG, Heidelberg, Germany 15:14-15:21 Establishment and validation of 301 classification scheme for type B aortic dissection: Insights from ROBUST in China

Wei Guo, Beijing, China 15:21-15:30

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Spinal cord ischaemia

Chairing: Tara Mastracci, London, United Kingdom Moderator: Tilo Kölbel, Hamburg, Germany 16:00-16:08 Multistaged endovascular approach to thoracoabdominal pathology with fenestrated and branched endografts

Luca Bertoglio, Milan, Italy 16:08-16:16 The influence of hyperglycaemia on spinal cord ischaemia

Jade Hiramoto, San Francisco, United States 16:16-16:24 Neuromonitoring to guide temporary sac perfusion during endovascular TAAA repair Gustavo Oderich, Rochester, United States 16:24-16:32 Perioperative cerebrospinal fluid drainage for complex endovascular aneurysm repair cases Bijan Modarai, London, United Kingdom 16:32-16:42

Audience participation, discussion and polling

J uxtarenal, complex EVAR and challenging neck

16:42-16:50 Hospital workflow surrounding fenestrated and branch aortic repair: Nursing, anaesthesia, and critical care

Gustavo Oderich, Rochester, United States

Thursday 18 April 2019

16:50-16:58 Results from the French multicentric study on chimney repair of pararenal aneurysms Raphael Coscas, Boulogne-Billancourt, France 16:58-17:06

Audience participation and discussion

17:06-17:16

CX Debate: FEVAR/BEVAR is preferred for juxtarenal reconstruction For the motion: 17:06-17:11 Gustavo Oderich, Rochester, United States Against the motion: 17:11-17:16 Konstantinos Donas, Munster, Germany

17:16-17:21

Audience participation, discussion and polling

17:21-17:29 Experience with new balloon-expandable endoprosthesis in FEVAR and BEVAR Giovanni Torsello, Münster, Germany 17:29-17:37 Fenestrated EVAR device cuff in the treatment of failed EVAR devices

Michel Reijnen, Arnhem, Netherlands 17:37-17:45

Audience participation and discussion

17:45-17:55

CX Debate: Created-neck FEVAR beats chEVAR every time For the motion: 17:38-17:43 Eric Verhoeven, Nuremberg, Germany Against the motion: 17:43-17:48 Ralf Kolvenbach, Düsseldorf, Germany

17:55-18:00

Audience participation, discussion and polling

86 2019

Vascular & Endovascular Challenges Update

PERIPHERAL CRITICAL ISCHAEMIA CHALLENGES – PART 1

Lower Main Auditorium – 08:00-10:00 Interdisciplinary Leg Initiative

Chairing: Cliff Shearman, Southampton, United Kingdom Moderator: Robert Hinchliffe, Bristol, United Kingdom 08:00-08:08 Approaching critical limb ischemia from a population health point of view Barry Katzen, Miami, United States 08:08-08:16 The geriatric patient in the age of modern endovascular treatment options Marianne Brodmann, Graz, Austria 08:16-08:24 Management of critical limb ischaemia of the lower limbs: Guidelines according to international scientific experience

Athanasios Giannoukas, Larissa, Greece 08:24-08:36 Audience participation, discussion and polling 08:36-08:44 Pilot assessment of the angiosome concept by intraoperative fluorescence angiography after tibial bypass surgery

Ulrich Rother, Erlangen, Germany 08:44-08:52 GLobal Anatomical Staging System: Draft guidelines for chronic limb threatening ischaemia Michael Conte, San Francisco, United States 08:52-09:00 Combination approach in below-the-knee lesions

Michael Lichtenberg, Arnsberg, Germany 09:00-09:12

Audience participation and discussion

09:12-09:20 How to reduce dissections below-the-knee: Techniques & devices

Jos van den Berg, Lugano, Switzerland 09:20-09:28

TOBA II BTK update

09:28-09:36

Audience participation and discussion

Michael Lichtenberg, Arnsberg, Germany

09:36-09:44 Extended limb salvage operations for threatened ischaemic limbs

Enrico Ascher, Brooklyn, United States 09:44-09:52 Determinants of long-term outcomes and costs in the management of critical limb ischaemia: A population-based cohort study

Barry Katzen, Miami, United States 09:52-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOPS

Coffee Symposium: Below the knee symposium

Chairing: Marc Bosiers, Dendermonde, Belgium

Amine Chouiter, Neuchatel, Switzerland

10:15-10:28 Multidisciplinary foot clinics, a pathway to limb salvage?

Paul Moxey, London, United Kingdom

2019

87

Thursday 18 April 2019

10:03-10:13 The pedal access approach

Vascular & Endovascular Challenges Update

ERIPHERAL ARTERIAL P PODIUM 1ST SESSION Lower Main Auditorium –

10:30-12:30

Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Thomas Zeller, Bad Krozingen, Germany 10:30-10:38 Podium 1st: First results of the MUST trial and further updates on the use of microbubbles in thrombolysis

Kak Khee Yeung, Amsterdam, Netherlands 10:38-10:46 Podium 1st: Angiography alone in the lower limb: First results comparing IVUS and angiography in the leg

Konstantinos Stavroulakis, Münster, Germany 10:46-10:54 Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry

Andrew Holden, Auckland, New Zealand 10:54-11:06

Audience participation and discussion

11:06-11:14 Podium 1st: The case for treating aortoiliac occlusive disease with a covered device: Early experience with new balloon-expandable endoprosthesis Michele Antonello, Padua, Italy 11:14-11:22 Podium 1st: DCB IDE below-the-knee six-month results with in-depth look at Rutherford 5 patients Patrick Geraghty, St Louis, United States 11:22-11:30 Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms

Andrew Holden, Auckland, New Zealand 11:30-11:42

Audience participation and discussion

11:42-11:50 Podium 1st: Two-year data from the MIMICS-2 study

Timothy Sullivan, Minneapolis, United States 11:50-11:58 Podium 1st: ZILVERPASS study – final 12-month and preliminary 24-month results Marc Bosiers, Dendermonde, Belgium 11:58-12:06

Audience participation and discussion

12:06-12:14 Podium 1st: Multivariate analysis of 2,400 patients using a drugeluting stent – patency data Michael Dake, Tucson, United States 12:14-12:22 Podium 1st: REPLACE study – heparin-bonded ePTFE graft vs. ePTFE graft Yann Goueffic, Nantes, France 12:22-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Thursday 18 April 2019

ERIPHERAL CRITICAL ISCHAEMIA P CHALLENGES – PART 2 Lower Main Auditorium – 13:30-18:00 M edical therapy and drug coating

Chairing: Michael Edmonds, London, United Kingdom Moderator: Keith Harding, Cardiff, United Kingdom 13:30-13:38 Survival after lower extremity revascularisation for critical limb ischaemia is better with high dose statins

Marc Schermerhorn, Boston, United States 13:38-13:46 COMPASS and VOYAGER PAD are trying to answer our open questions for secondary prophylactic treatment in patients with peripheral arterial disease Marianne Brodmann, Graz, Austria 13:46-13:54 Will drug-coated balloons and stents significantly impact our treatment of critical limb ischaemia?

Peter Schneider, Honolulu, United States 13:54-14:02

88 2019

Audience participation, discussion and polling

Vascular & Endovascular Challenges Update

14:02-14:10 Percutaneous transluminal lower limb angioplasty for ischaemic foot ulcers: Five-year experience Mohamed Cassim, Nawala, Sri Lanka 14:10-14:18 Patients awareness of peripheral arterial disease and the use of ankle-brachial Index measurement

Jakob Sustersic, United Kingdom 14:18-14:26

Audience participation and discussion

14:26-14:34 Adequate wound care after successful endovascular treatment, a keystone for success Marianne Brodmann, Graz, Austria 14:34-14:42 Rutherford 6 wounds: The utility of multivessel revascularisation and inflow strategies Peter Schneider, Honolulu, United States 14:42-14:54

Audience participation and discussion

14:54-15:02 Footwear technology for diabetic foot ulcer patients

Sjef van Baal, Almelo, Netherlands 15:02-15:10 Impact of hyperbaric oxygen on more advanced, Wagner grade 3 and 4 diabetic foot ulcers – matching therapy to specific wound conditions William Ennis, Oak Lawn, United States 15:10-15:18 Diabetes medications: Impact on inflammation and wound healing

John Lantis, New York, United States 15:18-15:30

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

M ini-symposium on arterial disease below the ankle

Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Trevor Cleveland, President BSIR, Sheffield, United Kingdom

16:00-16:08 Indications and techniques for below-the-ankle angioplasty

Roberto Ferraresi, Milan, Italy 16:08-16:16 The place for distal bypasses in below-the-ankle treatment

Eric Ducasse, Bordeaux, France 16:16-16:24

Audience participation and discussion

M ini-symposium on the ischaemic renal foot and Charcot foot

16:24-16:32 Diabetic patients in renal failure high rates of morbidity and mortality

Michael Edmonds, London, United Kingdom 16:32-16:40 Pathophysiology of lower limb and dialysis

Robert Hinchliffe, Bristol, United Kingdom Audience participation and discussion

16:48-16:56 Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus

Francis Game, Derby, United Kingdom 16:56-17:04 Chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot

Maarit Venermo, Helsinki, Finland 17:04-17:12 Understanding the ischaemic Charcot foot patient

Michael Edmonds, London, United Kingdom 17:12-17:24

Audience participation and discussion

17:24-17:32 Surgical reconstruction of Charcot foot

Venu Kavarthapu, London, United Kingdom 17:32-17:40 Bypass outcomes where no autologous vein available

Robert Hinchliffe, Bristol, United Kingdom 17:40-17:48 Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): Results from a multicentre randomised controlled feasibility trial

Graeme Ambler, Bristol, United Kingdom 17:48-18:00

Audience participation and discussion

2019

89

Thursday 18 April 2019

16:40-16:48

Vascular & Endovascular Challenges Update

Monday 15 April 2019

Tuesday 16 April 2019

Wednesday 17 April 2019

Thursday 18 April 2019

90 2019

Thursday 18 April 2019

Vascular & Endovascular Challenges Update

Thursday

Additional Events

2019

91

Vascular & Endovascular Challenges Update

CX Innovation Showcase llll Thursday 18 April – Pillar Hall Learning Centre

Innovation challenges

Chairing: Frans Moll, CX Advisory Board, Utrecht, Netherlands Moderator: Stephen Greenhalgh, London, United Kingdom 07:30-07:40 Confessions of a mad inventor

Lindsay Machan, Vancouver, Canada

07:40-07:50 Challenging the genius theory of innovation and discovery

Frank Criado, Baltimore, United States 07:50-08:00 Supporting the physician inventor from prototype to commercialisation Derek Young, Dublin, Ireland 08:00-08:10 How do you exit your device well in the 21st century?

Chas Taylor, Horsham, United Kingdom 08:10-08:20

Audience participation and discussion

Artificial intelligence

08:20-08:30 How artificial intelligence will change how we practise medicine

Lindsay Machan, Vancouver, Canada 08:30-08:40 Artificial intelligence in vascular surgery

Tom Carrell, Barrington, United Kingdom 08:40-08:50

Audience participation and discussion

Robotics

08:50-09:00 Endovascular robotics

Willem Wisselink, Amsterdam, Netherlands

09:00-09:10 Corindus Vascular Robotics CorPath GRX system

Matt Lemay, New Mexico, United States 09:10-09:20

Audience participation and discussion

Peripheral innovation

Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 09:20-09:30 Comparison of paclitaxel and sirolimus coated balloons

Aloke Finn, Gaithersburg, United States 09:30-09:40 New Xtreme Touch sirolimus-eluting drug-coated balloon

Edward Choke, Singapore

Thursday 18 April 2019

09:40-09:50 Temporary drug-coated Spur system to address the challenges of DCB technology Andrew Holden, Auckland, New Zealand 09:50-10:00

Audience participation and discussion

10:00-10:30

COFFEE AND VISIT TO HANDS-ON WORKSHOP

C3@CX

Chairing: Rajesh Dave, Memphis, United States Moderator: Michael Lichtenberg, Arnsberg, Germany

10:03-10:11 Lifting the curtain on aortoiliac CTO recanalisation techniques and choice of stent Rajesh Dave, Memphis, United States 10:11-10:19 Controversies in venous intervention

Nilesh Balar, New York, United States 10:19-10:27 New wireless laser ablative technology: Mechanism and initial experience Charles Bailey, San Antonio, United States

Peripheral innovation (continued)

10:30-10:40 Initial experience with the MicroStent in below-the-knee arteries for critical limb ischaemia Robert Beasley, Miami, United States 10:40-10:50 B-Laser atherectomy system to treat peripheral artery disease

Yoel Zabar, Rehovot, Israel

92 2019

Vascular & Endovascular Challenges Update 10:50-11:00 Smart stent to monitor blood flow and detect restenosis

York Hsiang, Vancouver, Canada 11:00-11:10 CaveoVasc protection system to reduce bleeding complications during catheter directed thrombolysis – results from the first-in-man study Elias Noory, Bad Krozingen, Germany 11:10-11:20 Use of occlusion perfusion catheter in peripheral arterial disease (Copper BTK) Rex Teeslink, Augusta, United States 11:20-11:30 TAPAS catheter delivered paclitaxel

Ronald Solar, San Diego, United States 11:30-11:40

Audience participation and discussion

Aortic innovation

Chairing: Bob Mitchell, Irvine, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 11:40-11:50 Off-the-shelf Nexus endograft for arch aneurysms

Mario Lachat, Hinteregg, Switzerland 11:50-12:00 Expandable modular branched graft thoracoabdominal and iliac branch Bao Bui, Sherbrooke, Canada 12:00-12:10 Total endovascular repair of zone 0 landing aortic arch aneurysms with Najuta Fenestrated Thoracic Stent Graft: A retrospective analysis of 492 cases Dai Yamanouchi, Madison, United States 12:10-12:20 Predicting AAA growth/rupture: Can 3D ultrasound help with AAA management and repair decisions

Steven Rogers, Manchester, United Kingdom 12:20-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOP

L unch Symposium: Ramifications of the MDR from different perspectives

Chairing: Bob Mitchell, Irvine, United States Moderator: Stephen Greenhalgh, London, United Kingdom 12:30-12:40 The regulatory perspective

Daniel Shoukier, Zurich, Switzerland

12:40-12:50 The payer, provider and patient perspective

Peter Gaines, Sheffield, United Kingdom 12:50-13:00

The large company perspective

Aine Smalley, United States

13:00-13:10

The small company perspective

Gido Karges, Wangs, Switzerland

13:10-13:20

The innovation perspective

13:20-13:30

Audience participation and discussion

Aortic innovation (continued)

13:30-13:40 In-house 3D printing for complex aortic endovascular procedures

Jan Heyligers, Tilburg, Netherlands 13:40-13:50 Fluid dynamics in fenestrated arch endografts

Santi Trimarchi, San Donato Milanese, Italy 13:50-14:00 Long term results of new lock stent device for vessel banding in a swine mode Carlo Setacci, Siena, Italy 14:00-14:10

Nellix: Failure or phoenix

14:10-14:20

Audience participation and discussion

Matt Thompson, Irvine, United States

Venous innovation

Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Bob Mitchell, Irvine, United States 14:20-14:30 Technique & preliminary results of HIFU for varicose veins

Alfred Obermayer, Vienna, Austria

Vascular access innovation

14:30-14:40 New Pristine Access Technologies dialysis access catheter

Michael Tal, Tel Aviv, Israel 14:40-14:50

Audience participation and discussion

2019

93

Thursday 18 April 2019

Jeffrey Jump, Mont-sur-Rolle, Switzerland

Vascular & Endovascular Challenges Update

Acute stroke innovation

14:50-15:00 Endovascular magneto-motive nano-robotic stroke therapy

Sean Morris, United States

Michael Tones, United States 15:00-15:10 Neuroprotection by endovascular selective cerebral hypothermia

Ronald Solar, San Diego, United States

Wound care innovation

15:10-15:20

CSA: Next-generation wound care

15:20-15:30

Audience participation and discussion

Bob Mitchell, Irvine, United States

15:30-16:00 TEA AND VISIT TO HANDS-ON WORKSHOP

Diagnostic and imaging innovation

Chairing: Andrew Holden, Auckland, New Zealand Moderator: Stephen Greenhalgh, London, United Kingdom 16:00-16:10 The future of vector flow imaging is in 3D

Lars Lönn, Copenhagen, Denmark 16:10-16:20 Update on holographic medical imaging to support operative procedures: The VPI Technology Jan Heyligers, Tilburg, Netherlands 16:20-16:30 Wearable technologies and telemonitoring for vascular disease to keep patients out of hospital Celia Riga, London, United Kingdom 16:30-16:40

Audience participation and discussion

Updates from previous Dragons’ Den winners

Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 16:40-16:45 2018 Coramed antioxidant

Kieran Murphy, Toronto, Canada

16:45-16:50 2015 The Bullet Proof vascular access graft (InnAVasc)

Shawn Gage, Raleigh, United States 16:50-16:55 2010 The HQS (Alseal) introducer

Claude Mialhe, Monaco, Monaco

Dragons’ Den

Panel: A ndrew Holden, Auckland, New Zealand Frans Moll, CX Advisory Board, Utrecht, Netherlands Bob Mitchell, Irvine, United States Peter Phillips, Didcot, United Kingdom Chas Taylor, Horsham, United Kingdom Jeffrey Jump, Mont-sur-Rolle, Switzerland Alan Edwards, Ruthin, United Kingdom

16:55-17:00 Introduction to Dragons’ Den

Stephen Greenhalgh, London, United Kingdom

Thursday 18 April 2019

17:00-17:03 Phpc (phenox hydrophilic coating) for reduced thrombogenicity of stents Hans Henkes, Stuttgart, Germany 17:03-17:05

Questions from the Dragons

17:05-17:08 Nanoscale Medical Devices: A new frontier in the imaging and treatment of critical limb ischaemia

Sean Morris, Missouri City, United States 17:08-17:10

Questions from the Dragons

17:10-17:13 Community Portable Infrared Thermography (C-PIT): Improving outcomes in patients with diabetic foot disease

Colette Cook, Ellesmere Port, United Kingdom 17:13-17:15

Questions from the Dragons

17:15-17:18

Second-generation venous stent

17:18-17:20

Questions from the Dragons

Cees Wittens, Maastricht, Netherlands

17:20-17:23 Novel restorative vascular access graft technology

Luke Burke, Eindhoven, The Netherlands 17:23-17:25

Questions from the Dragons

17:25-17:28 Butterfly iQ pocket-sized ultrasound John Martin, Annapolis, United States 17:28-17:30

Questions from the Dragons

17:30-17:33 HeadPeace radiation protection textile Petra Apell, Gothenburg, Sweden

Fredrik Gellerstedt, Goteborg, Sweden 17:33-17:35

94 2019

Questions from the Dragons

Vascular & Endovascular Challenges Update 17:35-17:38

EVARPlanning’s platform

17:38-17:40

Questions from the Dragons

Paolo Spada, Buccinasco, Italy

17:40-17:43 Motilant AI technology to detect aortic ruptures

Sandip Sarkar, London, United Kingdom 17:43-17:45

Questions from the Dragons

17:45-17:48

New cap for endovascular

17:48-17:50

Questions from the Dragons

17:50-17:53

SiteSeal: A new closure device

17:53-17:55

Questions from the Dragons

Claude Mialhe, Monaco Rex Teeslink, Augusta, United States

17:50-17:55 Voting by the Dragons and announcement of the winner followed by photograph with Dragons’ Den winner

CX Venous Techniques & Technologies (edited cases) – Day 2 l Venous City – 09:30-10:30 and 13:00-13:30

CX Venous edited cases – Morning

Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Steve Elias, Englewood, United States 09:30-09:50 Mechanical thrombectomy in the treatment of acute venous occlusion Thomas Heller, Rostock, Germany 09:50-10:10

Abre venous stenting

10:10-10:30

Venous obstruction management

Stephen Black, London, United Kingdom Steven Dubenec, Sydney, Australia

CX Venous edited cases – Afternoon 13:00-13:20 JETi in a typical iliofemoral thrombosis 13:20-13:30 Interactive case vignettes

Bao Bui, Sherbrooke, Canada

CX Venous Workshop – Day 2 l Venous City – 09:30-15:30

Practical hands-on skills

Facilitators: T ristan Lane, London, United Kingdom Hayley Moore, London, United Kingdom

Cannulation

Roshan Bootun, London, United Kingdom

Device positioning

Gregory Fulton, Wilton, Ireland Saroj Das, Uxbridge, United Kingdom

Tumescent anaesthesia

Matthew Metcalfe, Stevenage, United Kingdom

D iagnostic venous ultrasound

Diagnostic venous ultrasound

Mary Ellis, London, United Kingdom Hema Rao, London, United Kingdom

2019

95

Thursday 18 April 2019

Manj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom

Vascular & Endovascular Challenges Update

Pelvic vein disorders

Pelvic vein embolisation

Jocelyn Brookes, London, United Kingdom

Transvaginal duplex scanning

Plethysmography

Air plethysmography

Yee Jia Ng, Singapore

Christopher Lattimer, London, United Kingdom Teresa Rola, London, United Kingdom

Strain gauge plethysmography

Oskar Nelzen, LinkĂśping, Sweden

Interventions for acute DVT

8F power aspiration with Indigo System

Jasmin Al-Gaddooa, Germany, Belin Aspirex S – Rotational thrombectomy Thomas Heller, Rostock, Germany

Deep vein thrombosis

Bekim Hymeraj, RD Global, Ankara, Turkey Oguz Dinc, RD Global, Ankara, Turkey

EKOS Accoustic Pulse Thrombolysis treatment

Mert Dumantepe, Istanbul, Turkey

Houman Jalaie, Aachen, Germany JETi

David Look, Walk Vascular, Irvine, United States

Acute venous thrombosis

Investigation for occult malignancy after acute DVT

Gerry Stansby, Newcastle-upon-Tyne, United Kingdom

Superficial vein thrombosis

Raghvinder Gambhir, Chessington, United Kingdom Thrombophilia assessment in acute DVT

Adam Gwozdz, London, United Kingdom Acute DVT imaging and clot ageing

Brahman Dharmarajah, London, United Kingdom

Comparison of CT, MR and IVUS

Chung Sim Lim, London, United Kingdom

Cancer-related thrombosis

Francis Mattey, London, United Kingdom

Deep vein stenting ABRE venous stent

Optimed venous portfolio

Venovo venous stent

Erin Murphy, Charlotte, United States Steven Dubenec, Sydney, Australia

Zilver Vena case discussions and hands-on

Marta Ramirez Ortega, Madrid, Spain

Thursday 18 April 2019

Vena cava filters

ALN vena cava filter

Alain Nigon, ALN, Bormes Les Mimosas, France

Cava filters

Valve reconstruction

SailValve and VenoValve

Prosthetic valve technologies

Nadeem Qazi, London, United Kingdom

Steve Elias, Englewood, United States Hayley Moore, London, United Kingdom

Additional stations

Vascular ultrasound training simulator

Usman Jaffer, London, United Kingdom

IVUS in deep venous stenting

David Greenstein, London, United Kingdom

Use of IVUS for upper limb and SVC interventions

Sriram Narayanan, Singapore Paget-Schroetter syndrome Aero Wrap, Sun-Scientific

John Thompson, Exeter, United Kingdom Vikram Ravikumar, New York, United States

Endophlebectomy and open deep venous surgery

Joseph Shalhoub, London, United Kingdom

96 2019

Vascular & Endovascular Challenges Update Venous therapies from acute to chronic solutions

Domenico Baccellieri, Milan, Italy SVS/IVC stenting procedures

PPG for dynamic assessment of venous function

Mohammed Aslam, London, United Kingdom

CX Vascular Access Techniques & Technologies (edited cases) CX Vascular Access Workshop – 09:00-10:00

Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom

09:00-09:20 The Ellipsys procedure for endo AVF

Jeffrey Hull, North Chesterfield, United States 09:20-09:40

Using WavelinQ for fistula creation

Panagiotis Kitrou, Patras, Greece

09:40-10:00 Revision of cephalic arch stenosis with a covered endoprosthesis

Daniel Patel, Daytona Beach, United States

CX Vascular Access Workshop CX Vascular Access Workshop – 09:00-16:00

Domenico Valenti, London, United Kingdom Kate Sommerville, London, United Kingdom Annette Quinn, London, United Kingdom Nicola Milburn, London, United Kingdom Emily Hillier, London, United Kingdom Nicholas Zakikhani, London, United Kingdom Phil Hickman, London, United Kingdom

Fist Assist for vein enhancement

Piur Tomographic ultrasound

Tej Singh, Los Altos Hills, United States Gurdeep Jandu, Bolton, United Kingdom

Techniques in vascular access

Ellipsys EndoAVF System

Alexandros Mallios, Paris, France

WavelinQ 4F Endo AVF

Panagiotis Kitrou, Patras, Greece Arne Beutler, Kalrsruhe, Germany

Management of AV fistula/graft stenosis with stent grafts

David Kingsmore, Glasgow, United Kingdom Surgical techniques: Snuffbox fistula creation

Giambattista Gagliardo, Palermo, Italy Surgical techniques: Radiocephalic AVF

Teun Wilmink, Birmingham, United Kingdom

Surgical techniques: Brachiocephalic AVF

Hiren Mistry, London, United Kingdom Surgical techniques: Brachiobasilic AVF

Melanie Field, Birmingham, United Kingdom Grafts – techniques for EC grafts

Sapan Desai, Arlington Heights, United States

2019

97

Thursday 18 April 2019

Assessment of vascular access

USS stations with patients

Vascular & Endovascular Challenges Update Jaguar Support Catheter – micro cathether

Murat Katitas, Ankara, Turkey

Complex access

HeRO

James Gilbert, Oxford, United Kingdom

Surfacer

Guerkan Sengoelge, Vienna, Austria

Advance Enforcer 35 – A scoring balloon for dialysis access

Anders Bro, Bjaeverskov, Denmark Stents and stent grafts for vascular access

Matteo Barattini, La Spezia, Italy

Dialysis made simple

Dialysis central venous catheters workshop

Haimanot Wasse, Chicago, United States Fistula cannulation – It's not that easy!

Karen Tullett, Birmingham, United Kingdom

USS-guided cannulation Aurangzaib Khawaja, Birmingham, United Kingdom

Plastic cannulas for diaslysis

Zoe Roberts, Sheffield, United Kingdom Amardeep Gill, Kempston, United Kingdom

Complications of access

Treatment strategies with prosthetic vascular access and future prospects Matteo Tozzi, Varese, Italy

High flow and steal: Preserving the access Karl Illig, Tampa, United States Thrombosis, thrombolysis and thrombectomy

Kate Steiner, Stevenage, United Kingdom

Jason Wilkins, London, United Kingdom

Robert Jones, Birmingham, United Kingdom

CATD: Power aspiration with Indigo System

Andrea Unger, Hamburg, Germany

USS guided angioplasty

CX Day 2

Olivier Pichot, Grenoble, France

Workshop –

CX iWound Workshop – 09:30-15:30 Thursday 18 April 2019

Facilitators: W illiam Ennis, Oak Lawn, United States Keith Harding, Cardiff, United Kingdom John Lantis, New York, United States Thomas O’Donnell, Boston, United States

Complex lower limb compression

Curettage wound debridement

Julie Stanton, United Kingdom David Gray, United Kingdom

Automatic ankle-brachial index system

Anita Roberts, Cardiff, United Kingdom Debridement and compression solutions

Epifix/ReGen

Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom

Bill Tettelbach, Marietta, United States Leanne Atkins, United Kingdom

Optical detection of bacteria

3C Patch autologous therapy

Oxygen therapy

Tomas Serena, Warren, United States Magnus Löndahl, Lund, Sweden Robert Frykberg, Phoenix, United States

Diabetic foot and infra-red tomography

Susan Matthews, Oldham, United Kingdom

Michael Edmonds, London, United Kingdom

Geko for leg ulcers

Mölnlycke Granulox

Dawn Smiles, Leeds, United Kingdom Andrew Costello, Milton Keynes, United Kingdom

Footwear technology for diabetic foot ulcer patients

Sjef van Baal, Almelo, Netherlands

98 2019

Vascular & Endovascular Challenges Update

European Vascular Surgeons in Training – Prize Session Gallery Suite Learning Centre – 08:00-12:30

R eaching the limits of endo or open – when to change strategy Chairing: V assilios Zymvragoudakis, Dafni, Greece Florian Enzmann, Salzburg, Austria

08:00-08:30 Lower limb: Endovascular to open

Baris Ata Ozdemir, Bristol, United Kingdom 08:30-09:00 Lower limb: Open to endovascular

Konstantinos Katsanos, Patras, Greece 09:00-09:30

Aorta: Endovascular to open

Morad Sallam, London, United Kingdom

09:30-10:00 Vascular trauma to the neck: Open, endo or hybrid?

Vincent Jongkind, Amsterdam, Netherlands 10:00-10:30

TEA AND VISIT TO HANDS-ON WORKSHOPS

EVST Abstract Prize Session Chairing: L ewis Meecham, United Kingdom Salome Weiss, Bern, Switzerland

10:31-10:37 Effect of centralisation on abdominal aortic aneurysm repair outcomes in Catalonia (Spain) Paolo Tripodi, Barcelona, Spain 10:37-10:38

Discussion

10:38-10:44 Long-term outcomes of endovascular treatment versus open surgical repair for abdominal aortic aneurysms

Liliana Fidalgo Domingos, Valladolid, Spain 10:44-10:45

Discussion

10:45-10:51 Prediction of survival after 48 hours of intensive unit care following repair of ruptured abdominal aortic aneurysm – multicentric study for external validation of a new prediction score for 30-day mortality

Andreia Coelho, Porto, Portugal 10:51-10:52

Discussion

10:52-10:58 Endovascular boundaries in complex thoracic aorta aneurysms treatment Ana Carolina Semiao, Porto, Portugal Discussion

10:59-11:05 Preliminary experience with the Covera Plus self-expandable covered stent as bridging stent in branched thoraco-abdominal endovascular aneurysm repairs with standard (off-the-shelf) endograft

Nicola Leone, Baggiovara, Italy 11:05-11:06

Discussion

11:06-11:12 Aortic stump blowout in a hostile abdomen, a vascular challenge in emergency department Correia Ricardo, Lisbon, Portugal 11:12-11:13

Discussion

11:13-11:19 The CERAB technique in the treatment of an iatrogenic dissection of the abdominal aorta Ryan Melo, Lisbon, Portugal 11:19-11:20

Discussion

11:20-11:26 Treatment of superficial femoral and popliteal arteries long occlusions Leonid Magnitskiy, Russia 11:26-11:27

Discussion

11:27-11:33 Distal hybrids for long chronic total occlusion of superficial femoral artery with severely compromised runoff

Pavel Kuryanov, Saint Petersburg, Russian Federation 11:33-11:34

Discussion

11:34-11:40 Hybrid revascularisation procedures in the management of multiple level peripheral vascular disease Muhammed Labeb Eldeeb, Egypt 11:40-11:41

Discussion

2019

99

Thursday 18 April 2019

10:58-10:59

Vascular & Endovascular Challenges Update 11:41-11:47 Patient and lesion characteristics of in-stent restenosis of the internal carotid artery Zsuzsanna Mihaly, Budapest, Hungary 11:47-11:48

Discussion

11:48-11:54 Outcomes of modified surgical approach to treat thoracic outlet compression syndrome: The Venetian blind technique

Shanka Benaragama, Colchester, United Kingdom 11:54-11:55

Discussion

11:55-12:01 A single-centre experience using intravascular ultrasound as an adjunct in nutcracker syndrome

Maria Pilar Lamarca Mendoza, Toledo, Spain 12:01-12:02

Discussion

12:02-12:08 Novel non-thermal versus thermal endovenous ablation in superficial venous incompetence: A systematic review and meta-analysis of comparative studies Thomas Aherne, Dublin, Ireland 12:08-12:09

Discussion

12:09-12:15 Immediate versus early endovenous ablation in venous ulcers

Toni Pihlaja, Finland 12:15-12:16

Discussion

12:16-12:22 Endovenous laser ablation of great and small saphenous veins with 1470nm diode laser and radial slim fibres

Hovsep Manjikian, Moscow, Russia 12:22-12:23

Discussion

12:23-12:30

Prize giving

CX Peripheral Arterial Abstract Presentations – Day 3 l Dark Room Learning Centre – 10:30-15:20

Peripheral Arterial Abstract Presentations Chairing: I an Chetter, Hull, United Kingdom Mark Portou, London, United Kingdom

Thursday 18 April 2019

10:30-10:35 First human experience with the Xtremetouch-Neo sirolimus-coated balloon in percutaneous peripheral arterial interventions

George Dangas, New York, United States 10:35-10:40

Audience participation and discussion

10:40-10:45 Twenty four-month results of instent restenosis patients treated with a paclitaxel covered balloon in the real-world BIOLUX P-III all-comers’ registry Marianne Brodmann, Graz, Austria 10:45-10:50

Audience participation and discussion

10:50-10:55 Early and late outcome assessment of popliteal artery aneurysm open vs. endovascular repair Salvatore Turiano, Nicolosi, Italy 10:55-11:00

Audience participation and discussion

11:00-11:05 Outcomes of below-knee popliteal and tibial inflow venous bypass for critical limb ischaemia Goncalo Cabral, Sintra, Portugal 11:05-11:10

Audience participation and discussion

11:10-11:15 Rationale and design of a pivotal study for an autologous blood filter device for treatment of critical limb ischaemia

Bijan Modarai, London, United Kingdom 11:15-11:20

Audience participation and discussion

11:20-11:25 Rotarex mechanical atherectomy with thrombectomy in chronic arterial de novo lesions: Single-centre experience with 671 patients

Bruno Freitas, Leipzig, Germany

100 2019

Vascular & Endovascular Challenges Update 11:25-11:30

Audience participation and discussion

11:30-11:35 A comparative study of the patency of femoropopliteal bypass vs. long superficial femoral artery stenting

Maher Hamish, Northampton, United Kingdom 11:35-11:40

Audience participation and discussion

11:40-11:45 Inverted T bypass: Redefining the concept of non-revascularisable critical limb ischaemia Goncalo Cabral, Sintra, Portugal 11:45-11:50

Audience participation and discussion

11:50-11:55 The qualitative and the quantitative malnutrition in patients with the critical limb ischaemia Piotr Ciostek, Warszawa, Poland 11:55-12:00

Audience participation and discussion

12:00-12:05 Strategies for limb salvage in patients with end-stage peripheral arterial disease and neuromoduation

Beatrix Cucuruz, Nuremberg, Germany 12:05-12:10

Audience participation and discussion

12:10-12:15 “Via-pass”: A real alternative for the critical limb ischaemia after thrombosis of a vein bypass Javier Rio Gomez, Majadahonda, Spain 12:15-12:20

Audience participation and discussion

12:20-12:25 Endovascular graft bailout post reconstruction of popliteal artery injury. First case report Emad Eldeen Hussein, Heliopolis, Egypt 12:25-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Peripheral Arterial Abstract Presentations Chairing: B ijan Modarai, London, United Kingdom Sophie Renton, London, United Kingdom

13:30-13:35 Is amputation in the elderly CLI patients acceptable in the long term?

Chloé Peters, Breda, Netherlands 13:35-13:40

Audience participation and discussion

13:40-13:45 Perioperative complications after revascularisation in diabetic and non-diabetic critical limb ischaemia patients and its relation with preoperative HBA1C Roshan Rodney Sengodan, Coimbatore, India 13:45-13:50

Audience participation and discussion

13:50-13:55 Quality of life and traditional outcome results at one year in elderly patients suffering from critical limb ischaemia and the role of conservative treatment Stijn Steunenberg, Breda, Netherlands 13:55-14:00

Audience participation and discussion

14:00-14:05 The prognostic value of the WIfI classification in patients with chronic limb-threatening ischemia: A systematic review and metaanalysis Nick van Reijen, Amsterdam, Netherlands Audience participation and discussion

14:10-14:15 Effect of abnormal lipid profile on wound healing in critical limb ischaemia patients with successful infrapopliteal angioplasty

Roshan Rodney Sengodan, Coimbatore, India 14:15-14:20

Audience participation and discussion

14:20-14:25 Retrospective analysis of initial results of an atherectomy and thrombectomy device in patients with acute, subacute and chronic lower limb artery occlusion Christian Wissgott, Heide, Germany 14:25-14:30

Audience participation and discussion

14:30-14:35 The impact of a prior vascular procedure on the outcome of a future lower limb bypass for critical limb ischaemia

Alice Camagni, Ferrara, Italy 14:35-14:40

Audience participation and discussion

14:40-14:45 Prospective evaluation of the CELT arterial closure device in an outpatient based catheterisation laboratory

Syed Hussain, Peoria, United States 14:45-14:50

Audience participation and discussion

14:50-14:55 Retrograde use of the Outback re-entry catheter in complex infrainguinal arterial recanalisation

Lorenzo Patrone, London, United Kingdom 14:55-15:00

Audience participation and discussion

15:00-15:05 Totally percutaneous fem-pop bypass: From first human case to a routine technique Pierre Sarradon, La Seynen Sur Mer, France

2019

101

Thursday 18 April 2019

14:05-14:10

Vascular & Endovascular Challenges Update 15:05-15:10

Audience participation and discussion

15:10-15:15 Creation and management of arteriovenous fistula during complex peripheral revascularisation Claudia Martinez, Dublin, Ireland 15:15-15:20

Audience participation and discussion

CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2 l Dark Room Learning Centre

C X Venous Global Stars and Rising Stars (08:00-09:30) Chairing: A lun Davies, London, United Kingdom Johann Christoph Ragg, Berlin, Germany

08:00-08:05 Clinical and haemodynamic outcome of morbidly obese patients having severe chronic venou insufficiency with and without bariatric surgery: A comparative study Ahmed Naga, Alexandria, Egypt 08:05-08:10

Audience participation and discussion

08:10-08:15 A comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency

Fatih Islamoglu, Izmir, Turkey 08:15-08:20

Audience participation and discussion

08:20-08:25 Iliocaval stenting – diagnosis, technique and results

Marta Ramirez Ortega, Madrid, Spain 08:25-08:30

Audience participation and discussion

08:30-08:35 Outcomes of left renal vein stenting in patients with nutcracker syndrome Rabih Chaer, Pittsburgh, United States 08:35-08:40

Audience participation and discussion

08:40-08:45 Great saphenous vein diameters in phlebological practice in France: A report of the diagraves study by the French Society of Phlebology

Matthieu Josnin, La Roche Sur Yon, France 08:45-08:50

Audience participation and discussion

Thursday 18 April 2019

08:50-08:55 Vein valve defects and insufficiency in children

Johann Christoph Ragg, Berlin, Germany 08:55-09:00

Audience participation and discussion

09:00-09:05 Foam versus liquid in sclerotherapy for telangiectasia of the lower limb: Study protocol for a randomised controlled trial; the Fovelite study Matthieu Josnin, La Roche Sur Yon, France 09:05-09:10

Audience participation and discussion

09:10-09:15 Treatment of iliac and femoral vein occlusive disease with the Venovo venous stent: Twelve-month results from the VERNACULAR trial Michael Dake, Stanford, United States 09:15-09:20

Audience participation and discussion

09:20-09:25 Reducing hyperpigmentation after sclerotherapy: Midterm results of a multicentre, randomised, controlled, clinical trial

Alejandro Jose Gonzalez Ochoa, San Luis, Mexico 09:25-09:30

102 2019

Audience participation and discussion

Vascular & Endovascular Challenges Update

C X Venous Global Stars and Rising Stars (16:00-16:10) Chairing: M anj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom

16:00-16:05 Early and mid-term results of hybrid treatment approach for patients with acute iliofemoral deep vein thrombosis

Ali Baran Budak, Ankara, Turkey 16:05-16:10

Audience participation and discussion

C X Venous Abstract Presentations (16:10-17:50)

16:10-16:15 Treatment of chronic deep vein thrombosis using ultrasound accelerated catheter-directed thrombolysis with sequential balloon angioplasty Mert Dumantepe, Istanbul, Turkey 16:15-16:20

Audience participation and discussion

16:20-16:25 Aspiration thrombectomy for acute deep vein thrombosis of the left lower extremity of a child after cardiac radiofrequency ablation

Maria Antonella Ruffino, Turin, Italy 16:25-16:30

Audience participation and discussion

16:30-16:35 Novel compliant stent with specific design for truncular venous malformations: Results of a porcine model study

Pierfrancesco Veroux, Catania, Italy 16:35-16:40

Audience participation and discussion

16:40-16:45 New method and instrument for improved phlebectomy

Pierre Sarradon, La Seynen Sur Mer, France 16:45-16:50

Audience participation and discussion

16:50-16:55 The outcome of combined coiling and liquid sclerotherapy compared to coiling only on symptoms of pelvic congestion syndrome: A randomised controlled trial Mosaad Soliman, Mansoura, Egypt 16:55-17:00

Audience participation and discussion

17:00-17:05 Proper preoperative complex decongestive therapy and aggressive liposuction in combination with controlled compression: Paradigm shift in the management of lymphedema of lower limbs

Yasser Elkiran, Mansoura, Egypt 17:05-17:10

Audience participation and discussion

17:10-17:15 Continuing on aspirin or half of the therapeutic dose of DOACs for one year reduces the risk of recurrent VTE

Mosaad Soliman, Mansoura, Egypt 17:15-17:20

Audience participation and discussion

17:25-17:30

Audience participation and discussion

17:30-17:35 Thrombectomy devices in massive acute pulmonary embolism treatment: Initial single-centre experience with a novel technique using Aspirex through right jugular access

Bruno Freitas, Leipzig, Germany 17:35-17:40

Audience participation and discussion

17:40-17:45 Patient radiation exposure from embolo-sclerotherapy of vascular malformations Leeying Giet, London, United Kingdom 17:45-17:50

Audience participation and discussion

2019

103

Thursday 18 April 2019

17:20-17:25 Why hydatic pressure compresses leg veins but stockings do not

Christopher Lattimer, London, United Kingdom

Vascular & Endovascular Challenges Update

CX Abdominal Aortic Abstract Presentations – Day 2 l London Room Learning Centre – 08:00-18:00

Abdominal Aortic Abstract Presentations Chairing: F rank Criado, Baltimore, United States Anna Prent, London, United Kingdom

08:00-08:05 Major complications patients want to be informed about prior to abdominal aortic aneurysm surgery: A best-worst scaling study

Sylvana de Mik, Amsterdam, Netherlands 08:05-08:10

Audience participation and discussion

08:10-08:15 Impact of common iliac artery’s anatomy on the risk of endograft limb occlusion after EVAR Liborio Ferrante, Palmero, Italy 08:15-08:20

Audience participation and discussion

08:20-08:25 Are NHS vascular surgeons adequately prepared to meet the demands of the newly proposed NICE guidelines on AAA management?

Simon Glasgow, London, United Kingdom 08:25-08:30

Audience participation and discussion

08:30-08:35 Evolution of EVAR stent graft design provides opportunity to reduce perioperative radiation exposure Paul Hayes, Cambridge, United Kingdom 08:35-08:40

Audience participation and discussion

08:40-08:45 Localised aortic primary stenting for focal aortic stenosis; a review of nine patients with short-term outcomes Mohamed Ismail, Cairo, Egypt 08:45-08:50

Audience participation and discussion

08:50-08:55 The role of sarcopenia in survival of patients with abdominal aortic aneurysm: A prognostic factor review and meta-analysis of time-toevent data Maciej Juszczak, Birmingham, United Kingdom 08:55-09:00

Audience participation and discussion

09:00-09:05 Insight in national numbers of secondary reintervention procedures after primary abdominal aortic aneurysm surgery

Eleonora Karthaus, Amsterdam, Netherlands 09:05-09:10

Audience participation and discussion

09:10-09:15 Symptoms of depression and risk of abdominal aortic aneurysm. A population-based prospective study in Norway (the HUNT study)

Linn Aldstedt Nyronning, Trondheim, Norway

Thursday 18 April 2019

09:15-09:20

Audience participation and discussion

09:20-09:25 Screening cardiovascular patients for aortic aneurysms – high prevalence of AAA in coronary heart disease requiring intervention

Benedikt Reutersberg, London, United Kingdom 09:25-09:30

Audience participation and discussion

09:30-09:35 An automatised algorithm to evaluate the patent aortic lumen in noncontrast computed tomographies Gioele Simonte, Perugia, Italy 09:35-09:40

Audience participation and discussion

09:40-09:45 Treatment of calcified iliac stenosis using intravascular lithotripsy to facilitate percutaneous aortic intervention

Mazin Foteh, Austin, United States 09:45-09:50

Audience participation and discussion

09:50-09:55 Augmented reality in vascular surgery – 3D holographic imaging during endovascular aortic repair Natalia Wrzesinska, Nieporet, Poland 09:55-10:00

Audience participation and discussion

10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS

104 2019

Vascular & Endovascular Challenges Update

Abdominal Aortic Abstract Presentations Chairing: M eryl Davis, London, United Kingdom Kevin Mani, Uppsala, Sweden

10:30-10:35 Retroperitoneal versus endovascular approach for the treatment of asymptomatic infrarenal aortic aneurysms – a single-centre experience Gladiol Zenunaj, Ferrara, Italy 10:35-10:40

Audience participation and discussion

10:40-10:45 Analysis of aortic neck dilatation after endovascular aortic repair

Simone Hofer, Chur, Switzerland 10:45-10:50

Audience participation and discussion

10:50-10:55 Endovascular treatment of short and severe abdominal aortic lesions

Teodora Mares, Bucharest, Romania 10:55-11:00

Audience participation and discussion

11:00-11:05 Endovascular aortoiliac grafting in patients with juxtarenal aortoiliac occlusive disease Piotr Ciostek, Warszawa, Poland 11:05-11:10

Audience participation and discussion

11:10-11:15 Percutaneous revascularisation as a feasible option for complex aortoiliac occlusive disease with fair one-year outcome

Ahmed Allam, Benha, Egypt 11:15-11:20

Audience participation and discussion

11:20-11:25 3D aortic models for the urgent endovascular treatment of paravisceral penetrating aortic ulcers using physician-modified stent grafts Daniela Branzan, Leipzig, Germany 11:25-11:30

Audience participation and discussion

11:30-11:35 Endovascular treatment of terminal aorta occlusion

Mikhail Chernyavskiy, St Petersburg, Russia 11:35-11:40

Audience participation and discussion

11:40-11:45 Neck morphologic changes and clinical consequences of enlarged necks requiring 34–36mm devices Jose Pedro Pinto, Porto, Portugal 11:45-11:50

Audience participation and discussion

11:50-11:55 Quantitative description of aortic rigid and non-rigid deformation during endovascular aneurysm repair

Salma El Batti, London, United Kingdom 11:55-12:00

Audience participation and discussion

12:00-12:05 Long-term follow-up post surgical treatment of infected aortofemoral vascular graft: Limited, sequential vs. total graft replacement

Grzegorz Gorski, Warszawa, Poland 12:05-12:10

Audience participation and discussion

12:10-12:15 Endovascular treatment of aortoiliac disease using in situ fenestration Jeremie Jayet, Boulogne-Billancourt, France Audience participation and discussion

12:20-12:25 New off-the-shelf branched EVAR technique for thoracoabdominal aneurysms Marco Lourenco, Curitiba, Brazil 12:25-12:30

Audience participation and discussion

12:30-13:30

LUNCH AND VISIT TO HANDS-ON WORKSHOPS

Abdominal Aortic Abstract Presentations Chairing: P aul Hayes, Cambridge, United Kingdom Emma Wilton, Beaconsfield, United Kingdom

13:30-13:35 One-year outcomes of BeGraft stent grafts used as chimney grafts in conjunction with the Endurant device for the treatment of complex abdominal diseases Konstantinos Donas, Münster, Germany 13:35-13:40

Audience participation and discussion

13:40-13:45 Early outcomes of native and graft related abdominal aortic infection managed with orthotopic xenopericardial grafts

Baris Ata Ozdemir, Bristol, United Kingdom 13:45-13:50

Audience participation and discussion

13:50-13:55 Mid-term results following 295 endovascular aneurysm sealing cases with the nellix stent-graft system: A single-centre experience

Kate Stenson, London, United Kingdom 13:55-14:00

Audience participation and discussion

2019

105

Thursday 18 April 2019

12:15-12:20

Vascular & Endovascular Challenges Update 14:00-14:05 Patient-specific computational analysis of the impact of fenestrated and chimney endovascular aortic repair on haemodynamics in renal arteries Sabrina Ben Ahmed, Clermont Ferrand, France 14:05-14:10

Audience participation and discussion

14:10-14:15 Two-year outcomes of endovascular aneurysm sealing and chimney EVAS in abdominal aortic aneurysms based on calculated neck length: A single-centre study Patrick Berg, Kevelaer, Germany 14:15-14:20

Audience participation and discussion

14:20-14:25 Endovascular treatment of isolated common iliac artery aneurysms using iliac branch stent grafts without aortic component: A national multicentre registry Alessia Giaquinta, Catania, Italy 14:25-14:30

Audience participation and discussion

14:30-14:35 Long-term results of the chimney technique by use of a standardised combination of devices in the treatment of 211 patients with pararenal pathologies Konstantinos Donas, MĂźnster, Germany 14:35-14:40

Audience participation and discussion

14:40-14:45 Rupture after endovascular abdominal aortic aneurysm repair: A late challenge Nelson Camacho, Lisbon, Portugal 14:45-14:50

Audience participation and discussion

14:50-14:55 Cerebrovascular and cardiovascular complications in the survivors of ruptured abdominal aortic aneurysm

Terri-Ann Russell, Northamptonshire, United Kingdom 14:55-15:00

Audience participation and discussion

15:00-15:05 A comparison of survival after endovascular and open repairs of unruptured elective infrarenal abdominal aortic aneurysms in octogenarians Kane Treadwell, United Kingdom 15:05-15:10

Audience participation and discussion

15:10-15:15 Factors associated with elimination of endoleak type II during the first year post EVAR Konstantinos Spanos, Larissa, Greece 15:15-15:20

Audience participation and discussion

15:20-15:25 Emergency EVAR for complex abdominal aortic aneurysms

Maciej Juszczak, Birmingham, United Kingdom 15:25-15:30

Audience participation and discussion

15:30-16:00

TEA AND VISIT TO HANDS-ON WORKSHOPS

Abdominal Aortic Abstract Presentations Chairing: C olin Bicknell, London, United Kingdom Celia Riga, London, United Kingdom

16:00-16:05 Post-implantation syndrome and asymptomatic myocardial injury after EVAR Joel Sousa, Oporto, Portugal 16:05-16:10

Audience participation and discussion

Thursday 18 April 2019

16:10-16:15 Patient preferences and attitudes towards surveillance post EVAR

Bilal Azhar, London, United Kingdom 16:15-16:20

Audience participation and discussion

16:20-16:25 Long-term outcomes of surgical, endovascular and hybrid treatment of aortoiliac occlusive disease in patients younger than 60 years old

Swati Chaparala, Rochester, United States 16:25-16:30

Audience participation and discussion

16:30-16:35 Outcomes after contemporary elective EVAR: Five-year experience of a single NHS trust Lola Eid-Arimoku, Frimley, United Kingdom 16:35-16:40

Audience participation and discussion

16:40-16:45 Redefining the volume outcome relationship for endovascular aneurysm repair Jens Eldrup-Jorgensen, Portland, United States 16:45-16:50

Audience participation and discussion

16:50-16:55 Observing a decade of yearly standardised surveillance in EVAR – patients with ultrasound or CT scan: Results from a single centre

Anna Geraedts, Amsterdam, Netherlands 16:55-17:00

Audience participation and discussion

17:00-17:05 Long-term outcomes of endovascular aortic repair in patients with abdominal aortic aneurysm and ectatic iliac arteries

Lorenzo Gibello, Turin, Italy

106 2019

Vascular & Endovascular Challenges Update 17:05-17:10

Audience participation and discussion

17:10-17:15 Multicentre post-EVAR surveillance evaluation study (EVARSCREEN) Matthew Joe Grima, London, United Kingdom 17:15-17:20

Audience participation and discussion

17:20-17:25 Iliac branch endoprosthesis conformability is associated with freedom from adverse iliac events Donald Harris, Monona, United States 17:25-17:30

Audience participation and discussion

17:30-17:35 Post-EVAR aneurysm sac shrinkage is prognostically favourable but does not justify withholding follow-up

Jasper Langenberg, Breda, Netherlands 17:35-17:40

Audience participation and discussion

17:40-17:45 Secondary complication in an asymptomatic retroperitoneal lymphocele after an open abdominal aortic surgery: Management of a prosthetic vascular graft infection

Cristina Lozano Ruiz, Albacete, Spain 17:45-17:50

Audience participation and discussion

17:50-17:55 Fusion image laser fenestration in situ for endovascular repair of type Ia endoleak Marek Majewski, CRÉTEIL, France 17:55-18:00

Audience participation and discussion

CX Aortic Selected Posters Presentations l Poster Gallery – 12:30-13:30 Aortic Poster Presentations

Chairing: Emma Wilton, Beaconsfield, United Kingdom Moderator: Celia Riga, London, United Kingdom 12:30-12:33 Device conformability after thoracic endovascular aortic repair: A single-centre experience Jose Antonio del Castro Madrazo, Oviedo, Spain 12:33-12:35 Audience participation and discussion 12:35-12:38 Strategies to minimise risk of spinal cord injury during complex endovascular aortic repair Luis Mariano Ferreira, Buenos Aires, Argentina 12:38-12:40

Audience participation and discussion

12:40-12:43 Aortic remodelling effect of Zenith dissection endovascular system on acute type B aortic dissection with patent false lumen

Kenichi Hashizume, Shinagawa, Japan Audience participation and discussion

12:45-12:48 Geometric and haemodynamic analysis of abdominal branches after complex endovascular aneurysm repair

Enrique María San Norberto García, Valladolid, Spain 12:48-12:50

Audience participation and discussion

12:50-12:53 Short-stay EVAR: Which patients are suitable?

Ryan Preece, London, United Kingdom 12:53-12:55

Audience participation and discussion

12:55-12:58 Impact of baseline renal function on the five-year mortality in octogenarians undergoing EVAR followed up with CT angiogram

Simran Parmar, Newcastle-under-Lyme, United Kingdom 12:58-13:00

Audience participation and discussion

13:00-13:03 Factors associated with increased incidence of rupture in large (>80mm) AAA Petroula Nana, Larissa, Greece 13:03-13:05

Audience participation and discussion

13:05-13:08 Percutaneous groin access for EVAR in ruptured abdominal aortic aneurysm: The experience in Burapha University Hospital

Trakarn Chaivanit, Chonburi, Thailand 13:08-13:10

Audience participation and discussion

2019

107

Thursday 18 April 2019

12:43-12:45

Vascular & Endovascular Challenges Update 13:10-13:13 A new approach to endovascular aneurysm repair surveillance with contrast-enhanced ultrasound Claudio Castagno, Biella, Italy 13:13-13:15

Audience participation and discussion

13:15-13:18 Clinical and cost-effectiveness of open vs. endovascular repair for ruptured abdominal aortic aneurysm: 10-year single-centre experience of Japan Yukio Umeda, Gifu, Japan 13:18-13:20

Audience participation and discussion

13:20-13:23 Majority of elective small aneurysm repairs still fall within current SVS guidelines Thomas Heafner, Rochester, United States 13:23-13:25

Audience participation and discussion

13:25-13:28 Superior mesenteric artery open surgical revascularisation: A singlecentre experience Sandeep Mahapatra, Hyderabad, India 13:28-13:30

Audience participation and discussion

An Introduction to Vascular Surgery An Introduction to Vascular Surgery, Exhibition Hall – 09:00-15:30 The Vascular Society of Great Britain & Ireland, Rouleaux Club and CX Symposium are running An Introduction to Vascular Surgery for medical students, foundation doctors and core surgical trainees considering a career in Vascular Surgery.

Chairing: Sophie Renton, Secretary General VSGBI, London, United Kingdom

09:00-09:30

Registration

09:30-10:15

elcome and introduction to the Course W What is Vascular Surgery?

A career in Vascular Surgery – a junior’s perspective

10:15-12:15 Groups A and B: Hands-on training in vascular anastomosis Groups C and D: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops

Thursday 18 April 2019

12:15-13:00

LUNCH

13:00-13:30

ow to prepare your portfolio H How to apply for training in Vascular Surgery Why choose Vascular Surgery?

13:30-15:30

roups C and D: Hands-on training in vascular anastomosis G Groups A and B: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops

15.30

Feedback and close

108 2019

Vascular & Endovascular

Challenges Update

B O O K AVA I L A B L E N O W !

Edited by Roger M Greenhalgh Published April 2019 Available for purchase during CX 2019 (until 18 April) at the Registration Desk – Launch price Hardback £65 After 18 April, please visit www.cxsymposium.com/cx-books Hardback £85 Digital £42

www.cxsymposium.com

Tuesday 16 April 2019

Tuesday

Sponsored Events

Sponsored Events

Sponsored Satellite RD Global Sponsored Satellite (COFFEE) Lower Main Auditorium 10:00-10:30

Arterial and venous insufficiency treatment with RD Global innovative medical devices

Speaker: Raşit Dinç, Ankara, Turkey

10:00-10:05 Thermal ablation for varicose insufficiency with ThermoBlock RF technology

Tuesday 16 April 2019

10:05-10:10 Glue ablation innovative technology for varicose insufficiency with Venablock, VeinOff and Internal Compresion Therapy (ICT) 10:10-10:15 Deep vein thrombosis management with Mantis, Dovi Aspiration, Viper and Inca Filter 10:15-10:20 Peripheral artery disease treatment with Temren Atherectomy device and Drug Eluting Balloon 10:20-10:25 Vascular access with RD Global Technology: Jaguar Support Catheter, Microcatheter and Guide Catheter 10:20-10:25 Panel discussion This session will be presented in Turkish with simultaneous translation into English. To listen to the translation please download the Interprefy app on your phone, enter the code “cxsymposium” and click “Connect”. You can hold the phone to your ear as you would when making a phone call, or use headphones if you have them. Alternatively, use of the headsets provided.

Refreshments will be served in the Lower Main Auditorium.

Booth and pavilion activities Bentley Refreshing beer @ Bentley booth Booth 419 From 17:00 Enjoy a freshly draught Bavarian beer on Tuesday and Wednesday from 17:00 after a long congress day! We look forward to seeing you there.

Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.

Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Booth 440 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.

112 2019

Sponsored Events

Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.

Getinge

09:00-11:00

Open AAA (bifurcated graft)

14:00-16:00 Open AAA (bifurcated graft)

Merit Medical Meet the Experts Booth 470 15:00-17:00 Innovative solutions for vascular challenges: Discuss ClariVein tips and tricks with Leith Williams and discuss the Surfacer System with Guerkan Sengoelge. Refreshments will be provided

Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practise wireless, non-thermal laser atherectomy techniques.

Siemens First demonstration of Artis icono Booth 150 From 13:00

Experience procedural intelligence for EVAR

Straub Medical Booth 418 15:00 Arterial Workshop – Meet the Expert:

Miroslav Bulvas, Prague, Czech Republic

Terumo Aortic Booth 240 During exhibition hours each day

Individualised Solutions

Meet our engineers, clinical planners and specialists to learn more about the processes used in the planning and design of individualised devices; tailored solutions are available for treatment across the thoracic and abdominal aortic regions incorporating technologies from the Anaconda, Relay and TREO platforms. Learn about the unique Case Rehearsal Service offered with Fenestrated Anaconda that provides a prototype device alongside an accurate 3D printed model of your patient’s anatomy.

Sewing Operators

Our sewing operators will be demonstrating the intricate sewing techniques used in the manufacturing of a wide range of our products.

2019

113

Tuesday 16 April 2019

Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training.

Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability.

Wednesday 17 April 2019

Wednesday

Sponsored Events

Sponsored Events

Booth and pavilion activities Bentley Refreshing beer @ Bentley booth Booth 419 From 17:00 Enjoy a freshly draught Bavarian beer on Tuesday and Wednesday from 17:00 after a long congress day! We look forward to seeing you there.

Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.

Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Wednesday 17 April 2019

Booth 440 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.

Endologix Join Endologix for a reception to acknowledge early innovators and the ongoing dedication to evidence driven solutions.

Pillar Hall Learning Centre Reception at 17:45 Panel discussion at 18:15 Honourees:

Roger Greenhalgh, London, United Kingdom Andrew Holden, Auckland, New Zealand Marc Schermerhorn, Boston, United States Hence Verhagen, Rotterdam, Netharlands

Please register at endologix.com/cx2019 Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.

116 2019

Sponsored Events

Getinge Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training. Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability.

09:00-11:00

Renal stenting in complex aortic cases

12:00-14:00 Renal stenting in complex aortic cases 15:00-17:00

Renal stenting in complex aortic cases

Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practice wireless, non-thermal laser atherectomy techniques.

Siemens Booth 150

Experience procedural intelligence for EVAR

Straub Medical Booth 418 10:00 Arterial Workshop – Meet the Expert:

Miroslav Bulvas, Prague, Czech Republic 15:00 Venous Workshop – Meet the Expert:

Thomas Heller, Rostock, Germany

Terumo Aortic Booth 240 During exhibition hours each day

Individualised Solutions

Meet our engineers, clinical planners and specialists to learn more about the processes used in the planning and design of individualised devices; tailored solutions are available for treatment across the thoracic and abdominal aortic regions incorporating technologies from the Anaconda, Relay and TREO platforms. Learn about the unique Case Rehearsal Service offered with Fenestrated Anaconda that provides a prototype device alongside an accurate 3D printed model of your patient’s anatomy.

Sewing Operators

Our sewing operators will be demonstrating the intricate sewing techniques used in the manufacturing of a wide range of our products.

2019

117

Wednesday 17 April 2019

First demonstration of Artis icono

Sponsored Events

Thursday 18 April 2019

Thursday

Sponsored Events

Booth and pavilion activities Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.

Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Booth 440 09:00-11:00 and 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.

Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.

Getinge Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training. Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability.

Thursday 18 April 2019

09:00-11:00

Endovascular treatment of complex aortoiliac cases: Kissing stent

12:00-14:00

Endovascular treatment of complex aortoiliac cases: Kissing stent

Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practice wireless, non-thermal laser atherectomy techniques.

Siemens First demonstration of Artis icono Booth 150

Experience procedural intelligence for EVAR

Straub Medical Booth 418 09:30 Venous Workshop – Meet the Expert:

120 2019

Thomas Heller, Rostock, Germany

Vascular & Endovascular Challenges Update

The Charing Cross Symposium would like to thank all the Pavilion Sponsors and Major Sponsors.

Pavilion Sponsors

Major Sponsors

The Charing Cross Symposium programme is supported by educational grants from: Abbott Vascular Avenu Medical BD/Bard Bentley Biotronik Boston Scientific Cook Medical Cydar Medical Endologix GE Healthcare Getinge Gore HammerMed Intact Vascular

122 2019

Jotec/Cryolife Kaster Lifetech Scientific Mediplast Fenno Oy Medtronic Philips Healthcare Ra Medical Reapplix Secord Medical Shockwave Medical Straub Medical Terumo Aortic Vivasure

Vascular & Endovascular Challenges Update

CX 2019 CME Credits The Charing Cross Symposium 2019, London, United Kingdom, 15/04/2019-18/04/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 28 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.amaassn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

EACCME credits Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20.

Certificate of attendance and CME credits collection We send Certificates of Attendance following completion of our survey submitted at the end of the event.

We ask you to complete an electronic CME questionnaire. Please visit cx2019app.com to view and fill out the CX 2019 CME questionnaire. It will be available from Tuesday lunchtime. Your certificate will be emailed to the address you provided with your registration. fter the event – You can access the Certificate of attendance A and CME credits questionnaire online at www.cxsymposium. com/cme. Your certificate will be emailed to the address you provided with your registration.

2019

123

Vascular & Endovascular Challenges Update

CX Pick Up Point Delegate bags

Book & Bag Stand

CX Book pick up point Book & Bag Stand

CX Programme – Slim Jim Book & Bag Stand

Pavilion Sponsors Cook Medical

140

Gore

Endologix

155

Medtronic

250/260 450

Getinge

170

Terumo Aortic

240

BD

428

Merit Medical

470

Bentley

419

Philips

444

Boston Scientific

228

RD GLOBAL

238

Cydar Medical

229

Siemens Healthineers

150

JOTEC - CryoLife

440

Straub Medical

418

Lombard Medical

432

Major Sponsors

Exhibitors 3D Systems Simbionix

315

Legs Matter

136

Abbott Vascular

232

Lifetech Scientific

523

Advanced Oxygen Therapy Inc

138

LimFlow

714

ALN Implants Chirurgicaux

122

LINC

648

AndraTec

712

LSO Medical

220

Aortic Association

710

Medi

217

Avenu Medical

734

Micro Medical solutions

738

BALTON SP. Z.O.O.

304

Mölnlycke

134

BIBA Medtech Insights

110

Nanjing ECO Microwave

208

Biotronik

402

optimed

404

BTG

212

Orbus Neich

505

C3 interventional Academy

501

Penumbra

412

CACVS / i-MEET /DIVINE ID

118

Pie Medical Imaging

538

Cardionovum

716

Piur Imaging

215

CIRSE

644

R&D Surgical

720

Clinlogix

736

Ra Medical Systems

509

Concept Medical

401

Regen Medical

124

Corindus

400

Scanlan International

211

Edinburgh Surgery Online

135

Shockwave Medical

424

Edizioni Minerva Medica

646

SITE

501

Edwards Lifesciences

137

Therenva

533

ESVS

114

Vascular News

110

Evarplanning

132

EVC

213

Vascular Society and Circulation Foundation 207

EVF

117

EVT

119

F Care Systems

116

Firstkind

131

Fist Assist Devices

718

GE Healthcare

311

H&R Healthcare

308

Huntleigh

209

Intact Vascular

408

Laminate Medical

409

124 2019

Venclose

112

Venous News

110

VentureMed

732

Veryan Medical

438

Vivasure Medical

317

Walk Vascular

113

Wisepress Medical Bookshop

725

Ziehm Imaging

223

Vascular & Endovascular Challenges Update

New exhibitors at CX 2019 Advanced Oxygen Therapy Inc

Booth 138

Advanced Oxygen Therapy Inc. (AOTI) offers a wide range of its patented Topical Wound Oxygen (TWO2) systems allowing this unique multi-modality therapy to be delivered effortlessly across the continuum of care, all the way to the patient’s home. Leading clinical trials have shown TWO2 to heal chronic DFU, VLU and PU at an unprecedented rate with far lower recurrence. TWO2 is also effective in healing post-surgical and burn wounds. Over 1,500,000 TWO2 treatments have be delivered to patients to date. www.aotinc.net Clinlogix

Booth 736

Clinlogix is a Global Clinical Research Organisation working to improve human quality of life by supporting and accelerating innovation in the life science industry. Its full suite of clinical research services supports the regulatory and clinical development pathway of medical devices, biotechnologies and pharmaceuticals from bench to bedside. www.clinologix.com Concept Medical

Booth 401

Concept Medical is an India based research division of CMI founded in 2008, which is dedicated for research and development of drug delivering medical devices in various medicinal applications including cardiovascular and peripheral medical devices. Concept Medical believe in bringing innovations which inspires not only the industry but others to innovate and create something revolutionary, our products have been the leaders and not followers in the market.

Philosophy: Converting Concepts into reality. www.conceptmedicals.com Corindus Vascular Robotics

Booth 400

Corindus is a global technology leader in robotic-assisted vascular interventions. The company’s CorPath platform is the first FDAcleared and CE-marked medical device to bring robotic precision to percutaneous coronary and vascular procedures. Corindus is focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialised and timely medical care to patients around the world. www.corindus.com Evarplanning

Booth 132

EVARplanning is a software company founded by Paolo Spada, Vascular Surgeon in Milan, Italy. Well known for its free web-app for the endograft configuration, EVARplanning has now expanded its team and expertise, to provide a comprehensive preoperative system, based on advanced algorithms and cutting-edge sharing technologies. www.evarplanning.com Firstkind

Booth 131

Firstkind Ltd, a UK-based medical devices company, is the manufacturer of a ground-breaking platform technology, OnPulse, embedded in its wearable geko device, designed increase blood flow by combination of proprietary nerve and muscle stimulation, resulting in increased venous, arterial and microcirculatory blood flow – creating conditions favourable to wound healing. www.gekodevices.com

2019

125

Vascular & Endovascular Challenges Update Fist Assist Devices

Booth 718

Fist Assist Devices, LLC is a company based in Silicon Valley, CA USA. We have developed a patented, external wearable (Fist Assist) designed for arm vein enhancement and vein dilation before and after AV fistula surgery for renal failure patients and venipuncture procedures. The company is completing the FACT trial at The University of Chicago and all regulatory requirements before sales launch in Europe and the USA. www.fistassistdevices.com H&R Healthcare Ltd

Booth 308

H&R Healthcare Ltd is a UK based distributor with over 12 years’ experience supplying innovative and cost-effective medical products to the NHS. Our innovative products include: FlowOx, a novel system for the treatment of PAD-related problems such as pain, reduced walking distance and chronic ulcers. It is a non-invasive, gentle and easy-to-use device that works by generating pulsating negative pressure, perfusing the lower limb, thus improving the blood flow and oxygenation; Accel-Heal, using electroceutical energy that stimulates healing and reduces pain in leg ulcers. hrhealthcare.co.uk Huntleigh

Booth 209

A proud member of the Arjo family, Huntleigh has been committed to supporting healthcare professionals in improving outcomes and enhancing patient wellbeing since 1979. We do this through our proven solutions for Vascular Assessment & Treatment and Fetal & Patient Monitoring. With innovation and customer satisfaction as our guiding principles, we strive for clinical excellence and improved performance, for life. www.huntleigh-diagnostics. co.uk Intact Vascular

Booth 408

Intact Vascular is committed to developing safe, efficacious and easyto-use products for patients with vascular disease and the physicians who treat them. Founded in 2011, our core technology, the Tack Endovascular System is a first-of-its-kind dissection repair device that is purpose-built and designed to provide precision treatment of peripheral arterial dissections following balloon angioplasty, in either above- or below-the-knee therapeutic interventions. www.intactvascular.com LimFlow

Booth 714

LimFlow is a private, venture-backed medical device company transforming the treatment of critical limb ischaemia with a novel technology solution to perform percutaneous deep vein arterialisation. www.limflow.com medi

Booth 217

Global leaders in venous healthcare. Visit the stand to see Medi’s wound care therapy chain. Assess with the world’s fastest ABPI device – MESI ABPI MD – an accurate reading in one minute, with no need for prior resting before testing. Clean and debride with UCS pre-moistened debridement cloth – soft loop technology helps to catch wound debris and slough. Can be used both sides. Sterile and ready to use. Heal venous leg ulcers with juxtalite the only adjustable Velcro device with measurable compression. Eight sizes and two lengths for all stages of venous disease. www.mediuk.co.uk

126 2019

Vascular & Endovascular Challenges Update Micro Medical Solutions

Booth 738

Micro Medical Solutions is an innovative, US-based medical device company committed to the advancement of the least invasive technology for the treatment of patients suffering from CLI. MMS’ lead product, MicroStent, is a uniquely designed self-expanding stent for the treatment of BTK peripheral artery disease. MMS’ mission is to improve patient quality of life and clinical outcomes, reduce amputation associated with CLI, and lessen the healthcare economic burden. www.micromedicalsolutions.net Mölnlycke

Booth 134

Mölnlycke is a world-leading medical solutions company. We are here to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. www.molnlycke.co.uk Nanjing ECO Microwave System CO, LTD

Booth 208

Established in 2000, ECO is a leading manufacturer of medical instruments in China, which covers microwave, high frequency and laser systems. With the vision “To be no.1 in China and first-class in the world”, and mission to help employees realise their self-worth and contribute to human health, ECO is trying every effort to deliver advanced technology and provide product solutions to healthcare industry at home and abroad. www.ecomicrowave.com Orbus Neich

Booth 505

OrbusNeich is a global pioneer in the provision of life-changing vascular solutions. Portfolio includes peripheral devices; JADE, Sapphire II Pro PTA, Scoreflex PTA balloons & Teleport/ Teleport Control microcatheters together with coronary stents, balloons and microcatheters. OrbusNeich is the exclusive distributor of the Stealth 360 Peripheral Orbital Atherectomy System from Cardiovascular Systems, Inc. outside of the USA and Japan. www.orbusneich.com Regen Medical

Booth 124

Part of the Joint Operations family, Regen Medical is a leading distributor in the fields of burns and woundcare. Regen Medical prides itself on introducing new, innovate and ground-breaking products to the regenerative space within the UK. These include Epifix from MiMedx, a dehydrated Human Amnion/ Chorion Membrane (dHACM) Allograft. www.regenmedical.com Venclose

Booth 112

Venclose is a privately held, commercial-stage Silicon Valley medical technology company developing next-generation solutions for the treatment of venous reflux disease, also known as chronic venous insufficiency (CVI). CVI is a progressive medical condition affecting more than 40 million adults in the USA alone. The VENCLOSE RF Ablation System offers physicians more versatility than earlier generation endovenous radiofrequency ablation technologies and is commercially available in the USA and Europe. www.venclose.com

2019

127

Vascular & Endovascular Challenges Update

Product launches 2019 ARTIS pheno and ARTIS icono, Siemens

See minimally invasive treatment in a new light: Siemens’ new imaging systems ARTIS pheno and ARTIS icono with procedural intelligence allow you to optimise clinical operations in the Hybrid OR and achieve consistency across workflows with ease – regardless of procedural complexity.

Carnelian Support Catheter, Biotronik

Carnelian Support catheter is indicated to support guidewire in peripheral vascular procedures evolving the PVI product portfolio towards complex disease. Biotronik offers five different versions to allow physicians to choose the right tool suitable for challenging lesions. The multisegment shaft is optimally balanced providing additional strength, trackability and pushability.

Fortress Line Extension, Biotronik The Fortress introducer sheath is reinforced with a resilient and flexible stainless steel coil that provides a maximum degree of flexibility and stability to introduce devices to treat diseased arteries.

To further strengthen Fortress’ success Biotronik has added 65cm and 90cm lengths in 4F, 5F, 6F, to its portfolio providing physicians more opportunities during peripheral interventions.

Legacy Needle Holders and Forceps with the revolutionary Scan-II handle, Scanlan Scanlan International presents the new Legacy Needle Holders and Forceps with the revolutionary Scan-II handle. The unique ScanII handle combines flat surfaces for control with round sides for manoeuvrability. Scanlan titanium Legacy instruments are designed for optimal weight and balance. Surgeons say “it’s like an extension of my hands”.

Microwave Therapeutic System for varicose vein, Nanjing ECO Microwave System CO, LTD

The Microwave Endovenous ablation therapy, with 80oC ablation, coagulating protein of veins. It provides inside-out heat to the vein wall, with fewer complications (less ecchymosis, less edema, less pain) and a lower recurrence rate.

PerQseal, Vivasure Medical

Vivasure Medical has developed PerQseal, a fully absorbable patch-based closure device for large-bore arteriotomies up to 24F. PerQseal is simple and intuitive to use, sealing and healing the artery from the inside, without the need for sutures, collagen or metal clips. The implant is completely absorbable, leaving nothing behind.

Pulsar-18 T3, Biotronik

Pulsar-18 T3 SES designed for effective lesion treatment in the

128 2019

Vascular & Endovascular Challenges Update SFA, popliteal and infrapopliteal arteries up to 200mm. A unique combination for an improved implantation procedure: The 4F low profile decreases the risk of access site complications, while the triaxial shaft design facilitates accurate implantation of the proven Pulsar stent.

Stealth 360 Peripheral Orbital Atherectomy System, distributed by OrbusNeich, manufactured by Cardiovascular System, Inc

The Stealth 360 Peripheral Orbital Atherectomy System is a minimally invasive catheter-based system used to treat patients who suffer from peripheral arterial disease. It is designed to contact 360 degrees of the vessel wall with differential sanding that treats hard plaque while minimising damage to the media.

Valiant Navion stent graft system, Medtronic

Medtronic is introducing the Valiant Navion stent graft system, featuring a low 18F OD profile system for expanded access. Valiant Navion is broadly indicated to treat all pathologies of the descending thoracic aorta, and leverages the proven design of the Valiant and Endurant stent graft system platforms.

Satellite Sessions The following Satellite Sessions have been supported by educational grants from industry partners:

Tuesday 16 April

• Coffee Symposium: The paclitaxel safety controversy - from patient-level data to big data: What the newest clinical evidence is telling us (Medtronic) • Coffee Symposium: Arterial and venous insufficiency treatment with RD Global innovative medical devices (RD Global) • Coffee symposium: Innovative solutions for the treatment of visceral arteries in complex aortic procedures (Gore) • Lunch Symposium: Optimising DCB results for long-term success (Philips) • Tea Symposium: Aortoiliac obstructive disease: Endoluminal solutions (Gore)

Wednesday 17 April

• Coffee Symposium: Expanding aortic treatment indications (Gore) • Coffee Symposium: The rationale and evidence for focal dissection repair (Intact Vascular) • Lunch Symposium: Over 15 years of experience with a reliable, proven, trusted balloon-expandable covered stent (Getinge) • Lunch Symposium: New technologies and multi-disciplinary approach: How I treat failing access in my ESRD patients (BD) • Tea Symposium: From infrarenal AAA to complex TAAA repair: Endovascular outcomes and future hybrid innovations (Terumo Aortic) • Tea Symposium: Data update on a safe and efficient DCB in lower limb (BD)

Thursday 18 April

• Coffee Symposium: A roundtable on global trends and outcomes in aortic arch repair (Terumo Aortic) • Coffee Symposium: Below the knee symposium (Cook Medical) • Lunch Symposium: The freedom to do more with a new conformable and low-profile thoracic endograft (Medtronic)

2019

129

Vascular & Endovascular Challenges Update

Dorsett Shepherds Bush

Hilton London Kensington K West Hotel & Spa

Novotel London West

Co

Hilton London Olympia

Grand Hall Olympia

K+K Hotel George

130 2019

Vascular & Endovascular Challenges Update

Travel connections and hotels Airports

Public transport

Gatwick Gatwick is easily accessed via the Southern service to Clapham Junction.

From Clapham Junction, change onto the London Overground which will take you direct to Kensington (Olympia).

Approximate journey time 45 minutes.

Nearest station: Kensington (Olympia) Turn left out of the exit of the station onto Olympia Way and follow signs for Olympia Grand.

Heathrow Heathrow is easily accessed via the Heathrow–Paddington, ‘Heathrow Express’, link. When you arrive at Paddington, take the District Line to West Brompton, then one stop to Kensington (Olympia) via the London Overground. Approximate journey time 40–50 minutes.

Delegates are advised not to bring their cars as parking is restricted.

London Overground Direct services run from West Brompton, Clapham Junction, Balham, East Croydon, Shepherd’s Bush, Watford Junction, Milton Keynes Central, Willesden Junction, West Hampstead and Stratford.

The entrance to Olympia Grand is opposite the station exit in Olympia Way. London Underground The District Line trains to Olympia operate during weekends only.

London Buses Bus routes 9, 27, 28 and 391 all stop directly outside Olympia National Hall on Hammersmith Road.

opthorne Tara Hotel

Holiday Inn High Street

The Rembrandt Hotel

The Baileys Hotel London Millennium Gloucester Hotel

DoubleTree

by Hilton

2019

131

Vascular & Endovascular Challenges Update

Notes

2019

133

Vascular & Endovascular Challenges Update

Notes

134 2019

Vascular & Endovascular Challenges Update

Notes

2019

135

Vascular & Endovascular Challenges Update

Monday 15 April

07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0

Pillar Hall Learning Centre Tuesday 16 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre

07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Peripheral Proximal Arterial Ischaemia Challenges – p22 Venous & Lymphatic Challenges – p25

● CX Aortic Techniques & Technologies (edited cases) – p3

● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 – p37 ● CX Thoracic Aortic Global Stars and Rising Stars and Abs Presentations – Day 1 – p40 ● CX Acute Stroke Abstract Presentations – p36

CX Peripheral Workshop CX Aortic Workshop Poster Gallery Wednesday 17 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre CX Venous City

07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Aortic Podium 1st Session – p52

● Periphe T&T – p

● LINC@CX – p58 ● CX Vascular Access Masterclass – p62 iWounds – p64

● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p70 ● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 – p73 ● Venous Day 1 – p6

CX Peripheral Workshop CX Aortic Workshop CX iWounds Workshop Poster Gallery Thursday 18 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre CX Venous City CX Vascular Access Workshop CX iWounds Workshop Poster Gallery

136 2019

07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Thoracic Aortic Challenges – p84 Peripheral Critical Ischaemia Challenges – p87 ● ● ● ● CX Innovation Showcase – p92 ● CX Abdominal Aortic Abstract Presentations – p104

European Vascular Surgeons in Training – Prize Session – p ● CX Venous Global Stars and Rising Stars and Abstract Presentations – p102

● Venous Day 2 – p9 CX iWoun

● CX Vasc. Acces (edited cases) –